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 Extraintestinal pathogenic Escherichia coli (ExPEC) is a subset of E. coli that has 
evolved the ability to successfully colonize multiple host niches. It spends most of its 
time as a commensal within the gut as a frequent member of the microbiota. When 
ExPEC disperses to extraintestinal sites, it can cause diseases such as urinary tract 
infections (UTIs), bacteremia, and neonatal meningitis. The cumulative impact of ExPEC 
infections is quite high given the sheer prevalence of UTIs and the severity of bacteremia 
and neonatal meningitis. A deeper understanding of ExPEC host colonization could lead 
to innovative therapies that would reduce the disease and financial burden imposed by 
this pathogen. Here, we investigate the bacterial genetics that underpin host 
colonization, searching for ExPEC genes that are required for persistence in the gut and 
infection of extraintestinal sites. We employed three separate approaches, each 
uncovering a bacterial function critical for host colonization. (1) We studied how rqlI 
contributes to bacterial fitness in vivo, and found that in the absence of RqlI, the activity 
of the helicase RqlH is toxic, creating DNA lesions that trigger the bacterial DNA repair 
response, inhibit growth, and induce mutations. We propose that RqlH and RqlI 
function together to modify or repair DNA. (2) A high-throughput screen was employed 
to find ExPEC genes necessary for metabolism of intestinal mucus, which is thought to 
provide nutrients to commensal E. coli in the gut. The beta-oxidation pathway, which 
breaks down fatty acids, was found to be an important aspect of mucus metabolism. The 
beta-oxidation pathway was disrupted by misregulation of the glycerol degradation 
pathway, as observed in the glpG mutant, a strain that exhibited a defect in gut
	 iv 
colonization. (3) To see if canonical extraintestinal virulence factors are important for 
gut colonization, several mutants were created and tested in vivo. A mutant in type 1 pili 
had reduced fitness, which was only partly attributable to an increase in flagellar 
expression. Hopefully our work, and similar future endeavors to understand the 





“At a time when microbiologic research has gained us so many laurels by following the 
research methods of Koch into the regions of the etiology and pathology of infectious 
diseases, it would appear to be a pointless and doubtful exercise to examine and 
disentangle the apparently randomly appearing bacteria in normal feces and the 
intestinal tract, a situation that seems controlled by a thousand coincidences.” 
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The Many Sides of Escherichia coli 
The German pediatric infectious disease physician Theodor Escherich was the 
first to describe the bacterium Escherichia coli, which he called Bacterium coli commune 
[1, 2]. Escherich observed E. coli in infant fecal samples using both a microscope and 
culturing techniques, and began characterizing its metabolic capabilities. Due to its 
convenient growth in the laboratory and its genetic tractability, E. coli became a critical 
model organism that was put to use in experiments that shaped our current 
understanding of molecular biology [3]. Most of this historical work, in addition to much 
of modern-day cloning, has been performed in nonpathogenic fecal isolates of E. coli. 
However, contained within the E. coli species are bacteria that exhibit a wide array of 
interactions with the host, ranging from commensals to pathogens, in addition to strains 
that can act as either depending on the context [3]. Several subclasses of E. coli induce 
disease in the gut, and are defined by the type of disease they cause and their mechanism 
of pathogenesis. For example, enterohemorrhagic E. coli (EHEC) can be acquired from 
contaminated bovine meat, and causes bloody diarrhea and hemolytic uremic syndrome 
[4]. Another E. coli pathotype is extraintestinal pathogenic E. coli (ExPEC), a gut 
commensal that causes disease at extraintestinal sites such as the blood and the urinary 
tract. The E. coli strains that constitute the ExPEC pathotype are the main focus of this 
work. 
 
The Diseases and Domiciles of ExPEC 
ExPEC can cause many types of infections outside of the intestinal tract, the most 
prevalent of which is the urinary tract infection (UTI). ExPEC infection of the urinary 
tract occurs in an ascending manner, with the bacteria climbing the urethra to the 
bladder, which is sometimes followed by transit up the ureters to the kidneys [5]. 
Bladder infection, known as cystitis, causes many symptoms, including painful 
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urination, suprapubic pain, a frequent and urgent feeling of needing to urinate, and 
cloudy urine [6]. Bladder infections are sometimes accompanied with infection of the 
kidneys, known as pyelonephritis, the symptoms of which include back pain, vomiting, 
fever, and nausea, in addition to the symptoms associated with cystitis [6]. UTIs are 
typically addressed in the outpatient setting, with a diagnosis that is based on symptoms 
and medical history, and that is confirmed with urinalysis. Treatment involves a short 
course of antibiotics to clear the infection. UTIs can either be acquired in the community 
or contracted during a hospital stay, most often from a catheter [7]. The overwhelming 
majority of community-acquired UTIs are caused by ExPEC, whereas ExPEC is the 
etiological agent in only ~13% of catheter-associated UTIs [8, 9]. 
The prevalence of UTIs is quite high, and in the year 2000 in the United States 
alone, UTIs accounted for over 8 million office visits and 350,000 hospitalizations [10]. 
UTIs afflict women more often than men, with more than half of all women experiencing 
a UTI at some point in their lives, whereas the lifetime incidence rate for men is only 
about 14% [11, 12]. Although the personal economic cost of UTI treatment is often small, 
the aggregate economic impact of these infections is enormous. It is estimated that per 
annum, it costs roughly $2.3 billion (2010 USD) to treat community-acquired UTIs, 
$350 million (2007 USD) for nosocomial UTIs, and $2.14 billion (2000 USD) to treat 
pyelonephritis [13-15]. It is clear that better preventative measures and new strategies to 
treat UTIs have the potential to reduce not only the disease burden, but also the 
detrimental economic effects. 
ExPEC are also capable of infecting the bloodstream where they cause more 
serious symptoms, including death. ExPEC is the most common cause of bloodstream 
infections worldwide, followed by Staphylococcus aureus and Streptococcus 
pneumoniae [16]. There are many routes through which ExPEC is able to access the 
blood. For example, newborns can become infected in utero or during birth with bacteria 
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originating from the mother’s genitourinary tract [17]. Early onset neonatal sepsis, which 
occurs during the first 2 days of life, afflicted an average of 165 newborns per 1,000 live 
births every year from 2005-2008 in the United States, with a mortality rate of ~11%. 
ExPEC was the second leading etiological agent of neonatal sepsis behind Group B 
streptococcus, but was the leading cause of death, accounting for ~25% of all mortalities.  
In adults, ExPEC can cause urosepsis, which is characterized by bacterial 
dissemination from the urinary tract to the bloodstream. Evidence that this occurs is 
given by the observation that usually when a patient suffers from a UTI and bacteremia 
simultaneously, the same ExPEC strain can be isolated from both the urine and blood 
[18]. In a large study of ~3,600 bacteremia cases, E. coli caused ~24% of episodes, with 
the most common origin of ExPEC being the urinary tract, leading to a mortality rate of 
2.6% [19]. Therefore, although the urinary tract is frequently a source of ExPEC, the 
mortality rate remains quite low for this type of bacteremia. 
Alarmingly, the incidence of bloodstream infections has been increasing over 
time in some parts of the world, partly due to an ageing population [20]. This older 
cohort may be especially susceptible to ExPEC accessing the blood from the gut, 
especially in cases where the gastrointestinal barrier is no longer efficient, as occurs 
during chemotherapy-induced neutropenia [21, 22]. In cancer patients that suffer from 
bacteremia, Gram-negative bacteria are often responsible for the infection, with E. coli 
being the most common organism [23, 24]. Furthermore, these E. coli isolates often 
carry ExPEC virulence factors, suggesting that ExPEC is the most common type of E. coli 
to cause disease in bacteremic cancer patients [25]. Evidence that these bacteria 
originate from the gut is that the infecting strain can be isolated from both the gut and 
the blood simultaneously [22]. 
No matter the route or type of extraintestinal infection, the first step appears to 
usually be gut colonization. Indeed, the gut is thought to be the primary animal niche for 
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ExPEC, and evidence indicates that many healthy humans are colonized by ExPEC. 
Much of what we know about ExPEC colonization of the human gut comes from 
epidemiological studies that analyze the predominant E. coli isolate from the feces of 
volunteers [26]. The analyses involve dividing E. coli into 4 main phylogenetic groups, 
including A, B1, B2, and D [27]. Strains within the B2 phylogroup are enriched with 
ExPEC virulence factors [28], and over 80% of B2 strains exhibit virulence in a mouse 
model of septicemia [29]. Therefore, the prevalence of B2 strains within the gut is often 
assumed to be a rough estimate for ExPEC abundance. In studies that limit the analysis 
to the predominant fecal E. coli isolate, a B2 strain is found to be the major member of 
the E. coli population in almost 30% of healthy subjects on average [26]. This is in 
agreement with a more refined approach that utilized qPCR to quantify the presence of 
each of the 4 phylogenetic groups simultaneously in a given sample, and which found B2 
to be the dominant group in 37% of cases [30]. B2 E. coli was present—dominant or 
otherwise—in 70% of the individuals [30], suggesting that the majority of healthy 
humans carry ExPEC within their gut. 
The high frequency at which ExPEC is a member of the microbiota may, in part, 
be due to its ability to persist within the gut. When the phylogroup of the predominant E. 
coli fecal isolate is tracked over time in individuals, resident strains most often belong to 
the B2 group [31, 32], suggesting that ExPEC may persist within the gut better than 
other E. coli subclasses. However, a similar longitudinal study in a different cohort did 
not find an association of gut persistence with B2 group strains, but the B2 strains in this 
study did not carry many ExPEC virulence factors, suggesting that the correlation 
between B2 and ExPEC may not have held true in this instance [33]. Taken together, 
these data point to the possibility that ExPEC are able to remain as members of the gut 
microbiota for extended periods of time. 
In addition to being the source of ExPEC for initial infection, the gut is likely a 
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reservoir for recurring UTIs. Two lines of circumstantial evidence support this idea.	
First, in patients suffering from recurring UTIs, the same strain frequently causes the 
initial and subsequent infections [34]. This observation indicates that a reservoir exists 
that is not sufficiently cleared by antibiotic treatment. Second, as mentioned above, the 
same ExPEC strain can be isolated from the feces and urine of patients suffering from 
acute UTI [35-38], suggesting some sort of transit between the two niches. When these 
observations are considered together, it is clear that the gut may be able to act as a 
source of ExPEC for both initial and subsequent infections. This hypothesis has not been 
carefully tested, and raises several questions, including why the gut reservoir would not 
be cleared by antibiotic treatment during the initial UTI. In addition to the gut, other 
reservoirs that drive recurring infection could exist, including bacteria residing inside of 
bladder host cells, or a source of ExPEC located within a sexual partner or a household 
pet [37, 39, 40]. 
 
The Elusive Genetic Definition of ExPEC 
An E. coli strain belongs to the ExPEC pathogenicity group if it is isolated from 
an extraintestinal site during infection. ExPEC is defined by its potential for causing 
extraintestinal disease because it is currently not possible to identify an E. coli strain as 
ExPEC based on its genetic content alone. This is in part due to the wide genetic diversity 
of the E. coli species, which can even surpass the genetic difference between two 
eukaryotic species. For example, the total divergence between chimpanzees and humans 
is estimated to be 4-6%, which can mostly be attributed to small indels [41, 42]. In 
contrast, when the two E. coli strains 536 and MG1655 are compared, they exhibit a 
larger degree of dissimilarity [43]. For example, about ¼ of the genes in 536 have no 
ortholog in MG1655. This observation can be generalized to the entire species as a whole, 
and is apparent in the E. coli pan-genome, the cumulative genetic content of all E. coli 
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strains. The pan-genome can be divided into two parts, including the core and accessory 
genomes. The core genome consists of ~3,000 genes that are shared between all E. coli 
strains, whereas the accessory genome includes the genes that are not shared with all 
other E. coli strains [44]. There are an estimated 16,000 genes included in the pan-
genome, and this number is expected to rise as more E. coli strains are sequenced and 
new accessory genes are discovered [44]. 
Because of the wide genetic diversity observed in E. coli, and therefore between 
ExPEC strains, there is no gene or set of genes that appear to define ExPEC. There are 
several virulence factors that have been associated with ExPEC strains epidemiologically 
[5], but the association is never perfect, and their role in virulence is not always 
concretely known. Instead of one common set of virulence factors, it is likely that there 
are several gene sets that could allow ExPEC to cause pathogenesis, and these sets may 
vary from one ExPEC strain to the next. There are several genes that are considered to be 
canonical ExPEC virulence factors, some of which will be examined in this work, 
including the adhesive organelles type 1 and P pili, the a-hemolysin toxin, and the 
plasmid pUTI89. 
Pili are extracellular organelles that extend from the bacterial outer membrane 
and mediate adhesion to surfaces via the adhesin protein found at their tip. For type 1 
pili, the adhesin protein is FimH, which mediates binding to mannose residues on 
glycosylated proteins [45]. Type 1 pili are considered a virulence factor due to their 
ability to mediate various steps in bladder infection, including binding to the 
uroepithelium, induction of host cell exfoliation, invasion into host cells, and formation 
of intracellular bacterial communities [39, 46, 47]. Although similar in structure to type 1 
pili, P pili constitute a different type of pilus that terminates with PapG, an adhesin that 
binds to glycosphingolipids found on the surface of host cell membranes [48]. Several 
studies indicate that P pili may facilitate kidney colonization by binding to the kidney 
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epithelium [49-51]. Although ExPEC encode and express many types of pili, type 1 and P 
pili are the best studied, which likely contributes to their status as canonical virulence 
factors. 
The a-hemolysin toxin HlyA is often associated with ExPEC, being present in 
about half of all UTI isolates, but only 5% of all fecal isolates [52]. The toxin is lipidated 
and then released via a type 1 secretion system prior to its interaction with host cells 
[53]. Once adsorbed to host cells, hemolysin can exert many effects, including both cell 
death and alterations of cell signaling. The full physiological effects of hemolysin during 
extraintestinal infection are not entirely clear, although it has been associated with 
virulence in various models [54, 55]. Furthermore, it alters host inflammation through 
many mechanisms including lysis of leukocytes [56]. Hemolysin may even cause 
inflammation during gut colonization [57], suggesting that ExPEC may not act as a 
harmless inhabitant of the microbiota at all times. 
Bacterial pathogens often carry and exchange plasmids that encode various 
virulence factors. The prototypical ExPEC isolate UTI89 propagates a ~114 kb plasmid 
called pUTI89 that contains the genes required for plasmid transfer, some potential 
virulence genes, and many genes with unknown functions [58]. This plasmid has since 
been observed in other ExPEC isolates [59]. When pUTI89 was removed from UTI89, 
the bacteria exhibited poor fitness within the urinary tract, especially at early time points 
[60]. Although some specific plasmid-encoded genes that contributed to in vivo fitness 
were implicated, much of the genetic content of pUTI89 remains enigmatic. 
There are many other ExPEC genes that have been labeled as virulence factors in 
addition to type 1 pili, P pili, a-hemolysin, and pUTI89. Comparative genomics can be 
used to study the origin and evolution of these virulence factors, and the pathogens that 
encode them. For example, a comparison between ExPEC isolates and non-pathogenic E. 
coli strains helped to define regions that are specific to the ExPEC isolates [61]. Many of 
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these regions were pathogenicity islands, which are large stretches of DNA that encode 
virulence factors (such as a-hemolysin). These regions contain hints that they were 
acquired through horizontal gene transfer from a different species. For example, the 
DNA in pathogenicity islands frequently have a GC content and codon bias that are 
uncharacteristic of E. coli [62]. As many ExPEC virulence factors can be found within 
these islands, it appears that the pathogenic nature of ExPEC is, in part, a product of the 
horizontal acquisition of genetic content from other bacteria. 
It is expected that factors newly obtained via horizontal transfer are subsequently 
more finely molded by the evolutionary pressures that ExPEC experience. Given that 
most host-associated ExPEC is found within the gut, and that a given ExPEC strain 
spends most of its history in the gastrointestinal tract, it has been proposed that the gut 
is the main evolutionary arena for ExPEC [29]. In contrast to the gut, extraintestinal 
niches such as the urinary tract represent a more transient ExPEC home with a limited 
transmission frequency. How does an extraintestinal virulence factor evolve, and how is 
it maintained in the genome, when it is used so infrequently in a pathogenic context? It 
has been proposed that the hypothesis of coincidental evolution could be applied to the 
ecology of ExPEC [29]. In general terms, coincidental evolution is when a factor that 
evolved for survival in one niche happens to be beneficial in another [63]. When applied 
to ExPEC, the resulting conclusion is that the utility of extraintestinal virulence factors 
outside of the gut is secondary to their primary function within the gut. Very little 
evidence exists to support or refute this idea. Many studies have correlated ExPEC 
virulence factors with persistence within the gut, but a causal link was never established 
[29, 32, 64]. Another study attempted to demonstrate that pathogenicity islands 
important for extraintestinal infection also contribute to gut colonization, but it was clear 
that deletion of the islands led to complicating effects (e.g. increased flagellar 
expression) that made the results difficult to interpret [65]. Overall, the meshing of 
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horizontal gene transfer and coincidental evolution forms an attractive model for the 
evolution of ExPEC virulence factors. 
 
“A Pointless and Doubtful Exercise” 
When Theodor Escherich lectured regarding his studies of gut microbes, he 
highlighted the overwhelming complexity that can be found within the gut microbiota: 
“…it would appear to be a pointless and doubtful exercise to examine and disentangle the 
apparently randomly appearing bacteria in normal feces and the intestinal tract, a 
situation that seems controlled by a thousand coincidences” [1]. Indeed, the gut 
microbiota is composed of hundreds of bacterial species—in addition to viral and fungal 
communities—and is influenced by host genetics, diet, and the immune system, in 
addition to many other factors [66-68]. Here, we take a focused approach to increasing 
our understanding of this complex ecosystem by endeavoring to define the genes that are 
important for one member of the microbiota to colonize the gut. 
Many strategies are employed in this work to uncover genes important for ExPEC 
gut colonization. We take a candidate gene approach by querying the role of 
extraintestinal virulence factors within the gut, effectively testing the hypothesis of 
coincidental evolution as applied to ExPEC. Additionally, a more unbiased approach is 
utilized by performing a forward genetic screen to find genes important for metabolism 
of intestinal mucus. The results from these various strategies begin to paint a picture of 
the mechanism of ExPEC gut colonization, touching on various processes including DNA 
maintenance, metabolism, and interactions with the host. 
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4.1 Introduction
 Escherichia coli express a variety of pro-
teinaceous structures known as pili or 
ﬁ mbriae that extend as hair-like ﬁ bres from 
the outer bacterial membrane. An adhesin 
protein located at the distal tip of each pilus 
ﬁ bre enables the bacteria to att ach to various 
surfaces, facilitating colonization of environ-
mental and host niches. In the case of 
uropathogenic E. coli (UPEC), type 1 pili 
(T1P) and P pili enable bacteria to bind to 
host epithelial cells within the urinary tract, 
which can lead to a urinary tract infection 
(UTI).
Several species of pathogenic bacteria 
can colonize and cause disease within the 
human urinary tract. However, UPEC are 
responsible for the overwhelming majority of 
UTIs (Ronald, 2002; Foxman, 2010). In 
general, UPEC colonize the urinary tract via 
an ascending route, moving from the urethra 
meatus through the urethra and into the 
bladder where they can cause cystitis (bladder 
infection) (Hannan et al., 2012). UPEC can 
then climb the ureters and initiate pye-
lonephritis (kidney infection). Cystitis and 
pyelonephritis patients typically suﬀ er from 
painful and frequent urination, while pye-
lonephritis patients can also experience more 
severe symptoms such as fever (Hooton, 
2012). UTIs are one of the most common 
infections seen in the outpatient sett ing, 
accounting for well over 8 million doctor 
visits annually in the USA alone (Schappert 
and Rechtsteiner, 2011). Fift y percent of 
women will have a UTI by age 32 (Foxman 
and Brown, 2003), and 44% of patients will 
have another symptomatic episode within 1 
year aft er initial infection (Ikaheimo et al., 
1996). The majority of UTI patients suﬀ er 
from cystitis, whereas only 4% of patients 
develop pyelonephritis (Ikaheimo et al., 1996). 
A small fraction of pyelonephritis infections 
will progress to urosepsis, in which UPEC 
disseminate systemically (Jolley et al., 2012). 
Colonization of the urinary tract by 
UPEC is expedited by T1P and P pili. UPEC 
att ach to the bladder epithelium (or 
urothelium) via T1P, where they can 
subsequently trigger their internalization 
(Mulvey et al., 1998; Martinez et al., 2000). 
Within the cytosol of bladder superﬁ cial cells 
– which are binucleate and relatively large – 
the bacteria form T1P-dependent bioﬁ lm-like 
aggregates referred to as intracellular 
bacterial communities (IBC) (Eto et al., 2006; 
Wright et al., 2007; Jorgensen and Seed, 2012). 
As UPEC replicate within the host cell, 
individual bacterial cells can detach from the 
IBC, exit the host cell, and go on to bind, 
invade and colonize neighbouring superﬁ cial 
or underlying cells (Fig. 4.1) (Mulvey et al., 
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pyelonephritis, P pili are important mediators 
of UPEC att achment to the kidney urothelium 
(O’Hanley et al., 1985). In addition to their 
adhesive properties, T1P and P pili also 
trigger host responses that result in the 
release of cytokines and the inﬂ ux of 
neutrophils (Fischer et al., 2006; Godaly et al., 
2007).
4.2 Genetics and Structure of Type 1 
and P Pili
T1P and P pili are encoded by the ﬁ m and pap 
loci, respectively (Fig. 4.2A). Each set of loci 
encodes an adhesin, structural and assembly 
proteins, and regulators of pilus expression. 
ﬁ mH and papG encode the adhesins of T1P 
and P pili, respectively, and are essential for 
pili function (Roberts et al., 1994; Connell et 
al., 1996). The structures of both pili are very 
similar (Fig. 4.2B), consisting of two parts: a 
helical rod and an adhesive ﬁ brillar tip 
(Kuehn et al., 1992; Jones et al., 1995). The 
rods, which are comprised of 1000 or more 
FimA or PapA pilin subunits, are about 7 nm 
in diameter and vary from a few fractions of a 
micron to more than 5 Pm in length. Each rod 
is anchored to the outer membrane through 
its interaction with the usher, a trans-
membrane pore-forming protein (Thanassi et 
al., 2012). Distally att ached to each rod is a 
thinner (~3 nm), much shorter tip ﬁ brillum 
made up of two to three adaptor proteins and 
an adhesin. During pilus biogenesis the 
structural subunits are translocated from the 
Fig. 4.1. Overview of bladder colonization by type 1-piliated UPEC. Pathogens enter the lumen of the 
bladder by an ascending route and subsequently bind and invade via T1P the large, binucleated 
superﬁ cial epithelial cells present on the apical surface of the urothelium. Some bacteria are quickly 
redirected back out into the bladder lumen, while others trafﬁ c to late endosome-like compartments 
where they can persist indeﬁ nitely in a quiescent state. Alternatively, UPEC can enter the host cytosol 
and rapidly multiply, forming IBCs. Infected superﬁ cial cells eventually die or exfoliate, taking with them 
large numbers of UPEC that can go on to infect other hosts or other sites within the urinary tract. 
Exfoliation, as well as the inﬂ ux of immune cells like neutrophils, can compromise the barrier function of 
the urothelium. This allows UPEC to invade the smaller immature cells of the urothelium, where they can 
establish long-lived reservoirs that can persist in the presence of robust inﬂ ammatory responses and 
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bacterial cytosol into the periplasm. A 
chaperone then stabilizes and delivers the 
subunits to the usher protein in the outer 
membrane. Finally, the usher protein 
mediates addition of new subunits to the 
growing pilus (Allen et al., 2012; Thanassi et 
al., 2012).
4.3 Type 1 Pili
4.3.1 Adhesion
T1P-mediated adhesion of UPEC to 
superﬁ cial cells of the urothelium is one of 
the ﬁ rst steps during the infection process 
and can lead to host cell invasion, intracellular 
bacterial replication and persistence. FimH 
binds mannose on glycosylated host receptor 
proteins (Abraham et al., 1985b; Krogfelt et al., 
1990). FimH binds mannose through a 
binding pocket within an N-terminal lectin 
domain, which is joined by a linker to the 
C-terminal pilin domain, the portion of the 
protein that connects FimH to the pilus 
(Choudhury, 1999; Schembri et al., 2000).
The receptors engaged during the course 
of a UTI are not yet completely detailed, 
although several cell-surface proteins that 
bind T1P have been identiﬁ ed in vitro. FimH 
can bind to the uroplakin protein UPIa (Zhou 
et al., 2001), which – along with at least three 
other uroplakin proteins – is important for 
maintaining the permeability barrier of the 
urothelium (Wu et al., 2009). Because of its 
abundance on the urothelial surface, UPIa 
may be the predominant receptor that is used 
by UPEC to initiate infection. High-resolution 
electron microscopy showing T1P engaging 
the uroplakin-covered urothelium within the 
bladder of a mouse infected with UPEC 
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uroplakin interactions (Mulvey et al., 1998). 
Cryo-electron microscopy demonstrated that 
FimH interactions with UP1a could trigger 
conformational changes within uroplakin 
complexes, possibly transducing signals into 
host bladder cells (Wang et al., 2009). 
Other proteins bound by T1P include the 
D3β1 integrin heterodimer, β2 integrin 
(CD18), CD48, the carcinoembryonic antigen-
related cell adhesion molecule (CEACAM) 
family of proteins, glycoprotein 2 (GP2), Toll-
like receptor 4 (TLR4), and the extracellular 
proteins ﬁ bronectin, collagen and laminin 
(Sauter et al., 1991, 1993; Gbarah et al., 1991; 
Sokurenko et al., 1992; Kukkonen et al., 1993; 
Baorto et al., 1997; Poutt u et al., 1999; Eto et al., 
2007; Mossman et al., 2008; Carvalho et al., 
2009; Hase et al., 2009; Yu and Lowe, 2009). 
These receptors exhibit distinct expression 
patt erns and localization. D3β1 is located at 
cellular junctions and elsewhere throughout 
all layers of the urothelium (Southgate et al., 
1995). CEACAMs are also found on the 
urothelial surface (Kuespert et al., 2006), and 
CEACAMs, β2 integrin and CD48 are present 
on the surface of immune cells such as 
neutrophils and macrophages (Gbarah et al., 
1991; Sauter et al., 1991; Baorto et al., 1997). 
Despite in vitro evidence for T1P interaction 
with these receptors, corroboration by in vivo 
experiments is still lacking.
Regardless of what host receptors T1P 
exploit, the interaction must be strong enough 
so as to withstand the shear forces produced 
by the bulk ﬂ ow of urine during micturition. 
Interestingly, the receptor binding aﬃ  nity of 
FimH rises as ﬂ ow increases (Thomas et al., 
2002, 2004). Under low ﬂ ow conditions the 
pilin domain of FimH inhibits the lectin 
domain in such a way that the mannose 
binding pocket is in a low aﬃ  nity state (Le 
Trong et al., 2010). As ﬂ ow increases, the 
linker between the two domains stretches, 
releasing the inhibition on the lectin domain, 
allowing the binding pocket to adopt a high 
aﬃ  nity conformation. Thus, as ﬂ ow increases 
FimH binds more tightly to its receptor, 
ensuring that the bacteria are not dispelled 
into the urine.
Although ﬁ mH displays a high degree of 
conservation among various E. coli isolates 
(Abraham et al., 1988; Weissman et al., 2006), 
diﬀ erent ﬁ mH alleles do exist that vary in 
their abilities to bind mannose (Sokurenko et 
al., 1995). This diversity in mannose-binding 
ability is linked with sequence variations in 
the lectin domain and linker, as well as 
alterations in composition of the type 1 pilus 
rod (Schembri et al., 2000; Hung et al., 2002; 
Mulvey, 2002; Thomas et al., 2002). FimH 
from most T1P+ E. coli – including those from 
the gut – are capable of binding trimannose, 
but UPEC-associated ﬁ mH alleles oft en have a 
higher binding aﬃ  nity for monomannose 
residues (Sokurenko et al., 1997, 1998). 
Phylogenetic evidence indicates that the ﬁ mH 
alleles carried by UPEC isolates evolved 
under positive selection from ﬁ mH alleles 
encoded by commensal strains within the 
intestinal microbiota (Sokurenko et al., 1998; 
Weissman et al., 2006). UPEC are believed to 
persist within the gut without eliciting any 
overt pathology, and many UPEC isolates 
found in urine closely match strains from the 
patient’s colon (Russo et al., 1995). Together, 
these data suggest a model in which faecal-
borne UPEC strains that make their way into 
the urinary tract experience pressures that 
select ﬁ mH alleles that can mediate higher 
aﬃ  nity interactions with receptors containing 
accessible monomannose residues. Since 
FimH makes up only a small portion of the 
gross T1P structure, it is theorized that ﬁ mH 
alleles in UPEC strains are not modiﬁ ed under 
selective pressure to evade antigenic recog-
nition by the immune system (Weissman et al., 
2006). Rather, the composition and abundance 
of speciﬁ c N-linked glycan receptors in the 
urinary tract probably help drive the selection 
process within individual hosts (Taganna et 
al., 2011). Overall, these sorts of observations 
suggest that UPEC express ﬁ mH alleles that 
are uniquely evolved for life in the urinary 
tract.
4.3.2 Exfoliation
The presence of bacterial antigens within the 
bladder can stimulate the detachment of 
superﬁ cial cells from the urothelium (Mulvey 
et al., 1998). This exfoliation process occurs 
via an apoptosis-like mechanism and pro-
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to dispose of infected host cells via the urine 
(Aronson et al., 1988; Mulvey et al., 1998). 
However, exfoliation temporarily exposes the 
deeper portions of the urothelium. This gives 
the bacteria the opportunity to bind and 
invade the underlying immature intermediate 
and basal epithelial cells of the urothelium 
where they may be able to evade the immune 
system and establish long-lived reservoirs 
(see below) (Mulvey et al., 2001). 
In mouse models of UTI, FimH is 
necessary to cause exfoliation, and the 
expression of FimH by non-pathogenic 
laboratory E. coli strains allows them to 
induce exfoliation in vivo, similar to UPEC 
(Mulvey et al., 1998). Binding of FimH to 
bladder epithelial cells can inhibit the anti-
apoptotic function of the host transcription 
factor NF-κB, contributing to the induction of 
apoptotic pathways (Klumpp et al., 2001, 
2006). Binding of FimH to UPIa may stimulate 
the exfoliation process by triggering pro-
apoptotic signalling cascades via eﬀ ects on 
the cytoplasmic tail of neighbouring UPIIIa 
proteins (Thumbikat et al., 2009). Secreted 
bacterial toxins like D-hemolysin and 
cytotoxin necrotizing factor 1 can also 
promote the exfoliation process, acting 
synergistically with type 1 pili (Mills et al., 
2000; Wiles et al., 2008; Dhakal and Mulvey, 
2012). While UPEC and laboratory E. coli 
strains that lack FimH fail to induce 
appreciably high levels of exfoliation in vivo, 
these bacterial strains can eﬀ ectively trigger 
exfoliation in ex vivo experiments using 
bladder tissue explants (unpublished ob-
servations). These results indicate that type 
1 pili can accelerate bladder cell exfoliation, 
possibly by keeping bacteria in close contact 
with host cells against the ﬂ ow of urine, but 
other as-yet-undeﬁ ned factors and signalling 
events likely initiate the process. 
4.3.3 Invasion
T1P-mediated adhesion of bacteria to 
urothelial cells can lead to internalization via 
an endocytic-like mechanism in which the 
host plasma membrane zippers around and 
envelopes bound bacteria (Mulvey et al., 1998; 
Martinez et al., 2000). Bacteria are then 
traﬃ  cked into acidic, late endosome-like 
compartments via a pathway that involves 
Rab27b, a regulator of vesicular traﬃ  c that 
has been implicated in the delivery of 
uroplakin complexes to the host cell surface 
(Chen et al., 2003; Eto et al., 2006, 2008; 
Mysorekar and Hultgren, 2006; Bishop et al., 
2007). Within immature bladder epithelial 
cells, UPEC typically remains bound in the 
endosomal compartments, which are oft en 
enmeshed within a matrix of actin ﬁ laments 
(Eto et al., 2006). These bacteria are highly 
resistant to antibiotics, many of which cannot 
cross host membranes and are ineﬀ ective 
against non-replicating microbes (Blango and 
Mulvey, 2010). UPEC can persist in a 
quiescent state within endosomal compart-
ments for many days to weeks, serving as 
potential reservoirs for recurrent, relapsing 
and chronic UTIs that aﬄ  ict many individuals 
(Mulvey et al., 1998, 2001; Hvidberg et al., 
2000; Kerrn et al., 2005; Mysorekar and 
Hultgren, 2006; Blango and Mulvey, 2010). 
The FimH adhesin within T1P stimulates 
bacterial internalization by causing host 
receptors and signalling complexes to cluster 
and activate at sites of att achment, but the 
speciﬁ c mechanisms remain incompletely 
deﬁ ned (Martinez et al., 2000; Dhakal et al., 
2008). Receptors implicated in the invasion 
process include UP1a and D3β1 integrin, 
though other receptors may also be involved 
(Eto et al., 2007; Wang et al., 2009). For 
example, complement and the host receptor 
for opsonized bacteria, CD46, can synergize 
with T1P to enhance bacterial internalization 
(Li et al., 2009). The recruitment of host 
receptors and subsequent activation of 
signalling cascades that lead to UPEC 
internalization is apparently modulated by 
cholesterol-rich membrane domains known 
as lipid raft s, which serve as staging sites for 
many signalling events in the host plasma 
membrane (Duncan et al., 2004; Eto et al., 
2008). T1P-mediated entry into host cells also 
requires actin rearrangements and, not 
surprisingly, many diﬀ erent host regulators 
of actin dynamics (Martinez et al., 2000; 
Martinez and Hultgren, 2002; Duncan et al., 
2004; Eto et al., 2007; Visvikis et al., 2011). 
These include Src and focal adhesin kinases, 
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to dispose of infected host cells via the urine 
(Aronson et al., 1988; Mulvey et al., 1998). 
However, exfoliation temporarily exposes the 
deeper portions of the urothelium. This gives 
the bacteria the opportunity to bind and 
invade the underlying immature intermediate 
and basal epithelial cells of the urothelium 
where they may be able to evade the immune 
system and establish long-lived reservoirs 
(see below) (Mulvey et al., 2001). 
In mouse models of UTI, FimH is 
necessary to cause exfoliation, and the 
expression of FimH by non-pathogenic 
laboratory E. coli strains allows them to 
induce exfoliation in vivo, similar to UPEC 
(Mulvey et al., 1998). Binding of FimH to 
bladder epithelial cells can inhibit the anti-
apoptotic function of the host transcription 
factor NF-κB, contributing to the induction of 
apoptotic pathways (Klumpp et al., 2001, 
2006). Binding of FimH to UPIa may stimulate 
the exfoliation process by triggering pro-
apoptotic signalling cascades via eﬀ ects on 
the cytoplasmic tail of neighbouring UPIIIa 
proteins (Thumbikat et al., 2009). Secreted 
bacterial toxins like D-hemolysin and 
cytotoxin necrotizing factor 1 can also 
promote the exfoliation process, acting 
synergistically with type 1 pili (Mills et al., 
2000; Wiles et al., 2008; Dhakal and Mulvey, 
2012). While UPEC and laboratory E. coli 
strains that lack FimH fail to induce 
appreciably high levels of exfoliation in vivo, 
these bacterial strains can eﬀ ectively trigger 
exfoliation in ex vivo experiments using 
bladder tissue explants (unpublished ob-
servations). These results indicate that type 
1 pili can accelerate bladder cell exfoliation, 
possibly by keeping bacteria in close contact 
with host cells against the ﬂ ow of urine, but 
other as-yet-undeﬁ ned factors and signalling 
events likely initiate the process. 
4.3.3 Invasion
T1P-mediated adhesion of bacteria to 
urothelial cells can lead to internalization via 
an endocytic-like mechanism in which the 
host plasma membrane zippers around and 
envelopes bound bacteria (Mulvey et al., 1998; 
Martinez et al., 2000). Bacteria are then 
traﬃ  cked into acidic, late endosome-like 
compartments via a pathway that involves 
Rab27b, a regulator of vesicular traﬃ  c that 
has been implicated in the delivery of 
uroplakin complexes to the host cell surface 
(Chen et al., 2003; Eto et al., 2006, 2008; 
Mysorekar and Hultgren, 2006; Bishop et al., 
2007). Within immature bladder epithelial 
cells, UPEC typically remains bound in the 
endosomal compartments, which are oft en 
enmeshed within a matrix of actin ﬁ laments 
(Eto et al., 2006). These bacteria are highly 
resistant to antibiotics, many of which cannot 
cross host membranes and are ineﬀ ective 
against non-replicating microbes (Blango and 
Mulvey, 2010). UPEC can persist in a 
quiescent state within endosomal compart-
ments for many days to weeks, serving as 
potential reservoirs for recurrent, relapsing 
and chronic UTIs that aﬄ  ict many individuals 
(Mulvey et al., 1998, 2001; Hvidberg et al., 
2000; Kerrn et al., 2005; Mysorekar and 
Hultgren, 2006; Blango and Mulvey, 2010). 
The FimH adhesin within T1P stimulates 
bacterial internalization by causing host 
receptors and signalling complexes to cluster 
and activate at sites of att achment, but the 
speciﬁ c mechanisms remain incompletely 
deﬁ ned (Martinez et al., 2000; Dhakal et al., 
2008). Receptors implicated in the invasion 
process include UP1a and D3β1 integrin, 
though other receptors may also be involved 
(Eto et al., 2007; Wang et al., 2009). For 
example, complement and the host receptor 
for opsonized bacteria, CD46, can synergize 
with T1P to enhance bacterial internalization 
(Li et al., 2009). The recruitment of host 
receptors and subsequent activation of 
signalling cascades that lead to UPEC 
internalization is apparently modulated by 
cholesterol-rich membrane domains known 
as lipid raft s, which serve as staging sites for 
many signalling events in the host plasma 
membrane (Duncan et al., 2004; Eto et al., 
2008). T1P-mediated entry into host cells also 
requires actin rearrangements and, not 
surprisingly, many diﬀ erent host regulators 
of actin dynamics (Martinez et al., 2000; 
Martinez and Hultgren, 2002; Duncan et al., 
2004; Eto et al., 2007; Visvikis et al., 2011). 
These include Src and focal adhesin kinases, 
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4.3.5 Regulation of type 1 pili expression
T1P undergo phase variation, in which the 
expression of the ﬁ m operon can be turned on 
or oﬀ  by an epigenetic mechanism (Abraham 
et al., 1985a). In vitro, individual bacterial cells 
in a population will switch expression of T1P 
on and oﬀ  at a low rate, resulting in a mixed 
population of T1P+ and T1P− cells (Freitag et 
al., 1985). Phase variation has also been 
observed in human infection (Kisielius et al., 
1989). The switch from one state to another is 
accomplished by a DNA recombination event 
in which the ﬁ m promoter is inverted by the 
recombinases FimB and FimE (Fig. 4.2) 
(Abraham et al., 1985a). FimE primarily 
changes the orientation from on to oﬀ , and 
FimB changes the orientation equally from 
oﬀ  to on and from on to oﬀ  (Klemm, 1986; 
McClain et al., 1991; Gally et al., 1996).
The expression of T1P is controlled by 
several transcription factors (Table 4.1). T1P 
synthesis is modulated via transcriptional 
regulation of the recombinases, and by 
alteration of the conformation of DNA to 
facilitate recombination. The conditions that 
induce expression of T1P are not well 
elucidated, but studies of T1P regulators 
suggest that nutrient availability and 
environmental stresses play key roles.
T1P phase variation is also driven by 
crosstalk with P pili. The P pili regulator PapB 
dampens the expression of T1P by up-
regulating expression of FimE and inhibiting 
the synthesis of FimB (Xia et al., 2000; Holden 
et al., 2006). Conversely, T1P expression is 
capable of inhibiting P pili expression (Snyder 
et al., 2005). The complexity of these regu-
latory networks is further exasperated if one 
considers potential crosstalk with other 
systems, such as those that control bacterial 
motility and chemotaxis (Simms and Mobley, 
2008; Cooper et al., 2012).
4.3.6 Relevance of type 1 pili in 
pathogenesis
There is overwhelming evidence that T1P are 
important in animal models of UTI. UPEC 
strains that express T1P are able to infect mice 
bett er than non-piliated strains (Hultgren 
et al., 1985; Schaeﬀ er et al., 1987). In 
competitive assays in which a speciﬁ c mutant 
bacterial strain is mixed one-to-one with the 
wild-type parent strain and injected into 
mice, Keith et al. (1986) found that mutants 
lacking functional T1P are outcompeted by 
wild-type bacteria within the bladder. In non-
competitive assays, ﬁ mH null mutants have 
reduced survival within the mouse urinary 
tract and are signiﬁ cantly less immunogenic 
(Connell et al., 1996). Blocking T1P att achment 
to the murine urothelium using soluble FimH 
receptor analogues like D-D-mannosides 
inhibits UPEC colonization (Klein et al., 2010; 
Cusumano et al., 2011; Jiang et al., 2012), as 
does passive immunization with antibodies 
directed against T1P (Abraham et al., 1985). 
Immunization of animals with puriﬁ ed pili 
or, even bett er, the puriﬁ ed FimH adhesin or 
antigenically modiﬁ ed variants of FimH can 
provide signiﬁ cant protection against 
experimental UTI (Silverblatt  and Cohen, 
1979; Silverblatt  et al., 1982; Langermann, 
1997; Poggio et al., 2006; Karam et al., 2012). 
These observations are underscored by 
results from an unbiased genetic screen in 
mice that showed T1P to be important for 
UPEC survival within the urinary tract 
(Bahrani-Mougeot et al., 2002), and microarray 
analysis of bacteria taken straight from the 
urine of infected mice indicating that T1P are 
upregulated during UTI (Snyder et al., 2004).
Evidence that T1P are crucial for UPEC 
colonization of the urinary tract in humans is 
less straightforward. Despite the fact that 
most UPEC isolates encode T1P (Norinder et 
al., 2012), several studies have found that T1P 
are oft en absent on the surface of E. coli strains 
present in urine samples collected from 
patients with UTI (Ofek et al., 1981; Pere et al., 
1987; Lim et al., 1998; Hagan et al., 2010). Such 
observations, coupled with the fact that T1P 
are also encoded by most commensal non-
pathogenic E. coli isolates within the gut 
(Hagberg et al., 1983), brings into question the 
role of T1P as virulence factors within the 
human host. The existence of a group of 
E. coli strains that cause asymptomatic bac-
teriuria (ABU) further questions the utility of 
T1P as mediators of bacterial colonization in 
the human urinary tract. ABU isolates can 
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Table 4.1 Regulators of T1P expression.
Regulator Description
Relevant environ-
mental signals T1P +/−
Mechanism of T1P regu-
lation Reference
RpoS Regulates genes 
important for 








− Inhibits transcription of 
ﬁ mB, inhibiting T1P 
expression
Dove et al. (1997)












− Activates transcription 
of ﬁ mE
















Blomﬁ eld et al. 
(1993), Aberg 
et al. (2008)












Aberg et al. 
(2008)
leuX tRNA that recognizes 
rare codons for 
leucine to facilitate 
translation
+ Facilitates the 
translation of ﬁ mB 
by recognizing rare 
leucine-encoding 
codons in ﬁ mB 
mRNA
Newman et al. 
(1994)
Lrp Regulates expression 
of genes important 
for survival during 
nutrient deprivation; 









bending DNA. It is 
biased towards the 
ON phase
Gally et al. (1993)
IHF Integration host factor, 
modulates 
transcription of 
genes by bending 
DNA








H-NS Supercoils DNA to 
silence genes with 
high A+T content
− Supercoils DNA, 
facilitates 
recombination 












− Stimulates DNA gyrase 
activity which 
supercoils DNA and 
inhibits transcription
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high numbers within the lumen of the 
bladder without causing any overt in-
ﬂ ammatory responses and without binding 
to or invading urothelial cells (Hull et al., 
1999; Bergsten et al., 2005; Klemm et al., 2007). 
These strains typically lack functional T1P 
and P pili, as well as many other factors that 
are oft en associated with UPEC isolates 
(Klemm et al., 2006). ABU strains can out-
compete more pathogenic UPEC isolates, and 
are being developed as therapeutic tools to 
interfere with UPEC colonization of the host 
(Falagas et al., 2008). The engineered expres-
sion of recombinant T1P by the prototypical 
ABU strain 83972 causes increased host 
inﬂ ammatory responses in a mouse UTI 
model, but this eﬀ ect was not observed in 
human volunteers (Bergsten et al., 2007). 
Furthermore, an older study concluded that 
the 83972 strain expressing T1P was rapidly 
outcompeted by the non-adherent wild-type 
83972 strain in the human urinary tract 
(Andersson et al., 1991). While informative, 
these results are diﬃ  cult to interpret because 
the patient volunteers had complicated 
histories of recurrent or chronic UTIs that 
were unresponsive to antibiotic therapy. 
Overall, these results indicate that T1P 
are not an absolute requirement for bacterial 
colonization of the human urinary tract. For 
example, ABU isolates can apparently 
employ alternate T1P-independent strategies 
to persist within the host, probably taking 
advantage of more robust metabolic path-
ways present within their streamlined 
genomes to grow more eﬃ  ciently within the 
extracellular urine-saturated milieu of the 
bladder. In the case of bona ﬁ de UPEC isolates, 
the necessity of T1P remains debatable. While 
UPEC strains present in the urine of patients 
with UTI do not always have T1P present, the 
expression of these ﬁ bres can almost always 
be induced when the strains are grown in 
broth culture (Ofek et al., 1981; Pere et al., 
1987; Lim et al., 1998; Hagan et al., 2010). It can 
therefore be argued that the free bacteria 
present in the urine simply have their T1P in 
the oﬀ  phase, while those in the on phase 
remain associated with the urothelium and 
allow UPEC to persist within the urinary 
tract and ultimately cause disease (Hultgren 
et al., 1985; Lim et al., 1998). Indeed, evidence 
that T1P-mediated adherence, host cell 
invasion and IBC development are critical to 
the progression of UTIs in humans is 
mounting, as exempliﬁ ed by data showing 
the remnants of IBCs within urothelial cells 
that are shed into the urine of women 
suﬀ ering from UTI (Rosen et al., 2007).
4.4 P Pili
4.4.1 Adhesion
P pili play a part in colonization of the urinary 
tract by mediating adhesion to the GalD1-
4Gal disaccharide moiety found on globo-
series glycosphingolipids located on the 
surface of host cell membranes (Leﬄ  er and 
Svanborg-Eden, 1981; O’Hanley et al., 1985; 
Wold et al., 1988). Because there is a strong 
correlation between P pili and pyelonephritis, 
P pili have mostly been studied in the context 
of kidney infection (Kallenius et al., 1981; Plos 
et al., 1990). However, GalD1-4Gal glycolipids 
are found throughout the entire urothelium 
(O’Hanley et al., 1985), suggesting that P pili 
may play a role in cystitis in some instances. 
The binding of P pili to glycosphingolipids in 
the urothelium is currently the only known 
function of P pili. They are dispensable for 
other events such as host cell invasion 
(Martinez et al., 2000).
Like T1P, P pili may enable UPEC to 
bett er withstand the shear ﬂ ow of urine. P pili 
can unwind in vitro to ﬁ ve times their length 
in a reversible manner (Gong and Makowski, 
1992; Bullitt  and Makowski, 1995; Thanassi et 
al., 1998; Fallman et al., 2005). It is hypothesized 
that this unwinding gives the pilus more 
ﬂ exibility during urine ﬂ ow, preventing the 
pilus from breaking or detaching from the 
urothelium.
The adhesive tip subunit of P pili, 
encoded by papG, is highly polymorphic. 
Distinct alleles of papG correlate with UPEC 
strains isolated from diﬀ erent host species, as 
well as speciﬁ c host-associated niches. These 
alleles have diﬀ ering aﬃ  nities for GalD1-
4Gal, depending on the topography of the 
glycolipid receptors present (Stromberg et al., 
1990). Class II papG alleles are found in 
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(Ott o et al., 1993; Johanson et al., 1993; Johnson, 
1998; Johnson et al., 1998a), while class III 
alleles are encoded by human cystitis isolates 
as well as canine UTI strains (Johanson et al., 
1993; Johnson et al., 1998b, 2000). Other papG 
allele classes are less common and litt le is 
known about their binding propensities.
4.4.2 Regulation of P pili expression
Similar to T1P and most other ﬁ mbrial 
adhesins, P pili are subject to phase variation, 
switching between an on and oﬀ  state (Blyn et 
al., 1989; Kisielius et al., 1989). The frequency 
of phase switching can vary greatly depend-
ent upon strain background and culture 
conditions (Holden et al., 2007). Unlike T1P, 
phase variation in P pili is driven by 
diﬀ erential methylation of the pap promoter 
and not by DNA recombination (Blyn et al., 
1990). Methylation occurs at two GATC 
sequences within the promoter. GATC sites 
are found throughout the entire genome and 
are typically recognized and methylated by 
the enzyme DNA adenine methyl trans ferase 
(Dam). When the site proximal to the papBA 
operon (GATCprox) is methylated, pap genes 
are transcribed and P pili are produced (Fig. 
4.3). Conversely, when GATCprox is un-
methylated and the distal GATC site 
(GATCdist) is methylated, the main pap 
promoter PBA is not activated and P pili are 
not made.
Binding of the Leucine-responsive 
protein (Lrp) modulates the diﬀ erential 
methylation of the pap promoter in an 
autoregulatory fashion by competing with 
Dam for binding sites within the pap (PBA) 
promoter (Braaten et al., 1992; Kawamura et 
al., 2011). There are six binding sites for Lrp 
within the pap promoter (Fig. 4.3), two of 
which overlap the GATCprox and GATCdist 
methylation sites. When GATCprox is methy-
lated, Lrp binds more readily to GATCdist 
where it can stimulate expression of PapI 
(Goransson et al., 1989). PapI promotes 
interactions between Lrp and distal Lrp 
binding sites within the promoter, allowing 
Dam and RNA polymerase access to proximal 
Fig. 4.3. Model of phase switching of pap genes by multiple regulators. Methylation (CH3) sites and 
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sites upstream of papBA and thereby 
activating P pili expression (Nou et al., 1993; 
Kaltenbach et al., 1995; Kawamura et al., 2011). 
Increased expression of PapB can result in re-
occupation of the proximal, higher aﬃ  nity 
Lrp binding sites, resulting in the inhibition 
of P pili expression. Although Lrp typically 
activates genes important for amino acid 
metabolism and nutrient transport (Newman 
and Lin, 1995), the activity of Lrp within the 
pap gene cluster is not responsive to leucine 
(Braaten et al., 1992). 
Transcription of papBA is inhibited by 
the response regulator CpxR, part of the Cpx 
two-component system that senses and 
responds to membrane stress and unfolded 
periplasmic proteins (Hung et al., 2001; 
Hernday et al., 2004). When misfolded pilin 
subunits are sensed, CpxR downregulates the 
expression of P pili by blocking Lrp-binding 
(Hernday et al., 2004). The papBA operon is 
also repressed by the histone-like nucleoid-
structuring protein H-NS (Goransson et al., 
1990; White-Ziegler et al., 1998), a global 
regulator that can preferentially silence the 
transcription of A+T-rich DNA sequences by 
inducing DNA supercoiling (Fang and 
Rimsky, 2008). Repression by H-NS is relieved 
by PapB and PapB-mediated eﬀ ects on PapI 
expression, as well as Catabolite Responsive 
Protein (CRP) (Baga et al., 1985; Forsman et 
al., 1989, 1992; Goransson et al., 1989). CRP 
enables UPEC and other bacteria to respond 
to changing carbon sources and may act to 
enhance P pili expression when glucose 
availability is low (Baga et al., 1985; Goransson 
et al., 1989; Forsman et al., 1992; Weyand et al., 
2001). 
DNA replication itself can also aﬀ ect 
phase variable expression of the pap operon. 
Aft er DNA replication, Dam methylates the 
new, unmethylated DNA strand at most of 
the GATC sites in the genome. However, 
GATC sites within the pap promoter are not 
optimal targets for Dam (Peterson and Reich, 
2006). Slower methylation of sites within the 
pap promoter enables Lrp to competitively 
bind to the GATC sequences, blocking their 
methylation by Dam and repressing P pili 
expression (Hernday et al., 2003; Peterson and 
Reich, 2008). These regulatory eﬀ ects are 
dependent upon the concentrations of Lrp, 
and are likely complicated further by myriad 
regulatory factors that come into play during 
the course of a UTI.
4.4.3 Relevance of P pili in pathogenesis
The importance of P pili in UTI has been 
shown in rodents, monkeys and humans. In 
mice, the delivery of P pili-speciﬁ c antibodies 
provides passive protection against kidney 
colonization by UPEC (O’Hanley et al., 1985). 
UPEC strains, and even faecal isolates, that 
express recombinant P pili can outcompete P 
pili-negative counterparts within the kidneys 
of mice (Hagberg et al., 1983), but in other 
work P pili expression in mice was in-
consequential to the ability of a prototypic 
UPEC isolate to cause pyelonephritis (Mobley 
et al., 1993). In monkeys, immunization with 
puriﬁ ed P pili can interfere with the ability of 
UPEC to cause pyelonephritis (Roberts et al., 
1984), and in at least one instance disruption 
of the papG allele was shown to att enuate 
UPEC colonization of monkey kidneys 
(Roberts et al., 1994). Corroborating these 
primate studies is work showing that human 
pyelonephritic strains are more likely to have 
the pap genes and express P pili than cystitis, 
ABU and faecal isolates (Kallenius et al., 1981; 
Plos et al., 1990). In some studies with human 
volunteers, transformation of the ABU strain 
83972 with pap genes enhanced bacterial 
growth, survival and inﬂ ammatory eﬀ ects 
within the urinary tract (Wullt et al., 2000, 
2001; Wullt, 2003), but no eﬀ ects were seen in 
a similar, older study (Andersson et al., 1991). 
These varying results may be att ributable to 
diﬀ erences in the expression constructs used, 
the speciﬁ c pap alleles examined and the 
medical histories of the patient volunteers. 
In total, these results from animal and 
human studies indicate that P pili expression 
can impact the establishment and progression 
of kidney infections, but this may vary 
dependent on both strain and host back-
ground. The precise mechanisms by which 
P pili promote bacterial colonization of the 
kidneys is not entirely clear, though recent 
work employing intravital imaging of 
infected rat kidneys suggest that P pili may 
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the proximal tubules of the kidneys (Melican 
et al., 2011). Speciﬁ cally, P pili seem to 
promote early colonization of the kidney 
tubules, allowing UPEC to resist ﬂ ow 
generated by ﬁ ltration processes within the 
kidneys. Later, T1P expression may help 
adherent bacteria within the tubules assemble 
into bioﬁ lm-like aggregates that are even 
more resistant to elimination.
4.5 Type 1 Pili, P Pili and the Immune 
Response
The immune response to UPEC is mostly 
mediated by innate defences, with T and B 
cells and other components of adaptive 
immunity playing a smaller and less well-
studied role (Ragnarsdott ir and Svanborg, 
2012). The innate response involves activation 
of patt ern recognition receptors such as TLR4 
and subsequent upregulation of pro-in-
ﬂ ammatory responses, including increased 
expression of cytokines like IL-6 and IL-8 
(Frendeus et al., 2001; Ragnarsdott ir et al., 
2011). IL-6 stimulates fever, increases the 
production of C-reactive protein to activate 
complement and stimulates B cells to secrete 
mucosal IgG (Ragnarsdott ir and Svanborg, 
2012). IL-8 is a chemokine important for 
recruiting neutrophils to sites of infection 
where they can target and kill bacteria 
(Haraoka et al., 1999). These inﬂ ammatory 
responses can be initiated by a panoply of 
pathogen-associated molecules, including 
lipopolysaccharide (LPS). LPS binds and 
activates TLR4 via association with the TLR4 
co-receptor CD14 (Palsson-Mcdermott  and 
O’Neill, 2004). Interestingly, human urothelial 
cells in both the kidneys and bladder lack 
membrane-bound CD14, but are still 
responsive to UPEC (Samuelsson et al., 2004). 
In vitro studies suggest that FimH, by binding 
TLR4 directly, may inadvertently present LPS 
to TLR4 and thereby bypasses the need for 
CD14 (Hedlund et al., 2001; Samuelsson et al., 
2004; Fischer et al., 2006; Mossman et al., 
2008). P pili can also stimulate TLR4 
signalling, though through a more circuitous 
pathway (Fischer et al., 2007, 2010). Rather 
than interacting with TLR4 directly, the 
engagement of glycosphingolipid receptors 
by P pili leads to the release of ceramide from 
the host cell and this in turn binds and 
activates TLR4 even in the absence of LPS 
(Hedlund et al., 1999; Fischer et al., 2007, 
2010). These processes may enable the 
urothelium to modulate its sensitivity to LPS, 
avoiding the activation of potentially 
damaging inﬂ ammatory responses unless 
truly virulent T1P- or P pili-positive patho-
gens are present (Samuelsson et al., 2004). 
Activation of TLR4 via T1P and P pili 
may also beneﬁ t UPEC by eliciting tissue 
damage that could facilitate bacterial 
dissemination within the host. UPEC strains 
display an ability to survive longer than non-
pathogenic E. coli strains within macrophages, 
neutrophils and mast cells, and could 
potentially hĳ ack these immune eﬀ ector cells 
as an additional means to spread within the 
urinary tract (Baorto et al., 1997; Shin, 2000; 
Nazareth et al., 2007; Bokil et al., 2011). The 
ability of some UPEC isolates to dampen 
inﬂ ammatory responses under some con-
ditions may enable the pathogens to ﬁ ne-tune 
the host environment over the course of an 
infection (Hunstad et al., 2005; Billips et al., 
2007; Wiles et al., 2008; Hilbert et al., 2008; 
Loughman and Hunstad, 2011, 2012; Dhakal 
and Mulvey, 2012). This is, however, a 
potentially dangerous game for UPEC, as T1P 
interactions with receptors on neutrophils, 
macrophages and mast cells can stimulate 
oxidative burst and other antibacterial 
responses (Sauter et al., 1991; Tewari et al., 
1993; Malaviya et al., 1999; Ashkar et al., 2008). 
These can include the release of antimicrobial 
peptides, which can work in conjunction with 
soluble proteins like Tamm-Horsfall Protein 
(THP) and secretory IgA (sIgA) that can bind 
FimH and block UPEC interactions with host 
cells (Wold et al., 1990; Bates et al., 2004; Mo et 
al., 2004). 
4.6 Conclusion
Data accumulated over the past few decades 
indicate that T1P and P pili are preeminent 
virulence and ﬁ tness factors utilized by many 
UPEC isolates to eﬀ ectively colonize host 
tissues within the urinary tract. Ongoing 
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organelles can function in a complex array of 
biological activities, ranging from epithelial 
cell att achment and invasion to bioﬁ lm 
formation and the modulation of host 
inﬂ ammatory responses. The central roles 
that these pili have as mediators of UPEC 
pathogenesis within the urinary tract has 
made them prime targets for the development 
of vaccines and other antimicrobial thera-
peutics. Future studies will undoubtedly 
highlight new ways in which these organelles 
can aﬀ ect the onset and progression of UTIs. 
It is likewise probable that the coming years 
will reveal eﬀ ects that T1P and P pili have on 
the ﬁ tness of both pathogens and commensal 
strains at sites outside of the urinary tract. 
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Abstract
Extraintestinal pathogenic Escherichia coli colonize the human gut and can spread to other
body sites to induce diseases such as urinary tract infections, sepsis, and meningitis. A
complete understanding of the infection process is hindered by both the inherent genetic
diversity of E. coli and the large number of unstudied genes. Here, we focus on the unchar-
acterized gene rqlI, which our lab recently uncovered in a Tn-seq screen for bacterial genes
required within a zebrafish model of infection. We demonstrate that the ΔrqlImutant experi-
ences a growth defect and increased DNA stress in low oxygen conditions. In a genetic
screen for suppressor mutations in the Δrql strain, we found that the shortcomings of the
Δrqlmutant are attributable to the activity of RqlH, which is known in other bacteria to be a
helicase of the RecQ family that contains a phosphoribosyltransferase (PRTase) domain.
Disruption of rqlH rescues the ΔrqlI strain in both in vivo and in vitro assays, while the
expression of RqlH alone activates the SOS response coincident with bacterial filamenta-
tion, heightened sensitivity to DNA damage, and an increased mutation rate. The analysis
of truncation mutants indicates that, in the absence of RqlI, RqlH toxicity is due to its
PRTase domain. Complementary studies demonstrate that the toxicity of RqlH is modulated
in a context-dependent fashion by overlapping domains within RqlI. This regulation is seem-
ingly direct, given that the two proteins physically interact and form an operon. Interestingly,
RqlH and RqlI orthologs are encoded by a diverse group of bacteria, but in many of these
microbes, and especially in Gram-positive organisms, rqlH is found in the absence of rqlI. In
total, this work shows that RqlH and RqlI can act in a strain-specific fashion akin to a toxin-
antitoxin system in which toxicity is mediated by an atypical helicase-associated PRTase
domain.
Author Summary
Extraintestinal pathogenic Escherichia coli (ExPEC) cause the majority of urinary tract
infections, and are also able to infect the bloodstream, meninges, and various other sites
within the human host. These infections are becoming increasingly difficult to treat as
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ExPEC strains gain resistance to many of the antibiotics that are commonly used in the
clinic. The development of improved treatment strategies requires a deeper understanding
of the factors that promote ExPEC fitness and virulence within the host. In genetic screens,
we identified a functionally uncharacterized protein, RqlI, which promotes ExPEC survival
within diverse host environments. We find that RqlI binds to and works in tandem with
RqlH, a protein that has been shown in other bacteria to unwind DNA. In the absence of
RqlI, we found that RqlH can become toxic to ExPEC, causing DNA damage and slower
growth. A specific part of RqlH that is predicted to manipulate the nucleotides that make
up DNA is responsible for this toxicity. The ability of RqlH to inhibit bacterial growth
when not held in check by RqlI suggests that the specific inactivation of RqlI could have
therapeutic value in combating ExPEC and other pathogens that express these proteins.
Introduction
Extraintestinal pathogenic Escherichia coli (ExPEC) comprise a group of E. coli strains that
harmlessly reside within the gastrointestinal tract, but that are capable of infecting extraintest-
inal niches such as the urinary tract, bloodstream, and meninges [1,2]. Urinary tract infections
(UTIs) alone constitute a major global economic burden due to the high incidence rate of
UTIs. Indeed, more than half of all women will experience a UTI during their lifetime [3], with
bladder infections being responsible for more than $2 billion in medical care costs in the
United States annually [4]. Additionally, E. coli is the leading cause of bacteremia [5], and is
especially problematic in high risk, immunocompromised populations such as the elderly [6,7]
and cancer patients undergoing chemotherapy [8]. E. coli is also the leading cause of death in
early-onset neonatal sepsis [9]. The burden imposed by ExPEC infection is expanding as the
prevalence of antibiotic resistant strains increases [10], highlighting the need for a deeper
understanding of ExPEC-mediated pathogenesis.
A major hurdle in deciphering the ExPEC life cycle is the genetic heterogeneity inherent in
these strains. Each ExPEC isolate contains ~5,000 genes, of which about half comprise a core
genome that is shared with most other E. coli strains [11]. The genes outside of the core
genome are much less conserved and account for the bulk of the genomic heterogeneity
observed among ExPEC isolates. This flexible genome is in large part a consequence of hori-
zontal gene transfer among ExPEC strains and other bacteria. The ExPEC pan-genome, which
includes all distinct genes found within ExPEC isolates, contains at least 14,877 genes [11].
Due to the dynamic nature of the pan-genome, this estimate is likely to increase as more iso-
lates are sequenced [12]. Because of the genetic differences from one ExPEC isolate to another
it is difficult to define a specific set of genes that are universally required for ExPEC fitness.
Complicating matters further is the fact that many ExPEC-associated genes are functionally
undefined. One method for dealing with the large number of uncharacterized genes is to
employ high-throughput analyses that can assay the role of many genes in a given condition
simultaneously. One especially useful technique is Tn-seq, in which a pool of transposon
mutants is placed under a selective pressure, and the quantity of individual mutant variants
before and after the selection are enumerated by next-generation sequencing [13]. Despite
their utility, these types of analyses often result in lists of genes that are required for fitness
under a given condition without yielding clear insight into the actual functions of individual
genes. For example, in a recent Tn-seq screen for factors that affect ExPEC fitness in a zebrafish
infection model, many of the 981 genetic elements that were found to be important for host
colonization had never been studied [14]. Annotations for 152 of the 981 loci (15.5%) that
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were identified as required for zebrafish colonization include the words “hypothetical” or
“putative”. In addition, given the limitations of the current pipelines used to annotate genes,
many more of the identified loci are likely misannotated [15]. Thus, understanding why a gene
is important for fitness under a given condition can be complicated. This problem can be par-
tially remedied by comparing overlapping datasets from high-throughput experiments carried
out in various defined conditions [16,17]. This strategy can help uncover roles for previously
undefined genes, but additional detailed analysis is still required to validate the high-through-
put data and to unambiguously specify gene function.
In our recent Tn-seq screen using the ExPEC cystitis isolate F11, we identified the hypothet-
ical gene EcF11_3933 as an important mediator of pathogen fitness during both localized and
systemic infections within the surrogate zebrafish host [14]. This gene, which we propose to
rename RecQ-Like Helicase Interactor (rqlI) for reasons that will become clear, was also critical
to the ability of F11 to colonize the mouse urinary tract and for pathogen survival in a mouse
model of sepsis. Considering the importance of rqlI to pathogen survival in diverse hosts and
host environments, we set out to define the specific function of RqlI. Here we report that RqlI
is especially critical for pathogen growth under low oxygen conditions, as found within many
host niches. In the absence of RqlI, the bacteria have higher mutation rates, increased activation
of the SOS stress response system, and decreased growth. These effects are remedied by dele-
tion of rqlH, a gene immediately upstream of rqlI that encodes RecQ-like Helicase (RqlH).
Deletion of rqlH also rescues the in vivo survival defects observed with the ΔrqlImutant in sev-
eral mouse models. Genetic and biochemical analyses indicate that a function of RqlI within
ExPEC is to limit the genotoxic effects of RqlH, which we mapped to an unusual phosphoribo-
syltransferase (PRTase) domain localized at the C-terminus of RqlH. Interestingly, we find that
RqlH and RqlI homologs are encoded by a diverse collection of bacterial species, though the
rqlH and rqlI genes are not always paired as in F11. These observations suggest that RqlI can
have both RqlH-dependent and RqlH-independent functions, and that these two proteins have
important roles in the life cycles of a wide range of bacteria.
Results
The ΔrqlI mutant exhibits a growth defect in microaerobic conditions
An initial analysis of the RqlI protein revealed the presence of three putative domains (Fig 1A).
First, RqlI is predicted to contain a molybdenum cofactor (MoCo) binding domain, which is
often found in proteins that facilitate metabolism in low oxygen environments [18]. For exam-
ple, MoCo facilitates redox reactions critical for using alternative terminal electron acceptors
when oxygen is scarce. Second, overlapping the MoCo binding domain is a region with homol-
ogy to the DNA-protecting protein DprA, which has been shown to be important for the
uptake of exogenous DNA in naturally competent bacteria [19]. Third, at the C-terminus of
RqlI is a helix-turn-helix motif predicted to bind DNA.
Given the involvement of MoCo in anaerobic respiration [18], and given the putative
MoCo-binding domain contained within RqlI, we disrupted the rqlI gene in the reference
ExPEC strain F11 and tested the ability of the mutant to multiply in varying oxygen levels.
When grown for 24 hours in a modified M9 minimal media exposed to atmospheric oxygen
(~20% O2), F11ΔrqlI exhibits a slight growth defect in comparison to the wild type (WT) strain
(Fig 1B). However, in microaerobic culture conditions (6–12% O2) growth of the ΔrqlImutant
was markedly worse thanWT (Fig 1B). This defect was rescued by complementation with the
RqlI expression plasmid pCWR16. Furthermore, we found that the exponential phase genera-
tion time of the ΔrqlImutant was very similar to WT cells under aerobic conditions, but was
3-fold greater than WT bacteria in a microaerobic environment (Fig 1C). Under microaerobic
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conditions, deletion of rqlI also limited the growth of two other reference ExPEC strains,
CFT073 and 536 (Fig 1D).
The SOS response is activated in the ΔrqlImutant during microaerobic
growth
We examined the general morphology of F11ΔrqlI using light microscopy and noticed that the
mutant cells were often longer (more filamentous) than WT bacteria (Fig 2A–2D). The elon-
gated ΔrqlI mutant cells were especially abundant, and reached greater lengths, under micro-
aerobic or anaerobic conditions (Fig 2B–2D). One reason for bacterial cell length to increase is
the induction of the SOS response, which is initiated when DNA damage is sensed [20]. The
Fig 1. Growth of rqlI deletionmutants is severely impaired in low oxygen conditions. (A) A schematic of
predicted domains and homology regions of RqlI. (B) WT F11 or F11ΔrqlI were grown either aerobically or
microaerobically for 24 h in a modified M9media, at which point the cultures were titered. Under microaerobic
conditions, strains that carried either an IPTG-inducible rqlI expression vector (pCWR16) or the empty vector
control (pRR48) were grown in the presence of IPTG. (C) WT F11 or F11ΔrqlIwere grown either aerobically
or microaerobically, and the cultures were titered at two different time points during exponential phase in
order to calculate generation times. (D) The indicatedWT and ΔrqlImutant ExPEC isolates were grown
microaerobically for 24 h and titered. Bars indicate mean values ± SEM from three or more independent
experiments performed in triplicate. *, P! 0.05; ***, P! 0.001; ****, P! 0.0001; as determined by
Student’s t test.
doi:10.1371/journal.ppat.1005317.g001
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SOS response involves the upregulation of sulA expression, which functions to temporarily
inhibit cell division while DNA repair occurs. Using a PsulA-GFP fluorescent reporter construct,
we found that F11ΔrqlI expressed markedly higher levels of sulA than the WT strain in aerobic,
microaerobic, and anaerobic conditions (Fig 2E). The differences in sulA expression levels
between WT and the ΔrqlImutant grew more pronounced with decreasing amounts of oxygen
in the culture. In control samples, sulA expression levels in the WT and ΔrqlI strains were
Fig 2. The rqlImutant experiences increased genotoxic stress, especially under low oxygen conditions. (A-D) WT F11 or F11ΔrqlIwere grown 24 h
aerobically, microaerobically, or anaerobically, at which point bacteria were spread on a slide and imaged. (A) Representative images. (B-D) Histograms
show the distribution of bacterial cell lengths after growth at varying oxygen levels. (E) WT F11 and F11ΔrqlI strains carrying either the PsulA-GFP reporter
plasmid (pJLJ3) or an empty vector control (pJLJ1) were grown aerobically ±mitomycin C, microaerobically, or anaerobically, as indicated. Fluorescence
measurements were normalized to culture densities. Bars indicate mean values ± SEM from three or more independent experiments performed in triplicate.
*, P! 0.05; **, P! 0.01; ***, P! 0.001; as determined by Student’s t test.
doi:10.1371/journal.ppat.1005317.g002
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similarly increased upon treatment with the DNA-damaging agent mitomycin C. These fluo-
rescent measurements were confirmed by western blots probed with GFP-specific antibody (S1
Fig). In total, these data demonstrate that in the absence of RqlI there is increased activation of
the SOS response, coincident with an oxygen-sensitive decrease in bacterial replication.
RqlH provokes the SOS response and inhibits bacterial growth in the
absence of RqlI
In order to understand why sulA expression is increased in the ΔrqlI strain, a screen was
designed to search for factors that promote SOS induction in the absence of RqlI (Fig 3A). An
F11ΔrqlIΔlacZY strain was transformed with plasmid pCWR2 containing the lacZ gene driven
by the sulA promoter, providing a convenient readout of sulA expression levels on tetrazolium
lactose plates. On these plates, high LacZ expression—reflecting high sulA promoter activity—
results in colonies with pink to white color, while low LacZ activity due to low sulA promoter
activity results in a red colony color. F11ΔrqlIΔlacZY/pCWR2 was randomly mutagenized
using themariner transposon from pSAM_Ec [14], and then plated onto selective tetrazolium
lactose plates. Approximately 20,000 colonies were screened for darker colony color, indicative
of a decreased SOS response. Transposon insertion locations were mapped in potential sup-
pressor mutants, and six independent insertions were identified within rqlH (Fig 3B). This
gene encodes a homologue of theMycobacterium smegmatis RqlH protein (MSMEG_5935), a
RecQ-Like Helicase that is known to unwind dsDNA in a 3’ to 5’ orientation [21]. The F11 and
M. smegmatis RqlH proteins align along their entire lengths, with 41.2% identity (55.7% simi-
larity) overall (S2 Fig). Interestingly—and perhaps, in retrospect, not surprisingly—the F11
rqlH gene is also found adjacent to rqlI on the genome (Fig 4A). To confirm the results of the
screen, rqlH and rqlI were deleted from F11, separately and in combination, and PsulA-GFP
expression levels were measured under low oxygen conditions (Fig 3C). As before, GFP expres-
sion levels in the ΔrqlI strain were higher than in WT F11, whereas strains lacking only rqlH or
both rqlH and rqlI had GFP levels equal to that of WT. These data indicate that in the absence
of RqlI, RqlH can trigger the SOS response, resulting in increased sulA expression.
To test whether the reduction in growth of F11ΔrqlI under microaerobic conditions could
also be attributed to RqlH activity, WT F11 and the ΔrqlI, ΔrqlH, and ΔrqlHI strains were
grown in low oxygen cultures. Relative to the WT strain, only the ΔrqlImutant grew poorly in
these assays (Fig 3D). In addition, we found that overexpression of RqlH caused a marked
reduction in bacterial growth under both aerobic and microaerobic conditions (S3 Fig). This
effect was seen regardless of genetic background, but was more pronounced in strains that
lacked RqlI. Together, these results indicate that RqlH activity in the absence of RqlI both
induces the SOS response and inhibits bacterial growth.
RqlH increases bacterial sensitivity to DNA damage in the absence of
RqlI
As the SOS response is activated by DNA damage and is responsible for initiating DNA repair
programs, we examined the abilities of the rqlI and rqlHmutants to deal with exogenous DNA
damage. WT F11 and mutant derivatives were treated with the DNA crosslinking agent mito-
mycin C and surviving bacterial cells were quantified. The ΔrqlImutant had increased sensitiv-
ity to mitomycin C, a defect that was again rescued in the ΔrqlHI double mutant strain (Fig 3E)
and by complementation with the RqlI expression plasmid pCWR16 (Fig 3F). A similar trend
was observed when the cells were treated with UV light. The ΔrqlImutant was more sensitive
to both 25 and 50 J/m2 of UV treatment, although this effect was only statistically significant at
25 J/m2 (Fig 3G). In contrast, the ΔrqlH and ΔrqlHImutants survived UV exposure at levels
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Fig 3. Mutation of rqlH rescues the rqlImutant defect in vitro. (A) A schematic of the screen used to search for suppressor mutations of the ΔrqlImutant.
Bacteria carrying a PsulA-lacZ reporter plasmid (pCWR2) were transposon-mutagenized and screened on tetrazolium lactose agar for suppressor mutants
with decreased sulA promoter activity, (distinguishable by darker colony color). (B) A tetrazolium lactose plate demonstrating the colony colors for WT,
F11ΔrqlI, and four independent F11ΔrqlIΔrqlH::tn transposon mutants that were isolated from the screen. (C) Bacteria carrying pJLJ3 (PsulA-GFP) were
grown microaerobically and GFP levels and culture densities were measured to quantify sulA expression. (D) Microaerobic growth of WT, ΔrqlH, ΔrqlI, and
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similar to the WT cells. These data indicate that the ΔrqlImutant is more sensitive to DNA
damage in a manner that is dependent on RqlH.
To determine if the increased sensitivity of the ΔrqlImutant to exogenous DNA damaging
agents correlates with a decreased ability to deal with endogenous DNA damage, spontaneous
mutation rates that resulted in nalidixic acid resistance were quantified using fluctuation assays
[22]. WT F11 and the ΔrqlI, ΔrqlH and ΔrqlHI strains all exhibited low mutation rates of
about 3 mutations per 1010 cells per generation when grown under aerobic conditions (Fig
3H). Growth under microaerobic conditions did not change the mutation rates for WT F11,
F11ΔrqlH, or F11ΔrqlHI, but resulted in nearly an 80-fold increase in the mutation rate of the
ΔrqlImutant. These data suggest that in the absence of RqlI, RqlH makes ExPEC more sensi-
tive to DNA damage and the accumulation of spontaneous mutations.
rqlH and rqlI are co-expressed in an oxygen-insensitive fashion
Since the rqlH and rqlI genes are located immediately adjacent to each other on the genome,
but are separated from upstream and downstream genes, it is likely that they form a two-gene
operon (Fig 4A). To test this idea, we performed RT-PCR using primer sets spanning the rqlH
and rqlI loci, as well as one set internal to rqlI, as depicted in Fig 4A. Products expected if rqlH
and rqlI are co-transcribed as part of the same transcript were obtained from F11 cDNA, but
were not seen in control reactions that lacked reverse transcriptase (Fig 4B). These results indi-
cate that rqlH and rqlI form an operon.
Given that the ΔrqlImutant defect is exacerbated by microaerobic conditions, we tested
whether rqlHI transcription is modulated by oxygen levels. Using primers that are specific for
rqlH, for rqlI, or that span rqlHI, we were unable to detect any changes in rqlHI expression in
microaerobic growth as compared to aerobic growth (Fig 4C). In contrast, we observed that
transcription of frdA, which is sensitive to oxygen levels [23], was significantly upregulated in
F11 grown under microaerobic conditions.
The PRTase domain of RqlH is genotoxic in the absence of RqlI
RqlH contains an N-terminal helicase domain as well as a C-terminal phosphoribosyltransfer-
ase (PRTase) domain that is unique among known helicases [21]. The functional importance
of the PRTase domain is unclear, though it is dispensable for the ATPase and helicase activities
of RqlH inM. smegmatis [21]. To define domain(s) within RqlH that are responsible for the
genotoxic effects observed in the absence of RqlI, we expressed epitope-tagged RqlH and sev-
eral mutant variants in the K-12 strain MG1655, which lacks both RqlH and RqlI. Expression
of each RqlH variant was confirmed by western blot (S4 Fig). The recombinant MG1655 strains
were diluted into modified M9 minimal media and grown for 6 h with aeration, at which point
the optical density (OD600) of each culture and the numbers of viable bacteria (CFU/mL) were
measured. Expression of the WT RqlH significantly reduced both the growth of MG1655 and
the numbers of CFUs recovered (Figs 5 and S5). RqlH expression also stimulated the formation
ΔrqlHI strains, as measured by dilution plating of 24 h cultures. (E) Bacteria were grown aerobically for 4 h, at which point mitomycin C was added to a final
concentration of 0.25 μg/mL for 1 h. The cultures were titered immediately before and 1 h after addition of mitomycin C, and survival was calculated. (F) WT
and ΔrqlI cells carrying either an empty vector control (pRR48), or the RqlI expression plasmid pCWR16 were grown and tested for mitomycin C survival as in
(E). (G) Bacteria were grown aerobically for 4 h, then diluted and spread onto plates to get ~100 colonies per plate. The plates were then exposed to various
levels of UV radiation and incubated overnight, at which time percent survival was calculated. In C-G, bars indicate mean values ± SEM from three or more
independent experiments performed in triplicate. *, P! 0.05; ***, P! 0.001; ****, P! 0.0001 in comparison with WT; as determined by Student’s t tests.
(H) Bacteria were grown either for 4 h aerobically or 24 h microaerobically. Aliquots from each culture were used to titer viable bacteria, and the remaining
cultures were plated onto agar containing nalidixic acid. The numbers of nalidixic acid resistant mutants recovered were used as input for FALCOR to
calculate mutation rates (number of mutations per 1010 cells per generation). Bars indicate mean values ± 95% confidence intervals.
doi:10.1371/journal.ppat.1005317.g003
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Fig 4. rqlH and rqlI are co-expressed and are not regulated by oxygen levels. (A) A schematic of the
rqlHI operon and surrounding genes, with the three primer sets used in (B) indicated. (B) RNA was isolated
from F11WT bacteria growing aerobically, and cDNA was made and used as template in PCRs using the
three primer sets indicated in (A). Each primer set was used with a sample lacking reverse transcriptase (RT)
as a control. Ladder band sizes are indicated at left. (C) F11WT bacteria were grown either aerobically or
microaerobically, RNA was isolated, and cDNA was made. Several primer sets were used in qRT-PCR
reactions to measure levels of frdA, rqlH, rqlI, and rqlHI transcripts under the two oxygen conditions. All
expression values were normalized to 16S rRNA. Bars indicate mean values ± SEM from three or more
independent experiments performed in triplicate. *, P! 0.05; as determined by Student’s t test.
doi:10.1371/journal.ppat.1005317.g004
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of filamentous bacteria and the induction of the SOS response, as determined by microscopy
and by use of the SOS reporter strain MG1655 attTn7::PsulA-GFP (Figs 5 and S6). As seen with
F11, the toxic effects of RqlH expression in MG1655 were negated by co-expression of RqlI.
Deletion of the C-terminal PRTase domain (amino acids 509–690) of RqlH abrogated the
growth-inhibitory and SOS-inducing effects of RqlH expression in the absence of RqlI (Figs 5,
S5 and S6). To examine the role of the PRTase domain more specifically, residues within
the putative phosphoribosylpyrophosphate binding pocket of RqlH were mutated. Two
PRTase domain variants were tested: one having four conservative amino acid substitutions
(DIVD663EVME; [24]) within the putative binding pocket and one having a single alanine
replacement (D663A). These residues were chosen based on alignments of RqlH with two
phosphoribosyltransferases, PurF and Hpt, and by overlaying the crystal structure of PurF with
the predicted structure of RqlH (S7 Fig). Expression of either the DIVD663EVME or D663A
RqlH mutant variants had no notable effects on bacterial growth, activation of the SOS
response, or filamentation, and had only modest inhibitory effects on the numbers of viable
bacteria recovered from the cultures (Figs 5, S5 and S6). These data indicate that the PRTase
domain is necessary for RqlH-mediated toxicity, and therefore the defects associated with the
ΔrqlImutant. However, expression of the PRTase domain alone was not sufficient to inhibit
bacterial growth and did not trigger activation of the SOS response or filamentation, suggesting
that additional elements within RqlH cooperate with the PRTase domain to promote toxicity
in the absence of RqlI (Fig 5).
To better understand the role of the helicase domain of RqlH, we tested two mutant proteins
with single amino acid substitutions (K49A and D148A) that were previously shown to abro-
gate RqlH helicase activity inM. smegmatis [21]. When these mutant proteins were expressed
in MG1655, the bacteria grew to a normal density, but low CFU counts were recovered from
the cultures (Figs 5 and S5). This reduction in CFUs coincided with increased activation of the
SOS response and the development of more filamentous cells by the K49A and D148A mutants
(Figs 5 and S6). The loss of viable CFUs was not rescued by co-expression of RqlI, though RqlI
did diminish the effects of the K49A and D148A mutations on activation of the SOS response
and filamentation. Titers were restored to WT levels if RqlH carried both the K49A mutation
Fig 5. The RqlH PRTase domain is required for SOS induction in the absence of RqlI and RqlH-associated helicase activity.On the left are schematic
representations of the domains within the F11 RqlH protein and mutant variants that were expressed in MG1655 cells. Table summarizes the effects of each
RqlH expression construct on bacterial growth (OD600), viability (CFU/ml), cell length, and SOS induction (determined using the reporter strain MG1655
attTn7::PsulA-GFP). Results are from 6 h shaking cultures in modified M9 media, and are normalized to control bacteria carrying the empty vector pBAD33.
#; phenotype is rescued by co-expression of RqlI. *; phenotype is exacerbated by co-expression of RqlI. See S5 and S6 Figs for full data.
doi:10.1371/journal.ppat.1005317.g005
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within the helicase domain and the D663A mutation within the PRTase domain (Figs 5 and
S5). These data suggest that both RqlI and the helicase domain of RqlH are required to keep
the PRTase domain of RqlH in check. However, it is clear that these regulatory interactions are
complex. As a case in point, the combined expression of RqlI with the double mutant RqlH
K49A/D663A protein leads to a reduction in bacterial titers without a coordinate decrease in
culture density, as seen with the single K49A and D148A RqlH single mutants. (Figs 5 and S5).
These data are further complicated by the fact that mutations within helicases often have domi-
nant-negative effects that disrupt DNAmetabolism [25].
The discordance between culture densities and bacterial CFUs observed with recombinant
strains that express the K49A or D148A RqlH mutants ± RqlI, or with bacteria that express
both RqlI and the RqlH K49A/D663A double mutant (S5 Fig), is likely in part attributable to
stress-induced inhibition of septation and the formation of filamentous cells. Filamentous bac-
teria will increase the optical density of a culture, but may register as fewer CFUs in plating
assays. In our experiments, recombinant strains that reached WT culture densities but had
much less than WT titers tended to have more filamentous bacteria (Figs 5, S5 and S6). For the
K49A and D148A mutants, filamentation in the absence of RqlI correlated with activation of
the SOS response, but this phenomenon was notably less pronounced when RqlI was also
expressed (S6 Fig). The co-expression of RqlI with the K49A/D663A RqlH mutant protein had
little effect on SOS activation, even though filamentation levels were elevated and CFU counts
were markedly reduced. These data indicate that SOS-dependent and SOS-independent fila-
mentation may contribute to the reduced CFU counts recovered following growth of strains
that express RqlH helicase domain mutants.
The discrepancies between cell culture densities and titers seen with some of the recombi-
nant strains could also be explained by the generation of anucleate cells or by plating deficien-
cies, whereby cells may grow well in broth culture but poorly when spread onto agar. To test
the former possibility, bacteria were stained using the fluorescent DNA dye Hoechst and
imaged. By microscopy, no cells that lack DNA were detected among any of the recombinant
strains examined (see S8 Fig as an example). To test for plating deficiencies, bacteria were
diluted into fresh LB broth culture at the end of a 6 h growth period and the OD600 was tracked
over time. Those strains that had decreased CFU counts at the end of the initial 6 h incubation
also had a lag in growth when sub-cultured 1:100 into fresh broth, as indicated in S5 Fig as an
increase in the time required to reach an OD600 of 0.4. These results suggest that the recombi-
nant strains that reach WT density levels in culture, but have reduced titers on agar, have fewer
viable cells and have no inherent plating deficiencies.
Overlapping domains within RqlI counter the toxicity of RqlH
As already noted, RqlI contains three putative domains, including a region of homology to
DprA, a MoCo binding domain, and a helix-turn-helix (HTH) domain (Fig 1A). To test
whether these various domains are required for RqlI function, plasmids encoding different
truncation variants of RqlI were created and transformed into F11ΔrqlI. Western blots indi-
cated that the recombinant RqlI proteins were expressed, though at varying levels (S9 Fig). As
shown in Fig 1B, the growth defect observed with F11ΔrqlI under microaerobic conditions can
be partially rescued by expression of the full-length RqlI protein (1–400; pCWR16 in Figs 6
and S10A). Expression of the N-terminus of RqlI plus the DprA homology region (1–250;
pCWR6) also partially rescued growth of F11ΔrqlI. Of note, the 1–250 RqlI mutant comple-
mented F11ΔrqlI much like the full-length RqlI even though relatively low levels of the trun-
cated protein were detected (S9 Fig). Nearly complete rescue of F11ΔrqlI was attained by
expression of an RqlI truncation mutant (1–320) that lacked the C-terminal 80 residues,
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including the putative HTH domain (Figs 6 and S10A). These results indicate that the HTH
domain is not needed for full RqlI activity under microaerobic conditions, and that the HTH
domain may instead actually be somewhat inhibitory to bacterial growth in these assays. In
contrast, the expression of RqlI deletion mutants that lack the HTH domain as well as the N-
terminal 129 or 84 residues adjacent to the MoCo binding and DprA homology domains did
not complement F11ΔrqlI.
We also examined the ability of the RqlI variants to abrogate the inhibitory effects of RqlH
expression on growth of MG1655 under aerobic conditions (Figs 6 and S10B). Paralleling
results obtained with F11ΔrqlI, the expression of RqlI truncation mutants that lack the HTH
domain as well as the N-terminal 84 or 129 amino acids were unable to counter RqlH, while
the production of full-length RqlI or the 1–320 truncation mutant effectively rescued growth of
RqlH-expressing MG1655. In contrast, the 1–250 RqlI truncation mutant that restored growth
of the F11ΔrqlI strain under microaerobic conditions was unable to block RqlH-mediated tox-
icity in MG1655 under aerobic conditions. In total, these results indicate that the HTH domain
is dispensable to the ability of RqlI to interfere with the toxic effects of RqlH under either aero-
bic or microaerobic conditions. It is also clear that the N-terminus, including both the DprA
and MoCo binding domains, is required for full RqlI activity in these assays. However, the C-
terminal portion of the putative MoCo binding domain is differentially required, potentially
dependent on strain background and/or oxygen levels.
The RqlH and RqlI proteins interact
To test whether the ability of RqlI to keep RqlH activity in check involves physical interaction
between the two proteins, co-immunoprecipitations were performed using MG1655 expressing
FLAG-tagged RqlI and HA-tagged variants of either full-length RqlH or a C-terminal trunca-
tion mutant (1–509) that lacks the PRTase domain (Fig 7). As expected, the RqlH and RqlI
proteins were not detected in the control strain carrying the empty plasmid constructs. Full-
length RqlH was co-immunoprecipitated with RqlI, and vice-versa, suggesting that these two
proteins do associate. This interaction was abrogated in bacteria that express the RqlH 1–509
truncation mutant, indicating that RqlI likely binds the PRTase domain of RqlH. As a control
Fig 6. Domains within the N-terminus of RqlI counter the toxicity of RqlH, independent of the putative HTH domain. The schematics on the left
indicate the locations of predicted domains and homology regions within RqlI and various truncation mutants. The table summarizes the effects of each RqlI
expression construct on F11ΔrqlI titers recovered from 24 h cultures grown microaerobically. Whether or not expression of a given RqlI variant significantly
increased bacterial titers in comparison to the empty vector control is indicated under “Microaerobic Rescue”. The “RqlH Inhibition” column indicates if a
given RqlI variant could counter the toxic effects of RqlH when expressed in MG1655 grown for 6 h under aerobic conditions. See S10 Fig for full datasets.
doi:10.1371/journal.ppat.1005317.g006
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for the specificity of the co-immunoprecipitation procedure, we note that the lac operon
repressor protein LacI, which is not expected to interact with either RqlH or RqlI, was not
pulled down in these assays.
RqlI is required for ExPEC persistence within the gut
Our finding that RqlI is an especially important regulator of RqlH toxicity under low oxygen
conditions (Fig 3D) fits well with previous work in which we showed that RqlI is critical to
ExPEC survival within the urinary tract and bloodstream [14]. These niches, like many sites of
infection, have limiting amounts of oxygen available for use by facultative anaerobes like
ExPEC. Since a primary reservoir of ExPEC within vertebrate hosts is the intestinal tract, in
which oxygen levels are generally low [26], we set out to determine if RqlI was also important
to the fitness of F11 within the gut. For these studies, we used marked strains that carried chro-
mosomal ClmR or KanR cassettes. Adult Balb/c mice were inoculated via oral gavage with 109
CFU of F11 or F11ΔrqlI, and survival was tracked by titration of fecal pellets on selective plates.
WT F11 persisted within the gut at fairly steady levels (medians ~106 CFU/g feces) for more
than 10 d, while titers of the ΔrqlImutant were significantly reduced as early as day 1 (Fig 8A).
By the end of the experiment, only 2 of the 10 mice that received F11ΔrqlI remained colonized
with the mutant. The persistence defect observed with F11ΔrqlI was also evident when the
mutant was co-inoculated 1:1 with WT F11. In these competitive assays, the WT strain out-
numbered the ΔrqlImutant by more than a 1,000-fold within 3 d (Fig 8B).
To test if RqlI is important for gut colonization by other ExPEC strains, rqlI was deleted
from the urosepsis isolate CFT073 and from the pyelonephritis isolate 536. In competition
assays, CFT073ΔrqlI titers within the intestinal tract were greatly diminished within 3 d of
inoculation, mirroring the situation seen with F11 (S11A Fig). While 536ΔrqlI was also defec-
tive in gut colonization, the decline of this mutant was more gradual and less pronounced,
decreasing about a 100-fold relative to the WT 536 strain by day 7 post-inoculation (S11B Fig).
These results, coupled with our previous findings [14], indicate that RqlI promotes the coloni-
zation and persistence of various ExPEC strains within distinct host environments, including
the urinary tract, the bloodstream, and the intestinal tract.
To determine if the in vivo defects observed with the ΔrqlImutants are attributable to the
disregulation of RqlH activities, as seen in our in vitro assays, F11 with a complete deletion of
the rqlHI operon was competed 1:1 against the WT F11 strain in our mouse models for gut col-
onization, UTI, and bacteremia. Following oral inoculation of Balb/c mice with a 1:1 mixture
of F11 and F11ΔrqlHI, fecal bacterial titers were tracked over the course of 50 days (Fig 8C).
Fig 7. RqlH and RqlI proteins physically interact.MG1655 bacteria that express full-length FLAG-tagged
RqlI and HA-tagged RqlH (either full-length RqlH or the 1–509 truncation mutant lacking the PRTase domain)
were grown for 4 h, then an additional hour in the presence of IPTG and arabinose, prior to lysis under non-
denaturing conditions. As a control, MG1655 carrying the empty vectors pRR48 and pBAD33 were
processed in parallel. Lysates were immunoprecipitated using anti-FLAG or anti-HA antibodies, and
immunoprecipitates were resolved by SDS-PAGE in preparation for western blot analysis. Aliquots (5%) of
the cell lysates that were used as input for the immunoprecipitations were also resolved. Immunoblots (IB)
were probed using antibodies specific for the FLAG or HA epitopes or for LacI, as indicated.
doi:10.1371/journal.ppat.1005317.g007
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Median competitive indices stayed close to zero throughout the experiment, indicating that the
ΔrqlHI mutant does not have a defect in mouse gut colonization, in sharp contrast to the single
Fig 8. Decreased fitness ofΔrqlImutants within diverse host niches is attributable to RqlH. (A) WT F11 or F11ΔrqlI were inoculated into Balb/c mice
via oral gavage and feces were collected, homogenized, and plated to determine bacterial titers at the indicated time points. For competitive assays, (B) F11
and F11ΔrqlI or (C) F11 and F11ΔrqlHI were mixed 1:1 prior to delivery into mice via oral gavage. Graphs show competitive indices (CI), as determined by
dilution plating of fecal homogenates on selective media at the indicated time points. (D) F11 and F11ΔrqlHI were inoculated transurethrally as a 1:1 mixture
into the bladders of Balb/c. CI values were calculated from bacterial titers recovered from bladders at 3 d post-inoculation. (E) F11 and F11ΔrqlHIwere mixed
1:1 and injected intraperitoneally into mice to initiate systemic infections. At 12 h post-inoculation, the spleen, liver, and a kidney were isolated from each
mouse, homogenized, and titered to determine the CI of the ΔrqlHImutant. Bars indicate median values.
doi:10.1371/journal.ppat.1005317.g008
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ΔrqlImutant. Defects previously observed with F11ΔrqlI survival within the bladder and the
bloodstream of mice [14] were also ablated if rqlH was deleted together with rqlI (Fig 8D and
8E). In total, these data indicate that the toxicity associated with RqlH expression in the
absence of RqlI in our in vitro assays is also manifest in vivo within diverse host environments.
Although the in vivo defects associated with the rqlImutant are not particularly surprising in
light of our in vitro findings, it is noteworthy that the in vivo effects are generally greater in
magnitude than those seen in vitro.
RqlH and RqlI orthologs are found across multiple genera, but are not
always linked
Given the close relationship between rqlH and rqlI that we observed in F11, we wondered if
these proteins are always present as a pair within bacterial genomes, if they are always adjacent
to one another, and if they are widely distributed among bacteria. A search for orthologs of
RqlH and RqlI was undertaken using NCBI sequence databases, followed by analysis of the
results using custom Python scripts. We defined an ortholog as a hit that aligns with at least
75% of the RqlI or RqlH protein sequence and that has a percent positive score of at least 50
and an E-value of 1e-06 or better. In addition, putative orthologs had to successfully return the
original query protein (RqlI or RqlH) as the top hit in reciprocal BLAST searches against F11.
For a list of RqlI and RqlH orthologs, and for the raw data used in our analysis, see S1 Dataset.
Our results indicate that RqlH or RqlI orthologs are distributed across a phylogenetically
diverse range of bacteria, with a total of 240 distinct genera represented in the analysis. Unex-
pectedly, the majority of bacterial strains (55.3%) encoded an ortholog of RqlH, but had no
detectable ortholog of RqlI (Fig 9A). There was also a small portion (1.2%) of the bacteria that
contained only RqlI. 43.5% of bacteria within the database encoded both RqlI and RqlH.
By analyzing different bacterial subsets, we found that there is a striking difference in the
distribution of RqlH and RqlI orthologs in Gram-positive versus Gram-negative. The majority
(87.9%) of Gram-negative bacteria encode both RqlI and RqlH, with just 9.7% carrying only
RqlH (Fig 9B). In contrast, nearly all (99.6%) Gram-positive bacteria encode only RqlH, while
the remaining few have both proteins (Fig 9C). Bacteria with only an RqlI ortholog were found
exclusively among the Gram-negative bacteria (Fig 9B). These observations were echoed in our
analysis of specific individual genera. For example, 98.6% of the Escherichia strains (Gram-neg-
ative) encode both RqlH and RqlI (Fig 9D), while very few have only RqlH or only RqlI. Strep-
tomyces species—like most other Gram-positive taxa—encode only RqlH, with no detectable
orthologs of RqlI in any of the strains (Fig 9E). This is also the case for all strains ofMycobacte-
rium smegmatis, the Gram-positive acid-fast species in which RqlH was first identified [21].
Within strains that have both rqlH and rqlI orthologs, we found that the genes are always
oriented with rqlH upstream of rqlI, reminiscent of the operon structure in F11. In most of
these strains, the start of rqlI is close to or overlapping with the terminus of rqlH, though in
some strains the two genes are separated by more than 2 kbp. Fig 9F shows examples of the var-
iable arrangements of rqlH and rqlI within divergent species. In Klebsiella oxytocaM5aI and
Pseudomonas aeruginosa VRFPA06, the rqlH and rqlI genes are closely associated, or even
slightly overlapping, whereas within the cyanobacterium Trichodesmium erythraeum IMS101
the two genes are separated by an unannotated 2196 bp sequence. Occasionally, we identified
other annotated elements inserted between the rqlH and rqlI loci, as in Shigella sonnei 53G
where sequences encoding the PRTase domain of RqlH have been separated from the helicase
domain by an insertion element and a putative transposase. Together, these observations dem-
onstrate that rqlH and rqlI orthologs, when found together within the same genome, are largely
syntenic with the F11 rqlHI operon. The exceptions to this arrangement, as in Shigella sonnei
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53G, may reflect alternate ways in which bacteria have evolved to modulate the potentially
toxic effects of RqlH expression.
Fig 9. RqlH and RqlI homologs are found across various genera, either alone or together. F11 RqlH
and RqlI homologs were found using blastp and tblastn searches of various NCBI sequence databases. (A-E)
Distribution of strains containing only a homolog of RqlI (green), only RqlH (red), or both RqlH and RqlI (blue).
The numbers of bacterial strains that are associated with each pie section are indicated, with totals given
beneath each graph. Included are (A) distributions of RqlH and RqlI orthologs in all strains, (B) among Gram-
negative bacteria, (C) among Gram-positive organisms, (D) within the Escherichia genus, or (E) as part of the
Streptomyces genus. (F) Examples showing the arrangements of rqlH and rqlI orthologs in different bacterial
species.
doi:10.1371/journal.ppat.1005317.g009
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This study was aimed at functionally defining EcF11_3933, a hypothetical gene that we previ-
ously identified as an important facilitator of ExPEC fitness in zebrafish infection models and
in mouse models of UTI and sepsis [14]. Homologs of this gene are also expressed by UPEC
isolates recovered directly from the urine of women with UTI [27]. Results presented here indi-
cate that the EcF11_3933 gene product, which we have renamed RqlI for RecQ-Like Helicase
Interactor, is able to bind to and modulate the activity of the RecQ-Like Helicase RqlH. We
propose a model in which RqlI and RqlH act cooperatively to perform an as-yet undefined ben-
eficial function on bacterial DNA (Fig 10). Although more work is required to further vet this
idea, the hypothesis is supported by several pieces of data. First, the RqlH homolog inM. smeg-
matis is known to be a helicase belonging to the RecQ family [21], which includes several heli-
cases that perform general maintenance functions on prokaryotic and eukaryotic genomes
[28]. Second, RqlH and RqlI physically interact (Fig 7) and are encoded within the same
operon (Fig 4A and 4B). Third, the ΔrqlImutant experiences several defects that are attribut-
able to RqlH activities, all of which involve phenotypes associated with DNA stress. These
include induction of the SOS response, increases in cell length (filamentation), higher sensitiv-
ity to DNA damaging agents, and elevated mutation rates (Figs 2 and 3). We suggest that in the
presence of a partially functional or disregulated RqlH-RqlI system, some harmful DNA
byproduct(s) is created that leads to a loss in cellular growth and viability (Fig 10B). Interest-
ingly, the defects associated with disruption of the RqlH-RqlI system are exasperated under
low oxygen conditions, suggesting possible links with anaerobic respiration and/or other
redox-sensitive processes.
Fig 10. In the absence of functional RqlI the PRTase domain of RqlH elicits genotoxic effects.Model
depicts a possible function for the rqlHI operon. (A) The PRTase domain of RqlH alters a nucleotide (red)
within the bacterial genome, and (B) RqlI functions to resolve this modified nucleotide (light blue) with the help
of the helicase domain of RqlH. The resolution event could include further modification of the nucleotide or
restoring the nucleotide to its original structure. (C) In the absence of RqlI, the PRTase domain of RqlH
continues to alter chromosomal nucleotides, but these modifications are not resolved, producing effects that
are toxic to the bacteria, resulting in the induction of the SOS response, cell elongation, growth inhibition,
heightened sensitivity to DNA damaging agents, and increased mutation rates. Many of these phenotypes
are intensified under low oxygen conditions for unknown reasons.
doi:10.1371/journal.ppat.1005317.g010
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Our observations and the model presented in Fig 10 raise a number of questions concerning
the RqlH-RqlI system. Chief among these is the question of function. We were unable to detect
any decrease in bacterial fitness in ΔrqlHImutants in our in vitro experiments or in mouse
models of infection, using either competitive or non-competitive assays (Figs 8 and S11). These
results may reflect limitations in the resolution of the mouse models, or their inability to reca-
pitulate all aspects of natural colonization and infection processes. For example, our assays
employed human ExPEC isolates that may use different strategies to colonize the human versus
the murine intestinal tract. The intestinal microbiota associated with humans and mice are
often similar at the phyla level, but can be quite different qualitatively and quantitatively at
lower taxonomic levels [29,30]. Such differences may affect the types of nutrients and stresses
encountered by ExPEC within the gut and could potentially influence the requirements for
genes like rqlHI. ExPEC are versatile organisms, and so it is also feasible that RqlH-RqlI are
important to the survival of these pathogens within environmental reservoirs or at other sites
that were not modeled in our study.
The key to understanding the role of the RqlH-RqlI system in bacterial physiology may be
the PRTase domain of RqlH. Indeed, RqlH is unique among helicases because it possesses a
PRTase domain in addition to its helicase domain. PRTase domains can be found in proteins
that function in nucleotide salvage pathways by adding phosphoribosyl groups to spent nucleo-
tides. As an example, the guanine-xanthine phosphoribosyltransferase (Gpt) of E. coli catalyzes
the addition of phosphoribosyl pyrophosphate (PRPP) to guanine to make the nucleotide gua-
nosine monophosphate (GMP) [31]. Given the combination of a helicase with a PRTase
domain in a single protein, it is tempting to speculate that RqlH functions to add PRPP directly
to DNA, or that it adds PRPP to nucleobases while in association with DNA.
The function of rqlHImay be related to uptake of foreign DNA, as there are at least two con-
nections between the RqlH-RqlI system and natural transformation in competent bacteria. First,
RqlI contains a region of homology to DprA, a protein that has been shown to protect ssDNA
during the translocation of foreign DNA into naturally competent bacteria [32]. Of note, in addi-
tion to the DrpA homology region within RqlI, F11 and other ExPEC isolates encode a DprA
protein that is more closely related to the canonical DprA. However, DprA has no detectable
effect on transformation in a K-12 E. coli strain [33]. The second connection to natural transfor-
mation is the PRTase domain of RqlH, a domain that is found in a number of proteins involved
in competence in other bacteria. In Bacillus subtilis, two proteins encoded by the comF operon
are suggestive of the functional domains contained within RqlH. Specifically, the comF operon,
which B. subtilis requires for competence, codes for a putative helicase and a predicted PRTase
separated by an intervening gene with no known domains [34]. The Com cluster of genes that
facilitate transformation inHaemophilus influenzae also includes a gene (ComF) that is homolo-
gous to the PRTase domain of RqlH, but it is seemingly not associated with any nearby helicase
[35]. Arguing against a role of the rqlHI operon in natural transformation is the fact that it is gen-
erally thought that E. coli is not naturally competent, though it can be made chemically compe-
tent or electrocompetent in a laboratory setting. Nonetheless, incidences of natural
transformation by E. coli have been reported [36,37], but we have been unable to detect any
transformation events using our ExPEC isolates, in agreement with a recent report [38].
In light of our results showing that RqlH is toxic to E. coli strains in the absence of RqlI (Fig
3), it was surprising to find that many bacteria carry RqlH but do not encode RqlI homologs
(Fig 9). In particular, nearly all Gram-positive organisms that encode an RqlH homolog lack
any identifiable RqlI ortholog (Fig 9C). These observations may be explained in several ways. It
could be that RqlH on its own is not inherently toxic to some bacteria (e.g. Gram-positive
microbes) due to differences in their physiology in comparison with ExPEC and the K12 strain
MG1655. It is also possible that bacteria that lack rqlI express different, less toxic rqlH alleles
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than found in bacteria that encode both genes. However, we did not detect major differences in
the sequences of RqlH proteins from bacteria that have just RqlH versus those with both RqlH
and RqlI. Finally, RqlH activity could be kept in check by other proteins that are more distantly
related to RqlI. In this same vein, it is interesting to note that RqlI orthologs are more prevalent
among known pathogens (83.3% of RqlI homologs are encoded by pathogens in the TEA
proteomic database; see [14]), while RqlH orthologs are much less often pathogen-associated
(39.1%). Altogether, these observations suggest that RqlH function could vary depending on
bacterial strain background and the presence or absence of RqlI.
The observation that RqlH expression in the absence of RqlI is toxic to E. coli strains is remi-
niscent of a type II toxin-antitoxin (TA) system. These TA systems consist of a protein toxin
that is more stable than its cognate antitoxin protein, which binds to and inhibits the toxin
[39]. TA systems were originally found encoded on plasmids where they promoted plasmid
maintenance. In any cell that spontaneously loses the plasmid, the TA system is no longer tran-
scribed, and the remaining toxin protein outlasts the residual antitoxin, resulting in bacterial
cell stasis or death. In this and other similar situations, TA systems can be thought of as selfish
genetic elements that function only to proliferate without providing any benefit to the host bac-
terium. More recently, TA systems have also been shown to have beneficial functions that can
protect bacteria from stressors. For example, TA systems can promote the formation of antibi-
otic-insensitive persister cells [39] and select TA systems in ExPEC can promote stress resis-
tance and colonization of the urinary tract [40].
Results presented here indicate that RqlH and RqlI can in many ways act like a TA system,
meshing with data from others showing that an RqlH ortholog (PsyrT) in Pseudomonas syrin-
gae is toxic to the bacteria in the absence of the RqlI ortholog PsyrA [41]. However, we note
that if RqlH and RqlI are to be defined as a TA system, it would be non-canonical for the fol-
lowing reasons: 1) RqlH and RqlI are much larger (698 and 400 amino acids, respectively) than
typical TA system proteins (~100 amino acids); 2) rqlH is situated upstream of rqlI, whereas in
most type II TA systems the antitoxin is encoded upstream of the toxin; and 3) an ΔrqlHI
mutant exhibits increased survival (persisters) in the face of antibiotic treatments (S12 Fig), in
contrast to the results obtained when bona fide TA systems are deleted [40]. Finally, we suggest
that the distribution among most bacteria of RqlH orthologs that are encoded in the absence of
RqlI argues against the possibility that the RqlH-RqlI system always functions as a TA-like
genetic element, although it can resemble one within ExPEC strains.
Cumulatively, this work illustrates the complexities of assigning function to hypothetical
genes that are identified as fitness determinants in high-throughput screens, such as Tn-seq.
The ability of RqlI to counter the oxygen-sensitive genotoxic effects associated with RqlH helps
explain why ExPEC strains are dependent on RqlI expression within the microaerobic confines
of the gut and other extraintestinal niches. Specifically, our work indicates that RqlI functions
to modulate the context-dependent toxicity of the RqlH helicase and its PRTase domain, but
opens up many more questions concerning the functional relevance of the RqlH-RqlI system
among ExPEC strains and of the numerous other RqlH and RqlI orthologs identified among
thousands of phylogenetically diverse species. Future analyses detailing the regulation and
functionality of the RqlH-RqlI system and its many homologs may provide the basis for novel
anti-bacterial therapeutics that can unleash the toxic potential of RqlH.
Materials and Methods
Ethics statement
Mice were handled in accordance with protocols approved by the Institutional Animal Care
and Use Committee at the University of Utah (Protocol number 10–02014), following US
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federal guidelines indicated by the Office of Laboratory Animal Welfare (OLAW) and
described in the Guide for the Care and Use of Laboratory Animals, 8th Edition.
Bacterial strains, media, and plasmids
The ExPEC strains used in this study included the cystitis isolate F11, the urosepsis isolate
CFT073 and the pyelonephritis isolate 536, as well as the K-12 strain MG1655 (S1 Table).
Manipulations of chromosomal DNA, including both the generation of knockout strains and
the knockin strain MG1655 attTn7::PsulA-GFP were achieved with lambda-Red-mediated
recombination using plasmid pKM208 [42]. Knockout strains were produced using PCR prod-
ucts containing ~40 bp overhang regions with homology to target loci. To create the MG1655
attTn7::PsulA-GFP reporter strain, a tetA-sacB cassette was amplified from T-SACK cells [43],
and combined via PCR with two 500 bp arms homologous to the attTn7 site downstream of
glmS. Next, the tetA-sacB cassette was replaced with the PsulA-GFP reporter from pJLJ3 with
selection on Tet/SacB counter-selection agar, as described [43]. Primers used to create knock-
out and knockin constructs, as well as those used for mutant confirmation, are listed in S1
Table. All PCR products were purified with the DNA Clean & Concentrator-5 kit (Zymo
Research, catalog #D4004). Where indicated, antibiotic resistance cassettes were removed
using the flippase-expressing pCP20 plasmid, as described [44].
Bacteria used for genetic manipulations were grown in LB broth, whereas bacteria used for
both the in vivo and in vitro experiments were grown in modified M9 media. The modified M9
media contained M9 salts (6 g/L Na2HPO4, 3 g/L KH2PO4, 1 g/L NH4Cl, and 0.5 g/L NaCl), as
well as 1 mMMgSO4, 0.1 mM CaCl2, 0.1% glucose, 0.00125% nicotinic acid, 0.00165% thia-
mine, and 0.2% casein amino acids.
All plasmids used in this study are listed in S2 Table. For previously unpublished plasmids,
the primers utilized in their creation are also indicated. RqlI expression vectors were created by
inserting PCR products into the PstI and HindIII sites of pRR48, under control of an IPTG-
inducible promoter [45]. RqlH expression vectors were made by insertion at the SacI and HindIII
sites within pBAD33, downstream of an arabinose-inducible promoter [46]. Plasmids were gen-
erated using standard cloning techniques, the QuikChange II XL Site-Directed Mutagenesis Kit
by Agilent Technologies, or by overlap extension PCR [47], as indicated in S2 Table.
Colonization of mice with ExPEC
Female Balb/c mice were purchased from Jackson Labs and used between 7–8 weeks of age,
and all experiments were performed in accordance with IACUC-approved protocols. All
mouse experiments were repeated at least twice, and the total combined data from six or more
animals is presented. Bacteria used to inoculate mice were grown statically at 37°C in 20 mL
modified M9 in 250 mL Erlenmeyer flasks for 24 h, pelleted by spinning at 8000 r.c.f. for 8 min,
washed, and resuspended in phosphate buffered saline (PBS). For competitive assays, WT and
mutant bacteria were mixed in equal parts prior to inoculation. These experiments used bacte-
ria carrying either a chloramphenicol or kanamycin resistance cassette, allowing them to be
easily selected and distinguished from other bacteria within the microbiota, and enabling the
facile tracking of individual WT and mutant strains in competitive experiments.
To assess intestinal colonization by the ExPEC strains and their mutant derivatives, mice were
orally gavaged with 50 μl of a bacterial suspension containing 1x109 CFU of bacteria in PBS.
Fecal samples were collected at various time points post-gavage, homogenized in 1 mL 0.7%
NaCl, and briefly spun to pellet any insoluble debris. Supernatants were then serially diluted and
plated on LB agar containing chloramphenicol (10 μg/ml) or kanamycin (50 μg/ml). Fecal
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samples were also collected and plated prior to gavage to ensure that the resident microbiota did
not include any culturable chloramphenicol- or kanamycin-resistant bacteria.
For the UTI model, mice were anesthetized using isofluorane inhalation and slowly inocu-
lated via transurethral catheterization with 50 μl of a bacterial suspension containing ~1x108
bacteria in PBS. After 3 d, the bladders were extracted and homogenized in PBS. Homogenates
were then serially diluted and plated.
To initiate bacteremia/sepsis, mice were injected intraperitoneally with 200 μl of PBS con-
taining ~1x107 bacteria. The animals were monitored for signs of extreme morbidity and
euthanized at 12 h post-inoculation. The livers, kidneys, and spleens were then recovered and
homogenized in PBS. Bacterial titers present within the various tissues were quantified by plat-
ing serial dilutions of the homogenates.
Bacterial growth and reporter assays
To quantify bacterial growth in various oxygen levels, bacteria were grown overnight in M9 in
loose-capped tubes, then subcultured the following day 1:100 in M9. During the subculture
stage, the bacteria were grown on a shaking incubator for 24 h in 12-well plates either in aero-
bic conditions or in a Mitsubishi AnaeroPack 2.5 L Rectangular Jar holding a AnaeroPack-
Microaero sachet or AnaeroPack-Anaero sachet to model microaerobic and anaerobic condi-
tions, respectively. To calculate generation time, the bacteria were titered at two time points
during exponential phase.
To measure sulA-GFP expression in F11 bacteria carrying the pJLJ3 plasmid or the pJLJ1
empty vector control, bacteria were grown overnight in loose-capped tubes in M9 with kana-
mycin, then subcultured 1:100 into fresh M9 with kanamycin. Cells were then grown microaer-
obically and anaerobically for 24 h in 12-well plates, or aerobically for 4 h in loose-capped
tubes. For the control conditions, mitomycin C was added to a final concentration of 0.25 μg/
mL in aerobic cultures at 3 h, and then incubated for another hour. Both GFP fluorescence and
the OD600 were measured using a BioTek Synergy H1 plate reader.
For experiments with the MG1655attTn7::PsulA-GFP strain carrying various RqlH mutant
proteins, the cells were grown overnight in M9 with ampicillin and chloramphenicol in loose-
capped tubes The bacteria were then subcultured 1:100 into M9 with ampicillin, chlorampheni-
col, IPTG (1 mM), and arabinose (0.05%), and incubated aerobically in loose-capped tubes for
6 h. A growth curve was performed by again subculturing cells after the 6 h growth period
1:100 into fresh LB. The OD600 was then read every 30 minutes by a Bioscreen C machine.
In the assays, 1 mM IPTG or 0.05% arabinose was added to the media to induce expression
of RqlI, RqlH or their derivatives.
DNA damage sensitivity assays
Following overnight growth from frozen stocks, F11, F11ΔrqlH, F11ΔrqlI, and F11ΔrqlHI were
diluted 1:100 into modified M9 media and grown with shaking (aerobically) for 4 h in loose-
capped tubes. After addition of mitomycin C (0.25 μg/mL), the incubations were continued for
one more hour. Bacterial titers before and after mitomycin C treatment were determined by
plating serial dilutions. Survival rates were calculated as the numbers of viable bacteria present
after mitomycin C treatment as a percent of bacteria present prior to addition of the toxin.
To assess strain susceptibility to UV irradiation, bacteria were grown aerobically in loose-
capped tubes from overnight cultures for 4 h at 37°C, then serially-diluted and spread onto LB
plates in order to obtain ~100 cells per plate. Plates were then exposed to 0, 25, or 50 J/m2 UV
light produced by a Stratalinker 1800. The plates were then incubated overnight and surviving
bacteria quantified.
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To visualize bacteria, 5 μl of cells (~5x107 cells) resuspended in PBS containing 1 μg/mL
Hoechst dye were spread on a glass slide and incubated at room temperature until the PBS had
evaporated. A drop of FluorSave Reagent was added to each slide and a coverslip was placed on
top. Bacteria were imaged by fluorescence or phase-contrast microscopy using an Olympus
BX51 microscope equipped with a 100X oil immersion objective and a QImaging QIClick
Cooled CCD camera. To measure cell lengths, straight-line measurements from one tip of a
cell to the other were made using ImageJ [48]. For each bacterial strain, 6–10 fields and more
than 200 bacteria were examined.
Transposon screen
A PsulA-lacZ reporter plasmid (pCWR2) was created by overlap extension PCR using a promo-
terless lacZ plasmid (pCWR1) as a template (S2 Table). The reporter plasmid was introduced
into F11ΔrqlIΔlacZY::clm, and the resulting strain was randomly mutagenized by conjugation
with EcS17/pSAM-Ec donor bacteria as described [14]. For conjugation, bacteria were grown
overnight in LB broth, and 1 mL of donor cells were mixed with 0.5 mL of recipient cells,
washed once with LB broth, and then spread onto an LB plate. After a 5 h incubation at 37°C,
bacteria were recovered from the plate surface, resuspended in 1 mL of LB broth, and diluted
1:100. Aliquots (100 μl) were plated onto tetrazolium lactose plates containing ampicillin,
chloramphenicol, and kanamycin to select for transposon-mutagenized F11ΔrqlIΔlacZY::clm/
pCWR2 bacteria. Colonies that were darker than the F11ΔrqlI ΔlacZY::clm/pCWR2 strain were
re-streaked onto new tetrazolium lactose plates to verify decreased PsulA-lacZ activity. Transpo-
son mutants that returned sulA expression to WT levels underwent a secondary screen in a
broth-based modified Miller assay, as described [49]. For mutants that exhibited decreased
sulA expression on both tetrazolium lactose plates and in the Miller assays, transposon inser-
tion sites were mapped by arbitrary PCR. Briefly, 30 μl colony PCR reactions were carried out
using the pSAM-EC kan us1 primer paired with each of the arbitrary primers ARB1A, ARB1B,
and ARB1C (S3 Table). The thermocycler program for this reaction was as follows: 95°C for 5
min; 5 cycles of 94°C for 30 sec, 30°C for 30 sec, and 72°C for 1:30; 30 cycles of 94°C for 30 sec,
45°C for 30 sec, and 72°C for 2 min; and ending with a 5 min incubation at 72°C. A 2 μl aliquot
of this reaction was then used as template in a second PCR reaction using the pSAM-EC kan
us2 and ARB2 primers, in a total volume of 50 μl. The second thermocycler program was as fol-
lows: 94°C for 2 min; 30 cycles of 94°C for 30 sec, 55°C for 30 sec, 72°C for 1:30; and then 72°C
for 5 min. The entire volume of this second reaction was resolved on an agarose gel, and the
largest distinct band was gel-purified and sent for Sanger sequencing using the primer pSA-
M-EC kan us3.
Fluctuation assays
Bacteria were grown overnight in modified M9 media and then sub-cultured 1:100 into several
1 mL cultures. These were grown for either 4 h aerobically in loose-capped tubes or for 24 h
microaerobically in 12-well plates. A few cultures were serially diluted and plated onto LB agar
to quantify the total number of cells. The entirety of each remaining culture was then spread
onto LB plates containing 20 μg/mL nalidixic acid. The following day, colonies were counted to
quantify total bacterial titers as well as the numbers of nalidixic acid resistant cells. Results
were analyzed by the online FALCOR calculator for fluctuation assays to determine mutation
rates [50].
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To probe for rqlHImRNA, WT F11 was grown aerobically for 4 h in loose-capped tubes in
modified M9 media after being diluted 1:100 from an overnight culture. RNA was extracted
from cells using a Norgen Total RNA Purification Kit, then treated with DNase for 1.5 h, pre-
cipitated, and resuspended in water. To create cDNA, 0.5 μg of RNA was used with the Super-
script III First-Strand Synthesis Kit (Life Technologies). Control reactions lacking reverse
transcriptase were run concurrently. The cDNA and control reactions were then used as tem-
plate in PCR reactions using two primer sets that spanned the rqlH and rqlI gene junction, or
with one primer set internal to rqlI (S3 Table). For RT-qPCR, RNA was extracted from bacteria
grow under aerobic or microaerobic conditions and cDNA produced as described above. A
LightCycler 480 instrument was used to run the qPCR reactions using primers specific to frdA,
rqlH, or rqlI, or primers that span rqlH and rqlI (S3 Table). Results were normalized to 16S
rRNA levels.
Co-immunoprecipitations and western blots
For analysis of protein complexes, a control MG1655 strain carrying the empty vectors pRR48
and pBAD33, or recombinant MG1655 strains expressing FLAG-tagged RqlI and HA-tagged
RqlH or the RqlH (1–509) truncation mutant were diluted 1:100 from overnight cultures into
20 mL minimal M9 media with ampicillin and chloramphenicol. After 4 h of growth at 37°C,
IPTG (1 mM) and arabinose (0.05%) were added to induce expression of RqlI and RqlH,
respectively. Cultures were grown for 1 h more and bacteria were then pelleted by centrifuga-
tion and frozen. After thawing, bacterial pellets were resuspended in 500 μL B-PER Bacterial
Protein Extraction Reagent (Life Technologies) containing 1X cOmplete protease inhibitor
cocktail (Roche), 1 mM PMSF, and 1 μL/mL Lysonase (Merck Millipore), and then incubated
at room temperature for 10 min. A small aliquot of each lysate was set aside for use as input
controls for the immunoprecipitations. Lysates were incubated with Dynabeads Protein G (Life
Technologies) pre-loaded with mouse anti-HA (Santa Cruz; SC-7392) or rabbit anti-FLAG
(Sigma Aldrich; F7425) antibodies. After three washes in PBS, bead-protein complexes were
resuspended in 30 μL sample buffer (4% sodium dodecyl sulfate [SDS], 20% glycerol, 0.02%
bromophenol blue, 10% 2-mercaptoethanol, 0.125 M Tris-HCl [pH 6.8]) and heated for 5 min
at 95°C in preparation for SDS–polyacrylamide gel electrophoresis (PAGE). Input controls
(5% of initial lysates) for the co-immunoprecipitation experiments were similarly prepared for
SDS-PAGE. Following electrophoresis, proteins were transferred to Immobilon-FL PVDF
membranes (Millipore) that were then probed using antibodies specific for the FLAG or HA
epitope tags or for LacI (AbCam; ab33832). Blots were developed using HRP-conjugated sec-
ondary antibodies with the BM Chemiluminescence Blotting Substrate (Roche) and imaged
using a BioRad ChemiDoc MP system.
To analyze expression of the epitope-tagged RqlH and RqlI proteins and their variants, or to
confirm GFP expression levels by the reporter strain MG1655attTn7::PsulA-GFP, bacterial cells
were lysed and protein concentrations were determined as described above. Proteins from each
sample were resolved by SDS-PAGE, transferred to PVDF membranes, and probed using anti-
FLAG, anti-HA, or anti-GFP (Santa Cruz; SC-9996) antibodies. Subsequently, blots were
stripped and probed using anti-E. coli antibody (BioDesign) to ensure equal protein loading.
Distribution of RqlH and RqlI proteins
To find homologs of RqlH and RqlI among other bacteria, the F11 sequence of each protein
was used as a query for an online blastp search using the non-redundant protein sequences
database. Additionally, tblastn searches were performed against the non-redundant nucleotide
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and whole genome shotgun databases in order to find unannotated orthologs that would not
be present in the non-redundant protein database. All BLAST searches were done with an
expect threshold cutoff of 1e-06, and custom Python scripts utilizing the Biopython module
[51] were used to parse the results. The hits were reciprocally blasted against the F11 proteome,
and those that brought back the original query protein (i.e. RqlH or RqlI) as the top hit, aligned
with at least 75% coverage, and had a percent positive score of at least 50, were defined as
homologs. The species that carried homologs of only RqlH, only RqlI, or both were enumer-
ated. To examine synteny of the rqlH and rqlI genes within bacteria that carried both genes,
only hits originating from the blastp search were considered. Protein GenBank records were
accessed via EFetch with Biopython, and parsed to obtain the accession numbers of the nucleo-
tide sequences containing each rqlH or rqlI ortholog and its location within its respective
genome. The gene locations were then compared to determine orientation and proximity of
rqlH and rqlI to each other.
Persister assays
Persister cell assays were performed as described [40]. Briefly, bacteria were diluted 1:100 from
overnight cultures into 5 mL of LB broth and then grown with shaking (225 rpm) at 37°C for 2
h. At this point, an aliquot of each culture was taken for CFU enumeration prior to addition of
ampicillin (100 μg/mL) or ciprofloxacin (10 μg/mL). After a further 5 h incubation, 1 mL of
each culture was pelleted, washed once with LB broth, and surviving bacteria were determined
by plating serial dilutions. Percent survival, reflecting the numbers of persister cells in each
sample, was calculated by dividing the number of viable bacteria present after antibiotic treat-
ment by the number present prior to antibiotic addition.
Statistics
Results from in vivo competition assays were analyzed by one sample T tests. Results from non-
competitive assays in mice were analyzed by Mann-Whitney two-tailed t tests. Results from in
vitro assays were analyzed by unpaired Student’s t tests. Prism 5.01 (GraphPad Software, Inc.)
was used for all statistical tests, including Student’s t tests. P values of less than 0.05 were
defined as significant.
Supporting Information
S1 Table. Strains used in this study. Includes a list of the strains used in this study and prim-
ers used to create and verify them, if applicable.
(PDF)
S2 Table. Plasmids used in this study. Includes a list of the plasmids used in this study. If a
plasmid was made for this study, the primers and method used to create it is included.
(PDF)
S3 Table. Other primer sets used in this study. Includes primer pairs used for RT-PCR, RT-
qPCR, and arbitrary PCR.
(PDF)
S1 Dataset. Analysis of RqlH and RqlI distribution and synteny. Contains a list of RqlH and
RqlI orthologous proteins and the genomic locations of their respective genes. Quantification
of the various genera that contain RqlH and RqlI orthologs, as well as a list of all of the genera
included in this analysis, are also presented.
(XLSX)
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S1 Fig. Activation of the SOS response in WT F11 and F11ΔrqlI under varying oxygen con-
ditions. F11 (WT) or F11ΔrqlI (Δ) were grown in modified M9 media aerobically for 4 h or for
24 h under microaerobic or anaerobic conditions. Upper western blot shows levels of GFP
expressed from strains carrying the SOS activation reporter construct PsulA-GFP (“GFP”;
pJLJ3) or the empty vector control containing a promoterless GFP (“EV”; pJLJ1). Below is the
same blot probed with anti-E. coli antibody, presented as a loading control.
(TIF)
S2 Fig. Alignment of the RqlH proteins of F11 andMycobacterium smegmatis. F11 RqlH
(EcF11_3932) and M. smegmatis RqlH (MSMEG_5935) were aligned by EMBOSS Needle
using the default settings. The protein alignment demonstrates that these two proteins have
41.2% identity and 55.7% similarity. The shading indicates various domains as delineated by
Ordonez et al [1] and as indicated in the legend at right.
(TIF)
S3 Fig. Overexpression of RqlH reduces bacterial growth, especially in the absence of RqlI.
Wild type (WT), ΔrqlH, ΔrqlI, and ΔrqlHI cells carried either a control plasmid (pBAD33) or
an arabinose-inducible rqlH expression plasmid (pCWR21). The cells were grown overnight in
M9 with chloramphenicol to maintain the plasmids, and then were subcultured 1:100 into
fresh M9 with chloramphenicol. The bacteria were then grown either aerobically for 4 h, or
microaerobically for 6 h, at which time the cultures were titered to determine bacterial concen-
tration. Arabinose (0.05%) was present in all cultures, added either at the time of subculturing
(microaerobic), or after 2 h of growth (aerobic). Graphs show mean values ± SEM from three
experiments performed in triplicate. !, P" 0.05; !!!!, P" 0.0001 as determined by Student’s
t test.
(TIF)
S4 Fig. Expression of WT and mutant RqlH proteins.MG1655attTn7::PsulA-GFP strains car-
rying the indicated RqlH expression plasmids or the empty vector pBAD33 were grown aerobi-
cally for 4 h in modified M9 media and then processed for western blot analysis. Upper blot
was probed with anti-HA antibody to detect the epitope-tagged RqlH variants. !, non-specific
background band present in all lanes. At the bottom is the same blot probed with anti-E. coli
antibody, presented as a loading control.
(TIF)
S5 Fig. The RqlH PRTase domain is responsible for loss of cell viability in the absence of
RqlI.MG1655 strains carrying the empty vector pRR48 or the RqlI expression plasmid
pCWR16 were transformed with pBAD33-based constructs encoding full-length RqlH or vari-
ous RqlH variants, as indicated. See Fig 5 for a schematic of the WT and mutant RqlH proteins
that are expressed. Strains were diluted from overnight cultures and grown aerobically in modi-
fied M9 media. After 6 h, the (A) density (OD600) and (B) number of viable bacteria (CFU/mL)
were determined and normalized to the control strain (EV) carrying the empty vectors pRR48
and pBAD33. Graphs show mean values ± SEM from three experiments performed in tripli-
cate. #, P<0.05 versus EV controls, as determined by Student’s t test. (C) Following the 6 h
growth period, each recombinant strain was diluted 1:100 into fresh modified M9 media and
aerobic growth in 100-well honeycomb plates was assessed using a Bioscreen C instrument.
The time that it took each culture to reach an OD600 of 0.4 is graphed versus the log10-trans-
formed data from (B). These assays were carried out in media with added IPTG and arabinose
to induce expression of the recombinant RqlI and RqlH proteins.
(TIF)
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S6 Fig. The RqlH PRTase domain is necessary to induce filamentation and the SOS
response in the absence of RqlI.MG1655 attTn7::PsulA-GFP carrying the empty vector pRR48
or the RqlI expression plasmid pCWR16 along with the indicated WT and mutant RqlH
expression constructs were grown aerobically for 6 h in modified M9 media. IPTG and arabi-
nose were included to induce expression of the recombinant RqlI and RqlH proteins, respec-
tively. See Fig 5 for a schematic of the RqlH proteins that are expressed. (A) Bacterial cells were
imaged and measured using ImageJ. Boxes indicate median and interquartile ranges with whis-
kers extending to the 1st and 99th percentiles. (B) Western blots indicate levels of GFP expres-
sion downstream of the sulA promoter in the recombinant strains ± RqlI, as indicated. As a
loading control, blots were stripped and re-probed using anti-E. coli antibody.
(TIF)
S7 Fig. Putative active site residues within the PRTase domain of RqlH. (A) PurF, Hpt, and
the PRTase domain of RqlH were aligned using T-Coffee [1]. Regions corresponding to the
active sites of the PurF and Hpt PRTases are shown with residues known to interact with a
nucleotide highlighted in red [2,3]. Residues within RqlH that are predicted to interact with a
nucleotide are highlighted in green. (B) A portion of the crystal structure of PurF showing the
nucleotide-binding pocket. Adenosine monophosphate (AMP) is highlighted in green, while
residues that interact with AMP are red. (C) The predicted structure of the RqlH PRTase
domain generated by Phyre2 [4] was overlaid with the crystal structure of PurF. The putative
nucleotide-binding pocket of RqlH is shown, in the same orientation as PurF AMP-binding
pocket depicted in (B). Residues within RqlH that are predicted to be important for PRTase
activity are highlighted in green (C).
(TIF)
S8 Fig. Mutation of RqlH does not result in the development of anucleate bacteria.
MG1655 attTn7::PsulA-GFP carrying pRR48 and either pBAD33 (empty vector, EV) or
pCWR23 (for expression of the RqlH K49A mutant protein) were grown aerobically for 4 h in
the presence of arabinose for the induction of RqlH expression. Bacterial DNA was stained
with Hoechst dye, and samples were imaged by bright field and fluorescence microscopy. Rep-
resentative images are shown. In the merged images, the DNA signal is false-colored yellow.
(TIF)
S9 Fig. Expression of recombinant full-length and truncated RqlI variants. F11ΔrqlI was
transformed with the empty vector pRR48 or with plasmids encoding FLAG-tagged full-length
RqlI (pCWR16) or different RqlI truncation mutants, as indicated. See Fig 6 for a schematic of
the RqlI variants examined. Strains were grown microaerobically for 24 h in modified M9
media. Ampicillin and IPTG were included for plasmid maintenance and for induction of RqlI
expression, respectively. Upper blot shows levels of RqlI and its variants, detected using anti-
FLAG antibody. !, non-specific background band. Below, as a loading control, is the same blot
probed using anti-E. coli antibody.
(TIF)
S10 Fig. The putative HTH domain of RqlI is dispensable, while the N-terminus is required
for inhibiting RqlH toxicity. (A) WT F11 or F11ΔrqlI carrying empty vector (EV, pRR48) or
constructs for expression of full-length and RqlI truncation mutants were grown microaerobi-
cally in modified M9 media for 24 h before titering. See Fig 6 for a schematic of the RqlI vari-
ants that were tested. Graph shows mean titers ± SEM from three experiments performed in
triplicate. !, P<0.05 versus F11ΔrqlI control, as determined by Student’s t test. (B) Cultures of
MG1655 expressing different RqlI variants with or without RqlH, as indicated, were grown aer-
obically for 6 h and then titered. Bars indicate mean titers ± SEM from three experiments
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performed in triplicate. !, P<0.05 versus MG1655 with empty vector (EV) control plasmids, as
determined by Student’s t test. In these experiments, arabinose and IPTG were added to the
media to induce expression of the RqlH and the RqlI variants, respectively.
(TIF)
S11 Fig. RqlI is required for gut colonization by the ExPEC isolates CFT073 and 536. Adult
female Balb/c mice were inoculated via oral gavage with 1x109 bacteria comprised of a 1:1 mix
of (A) WT CFT073 plus CFT073ΔrqlI or (B) WT 536 plus 536 ΔrqlI. Graphs show competitive
indices (CI), as calculated by dilution plating of fecal homogenates on selective media at the
indicated time points. Bars represent median values; n = 8 to 10 mice.
(TIF)
S12 Fig. Persister cell development by WT F11 and F11ΔrqlI. Graph shows the percentage of
surviving bacteria present 5 h after addition of ampicillin (100 mg/mL) or ciprofloxacin (10
mg/mL) to cultures in log-phase growth. Percent survival was calculated by titering cultures
before and after antibiotic treatments. Data represent mean results ± SD from three indepen-
dent experiments. !, P<0.05 as determined by Student’s t test.
(TIF)
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Figure 3.S1. Activation of the SOS response in WT F11 and F11ΔrqlI under 
varying oxygen conditions. F11 (WT) or F11ΔrqlI (Δ) were grown in modified M9 
media aerobically for 4 h or for 24 h under microaerobic or anaerobic conditions. Upper 
western blot shows levels of GFP expressed from strains carrying the SOS activation 
reporter construct PsulA-GFP (“GFP”; pJLJ3) or the empty vector control containing a 
promoterless GFP (“EV”; pJLJ1). Below is the same blot probed with anti-E. coli 









Figure 3.S2. Alignment of the RqlH proteins of F11 and Mycobacterium 
smegmatis. F11 RqlH (EcF11_3932) and M. smegmatis RqlH (MSMEG_5935) were 
aligned by EMBOSS Needle using the default settings. The protein alignment 
demonstrates that these two proteins have 41.2% identity and 55.7% similarity. The 
shading indicates various domains as delineated by Ordonez et al and as indicated in the 








Figure 3.S3. Overexpression of RqlH reduces bacterial growth, especially in 
the absence of RqlI. Wild type (WT), ∆rqlH, ∆rqlI, and ∆rqlHI cells carried either a 
control plasmid (pBAD33) or an arabinose-inducible rqlH expression plasmid 
(pCWR21). The cells were grown overnight in M9 with chloramphenicol to maintain the 
plasmids, and then were subcultured 1:100 into fresh M9 with chloramphenicol. The 
bacteria were then grown either aerobically for 4 h, or microaerobically for 6 h, at which 
time the cultures were titered to determine bacterial concentration. Arabinose (0.05%) 
was present in all cultures, added either at the time of subculturing (microaerobic), or 
after 2 h of growth (aerobic). Graphs show mean values ± SEM from three experiments 







Figure 3.S4. Expression of WT and mutant RqlH proteins. 
MG1655attTn7::PsulA-GFP strains carrying the indicated RqlH expression plasmids or the 
empty vector pBAD33 were grown aerobically for 4 h in modified M9 media and then 
processed for western blot analysis. Upper blot was probed with anti-HA antibody to 
detect the epitope-tagged RqlH variants. *, non-specific background band present in all 









Figure 3.S5. The RqlH PRTase domain is responsible for loss of cell viability 
in the absence of RqlI. MG1655 strains carrying the empty vector pRR48 or the RqlI 
expression plasmid pCWR16 were transformed with pBAD33-based constructs encoding 
full-length RqlH or various RqlH variants, as indicated. See Fig 5 for a schematic of the 
WT and mutant RqlH proteins that are expressed. Strains were diluted from overnight 
cultures and grown aerobically in modified M9 media. After 6 h, the (A) density (OD600) 
and (B) number of viable bacteria (CFU/mL) were determined and normalized to the 
control strain (EV) carrying the empty vectors pRR48 and pBAD33. Graphs show mean 
values ± SEM from three experiments performed in triplicate. #, P<0.05 versus EV 
controls, as determined by Student’s t test. (C) Following the 6 h growth period, each 
recombinant strain was diluted 1:100 into fresh modified M9 media and aerobic growth 
in 100-well honeycomb plates was assessed using a Bioscreen C instrument. The time 
that it took each culture to reach an OD600 of 0.4 is graphed versus the log10-transformed 
data from (B). These assays were carried out in media with added IPTG and arabinose to 








Figure 3.S6. The RqlH PRTase domain is necessary to induce filamentation 
and the SOS response in the absence of RqlI. MG1655 attTn7::PsulA-GFP carrying 
the empty vector pRR48 or the RqlI expression plasmid pCWR16 along with the 
indicated WT and mutant RqlH expression constructs were grown aerobically for 6 h in 
modified M9 media. IPTG and arabinose were included to induce expression of the 
recombinant RqlI and RqlH proteins, respectively. See Fig 5 for a schematic of the RqlH 
proteins that are expressed. (A) Bacterial cells were imaged and measured using ImageJ. 
Boxes indicate median and interquartile ranges with whiskers extending to the 1st and 
99th percentiles. (B) Western blots indicate levels of GFP expression downstream of the 
sulA promoter in the recombinant strains ± RqlI, as indicated. As a loading control, blots 







Figure 3.S7. Putative active site residues within the PRTase domain of RqlH. 
(A) PurF, Hpt, and the PRTase domain of RqlH were aligned using T-Coffee. Regions 
corresponding to the active sites of the PurF and Hpt PRTases are shown with residues 
known to interact with a nucleotide highlighted in red. Residues within RqlH that are 
predicted to interact with a nucleotide are highlighted in green. (B) A portion of the 
crystal structure of PurF showing the nucleotide-binding pocket. Adenosine 
monophosphate (AMP) is highlighted in green, while residues that interact with AMP are 
red. (C) The predicted structure of the RqlH PRTase domain generated by Phyre2 was 
overlaid with the crystal structure of PurF. The putative nucleotide-binding pocket of 
RqlH is shown, in the same orientation as PurF AMP-binding pocket depicted in (B). 
Residues within RqlH that are predicted to be important for PRTase activity are 








Figure 3.S8. Mutation of RqlH does not result in the development of 
anucleate bacteria. MG1655 attTn7::PsulA-GFP carrying pRR48 and either pBAD33 
(empty vector, EV) or pCWR23 (for expression of the RqlH K49A mutant protein) were 
grown aerobically for 4 h in the presence of arabinose for the induction of RqlH 
expression. Bacterial DNA was stained with Hoechst dye, and samples were imaged by 
bright field and fluorescence microscopy. Representative images are shown. In the 



















Figure 3.S9. Expression of recombinant full-length and truncated RqlI 
variants. F11ΔrqlI was transformed with the empty vector pRR48 or with plasmids 
encoding FLAG-tagged full-length RqlI (pCWR16) or different RqlI truncation mutants, 
as indicated. See Fig 6 for a schematic of the RqlI variants examined. Strains were grown 
microaerobically for 24 h in modified M9 media. Ampicillin and IPTG were included for 
plasmid maintenance and for induction of RqlI expression, respectively. Upper blot 
shows levels of RqlI and its variants, detected using anti-FLAG antibody. *, non-specific 








Figure 3.S10. The putative HTH domain of RqlI is dispensable, while the N-
terminus is required for inhibiting RqlH toxicity. (A) WT F11 or F11ΔrqlI 
carrying empty vector (EV, pRR48) or constructs for expression of full-length and RqlI 
truncation mutants were grown microaerobically in modified M9 media for 24 h before 
titering. See Fig 6 for a schematic of the RqlI variants that were tested. Graph shows 
mean titers ± SEM from three experiments performed in triplicate. *, P<0.05 versus 
F11ΔrqlI control, as determined by Student’s t test. (B) Cultures of MG1655 expressing 
different RqlI variants with or without RqlH, as indicated, were grown aerobically for 6 h 
and then titered. Bars indicate mean titers ± SEM from three experiments performed in 
triplicate. *, P<0.05 versus MG1655 with empty vector (EV) control plasmids, as 
determined by Student’s t test. In these experiments, arabinose and IPTG were added to 







Figure 3.S11. RqlI is required for gut colonization by the ExPEC isolates 
CFT073 and 536. Adult female Balb/c mice were inoculated via oral gavage with 1x109 
bacteria comprised of a 1:1 mix of (A) WT CFT073 plus CFT073ΔrqlI or (B) WT 536 plus 
536 ΔrqlI. Graphs show competitive indices (CI), as calculated by dilution plating of fecal 
homogenates on selective media at the indicated time points. Bars represent median 








Figure 3.S12. Persister cell development by WT F11 and F11ΔrqlI. Graph shows 
the percentage of surviving bacteria present 5 h after addition of ampicillin (100 mg/mL) 
or ciprofloxacin (10 mg/mL) to cultures in log-phase growth. Percent survival was 
calculated by titering cultures before and after antibiotic treatments. Data represent 
mean results ± SD from three independent experiments. *, P<0.05 as determined by 
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Extraintestinal pathogenic Escherichia coli (ExPEC) benignly colonizes the 
mammalian gut, but can disperse to extraintestinal sites to cause disease. As inhabitance 
of the intestine is often a prerequisite for ExPEC-mediated pathogenesis, we set out to 
understand how ExPEC colonizes this niche. A Tn-seq screen was performed to search 
for genes within the ExPEC isolate F11 that are important for growth in intestinal mucus, 
which is thought to be a source of nutrients for commensal E. coli in the gut. Several 
genes that contribute to fitness in mucus broth were discovered, with the beta-oxidation 
pathway being especially important, indicating that metabolism of mucus includes 
utilization of fatty acids. Some genes that were important for mucus metabolism, but 
that are not traditionally a part of beta-oxidation, were found to contribute in some 
fashion to degradation of fatty acids as they were important for growth on oleic acid, a 
long chain fatty acid. This included the glpG gene, whose mutation led to a disruption of 
the downstream gene glpR, the transcriptional repressor of glycerol degradation. The 
ΔglpG mutant exhibited a defect during mouse gut colonization, indicating that glycerol 
degradation must be carefully regulated in vivo. This work helps to elaborate the process 
by which ExPEC colonizes the mammalian gastrointestinal tract. 
 
Introduction 
Extraintestinal pathogenic Escherichia coli (ExPEC) is a group of E. coli strains 
that can colonize the mammalian gut without causing any overt pathology. However, 
ExPEC can spread from the gut to extraintestinal niches such as the urinary tract, the 
meninges, and the bloodstream, and induce disease [1]. Urinary tract infections (UTIs) 
are most often caused by ExPEC bacteria, are typically resolved with antibiotic 
treatment, and are usually not life-threatening, especially when infection is limited to the 
bladder [1]. However, UTIs are quite prevalent, with half of all women requiring 
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treatment during their lifetime [2], and many women suffering from recurring UTIs [3]. 
This prevalence contributes to a high economic burden, with over $2 billion spent 
treating bladder infections each year in the United States [4]. In addition to UTI, ExPEC 
can infect the bloodstream and cause severe disease, especially in patients with a 
weakened immune response. For example, in the context of early-onset neonatal sepsis, 
ExPEC are the second leading etiological agent and the primary cause of mortality [5]. 
The concern surrounding the spectrum and prevalence of ExPEC pathogenesis is 
compounded by the reality that antibiotic resistant strains are increasing in frequency 
and are spreading worldwide [6]. In order to combat ExPEC more efficiently, it is critical 
that we understand the ExPEC life cycle in greater depth. 
There are many indications that the gut may act as a reservoir from which ExPEC 
can disseminate and cause disease. For example, during acute UTI, the same strain can 
frequently be isolated from both the patient’s urine and feces [7-9], and in most of these 
instances, the uropathogen is the predominant fecal E. coli strain [7]. ExPEC can also 
translocate directly from the gut to the bloodstream, especially in cancer patients. 
Indeed, ExPEC is the most common Gram-negative bacteria isolated from the blood of 
cancer patients with bacteremia, who have a reduced gut barrier function due to 
immunosuppression and altered gut mucosa [10]. In addition to spreading from the gut 
to an extraintestinal site within a single individual, ExPEC can spread from one person 
to another, as in the case of neonatal sepsis, in which the newborn becomes infected by 
ExPEC originating from the mother [11]. Therefore, although ExPEC is not known to 
cause serious disease in the gastrointestinal tract, an understanding of the gut 
colonization process could be helpful for developing future therapeutic options to 
combat extraintestinal infections. 
One element that may be key to gut colonization by ExPEC is the intestinal 
mucus layer, which functions to separate the host epithelium from the microbiota [12]. 
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In addition to acting as a barrier, the mucus layer can be an important niche for the 
microbiota, through its supply of nutrients, and by acting as an attachment point for 
certain microbes [13]. The mucus layer appears to be one site of colonization for E. coli 
commensal strains, which can associate with the mucus layer in the streptomycin-
treated mouse model of gut colonization [14, 15]. These E. coli commensal strains seem 
to prefer to utilize mucus as a source of nutrients, as they often grow in vitro in crude 
cecal mucus, but not in the cecal lumenal contents [15, 16]. There appears to be an 
association between the ability of a strain to grow in cecal mucus in vitro, and the ability 
of that strain to colonize the mouse gut [15-17], although this is not always a perfect 
correlation [18]. 
To better understand how ExPEC colonizes the gut, we set out to document the 
genes critical for growth in mucus in vitro by utilizing transposon sequencing (Tn-seq), a 
high-throughput method for determining the contribution of each bacterial gene to 
fitness under a given condition [19]. We found several genes that were important for 
growth in mucus, but not in the glucose control condition. Many of these mucus-specific 
genes were found to be important for proper metabolism of long chain fatty acids 
(LCFAs). One of these genes, which encodes GlpG, was found to be important for 
colonization of the mouse gut in the presence of the natural microbiota. The defect of the 
ΔglpG mutant strain is shown to be due to polar effects on glpR, the transcriptional 
repressor of the glycerol degradation pathway. These data demonstrate the importance 
of proper regulation of the glycerol degradation pathway during ExPEC colonization of 





A Tn-seq screen for ExPEC genes important for growth on  
intestinal mucus uncovers a role for beta-oxidation 
As E. coli has often been observed to associate with gastrointestinal mucus [14, 
15], and the mucus layer is known to be a source of nutrients for the microbiota [13], we 
reasoned that ExPEC genes required for metabolism of intestinal mucus may also be 
required for gut colonization. Therefore, a Tn-seq screen was devised in order to uncover 
genes important for mucus metabolism in vitro (Fig 4.1A). Three independently-derived 
mutant pools [20] were first expanded in LB, then subcultured into minimal media 
supplemented with either mucus or glucose. The bacteria were then grown for 24 h 
microaerobically to mimic the gut environment. A second round of 24 h of growth was 
performed in order to increase the stringency of the screen. After a total of 48 h of 
microaerobic growth in minimal media, the mutant populations were collected and the 
transposon insertion sites were sequenced in parallel with the input population. The 
abundance of individual mutants in the output and input pools were then compared, and 
a fitness score was derived for each mutant. After normalization and filtering (see 
Materials and Methods), each fitness score was calculated as the Log2(mutant abundance 
in output/mutant abundance in input). The median value of the various insertion site 
fitness scores for a given gene was defined as the fitness score for that gene. 
There were a total of 24,822 transposon insertion sites for which a fitness score 
was determined in both the mucus and glucose conditions. On average, there was one 
transposon insertion detected for every 210 nucleotides. This coverage allowed a fitness 
score to be calculated for 3,804 genes. In order to create a list of candidate genes that 
contribute to fitness in either the mucus media, the glucose media, or both, several 
cutoffs were used. Only genes with a fitness score of -2.0 or lower (i.e. a minimum of a 4-












Figure 4.1. Tn-seq uncovers a role for beta-oxidation in metabolizing mucus. 
(A) A schematic describing the Tn-seq experiment. An F11 transposon library was 
expanded aerobically in LB overnight, then subcultured 1:100 into a modified M9 
medium supplemented with either mucus or glucose. The bacteria were then grown for 
24 h microaerobically, at which point they were subcultured 1:100 into fresh media and 
grown for another 24 h microaerobically. This procedure was repeated for 3 
independently-derived transposon mutant pools. Samples of bacterial cells were taken 
from the LB broth at the beginning of the experiment (“input”), and from the mucus and 
glucose media after 48 h of growth (“mucus output” and “glucose output”). These input 
and output samples were then prepared for sequencing of the transposon insertion sites, 
and the abundance of the various transposon mutants in all of the samples was 
quantified by bioinformatics. The abundance of each mutant in the output and input 
samples was used to derive a fitness score for that mutant. The mutant fitness scores for 
the three samples were pooled and used to calculate a fitness score for each gene in both 
the glucose and mucus conditions. (B) Gene fitness scores are graphed according to the 
gene’s fitness score during growth in both the glucose and mucus broths. Only candidate 
genes are included in this graph, meaning that the gene fitness score was -2.0 or less (a 
4-fold reduction in fitness) with P ≤ 0.05. These thresholds were met in either the mucus 
condition (green dots), the glucose condition (red dots), or in both conditions (black 
dots). (C) Candidate genes were analyzed via GO analysis using PANTHER. Those genes 
that were not detected in the input sample (“Lost Gene Subset”), likely due to their 
essential nature, were also analyzed. Those GO categories that were significantly 
enriched in the Lost Gene Subset and the Mucus Candidate Subset when compared to 





candidate list (Fig 4.1B). These thresholds produced a list of 112 mucus-specific genes, 
171 genes with fitness defects only in the glucose condition, and 28 genes that exhibited a 
loss of fitness in both conditions. 
Several genes of note were found to be candidates in both the mucus and glucose 
media, likely because they are essential for microaerobiosis, a feature that both 
conditions had in common. For example, rqlI was found to be a candidate gene in both 
media, with a mucus score of -5.8 and a glucose score of -4.5. This is unsurprising as the 
ΔrqlI mutant exhibits a growth defect in low oxygen conditions due to the inherent 
toxicity of the helicase RqlH [21]. Another candidate gene important for low oxygen 
conditions was arcB, with a mucus score of -3.5 and a glucose score of -6.3. ArcB is a 
sensory histidine kinase that forms a two-component system with ArcA [22], a 
transcriptional regulator that is important for proper microaerobic metabolism [23]. In 
addition to rqlI and arcB, several proteins that are a part of NADH dehydrogenase I 
(NDH-1) were also candidate genes in both conditions, including nuoF, nuoG, and nuoL. 
Five other genes encoding NDH-1 components (nuoC, nuoI, nuoJ, nuoM, and nuoN) 
were candidates in the glucose condition, but had few or no transposon insertion 
mutants in the mucus broth, making it impossible to determine their importance in that 
medium. NDH-1 functions as part of the electron transport chain to transfer electrons 
from NADH to the quinone pool, and is especially efficient when fumarate or DMSO are 
being used as the terminal electron acceptor instead of oxygen [24]. The prevalence of 
NDH-1 components in the list of candidate genes, along with the presence of rqlI and 
arcB, highlights the importance of microaerobic metabolism in this Tn-seq experiment. 
To determine in an unbiased fashion if common pathways or functions were 
enriched in any of these candidate gene groups, gene ontology (GO) analysis was 
performed using Protein Analysis Through Evolutionary Relationships (PANTHER) [25]. 
As a control for the GO analysis, a gene subset was also analyzed which only included 
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genes that were not detected in the input sample, likely due to their essential nature. 
This essential gene subset was found to be enriched for the translation and biosynthetic 
process GO categories, both of which are made up of genes important for basic processes 
such as translation, transcription, and replication (Fig 4.1C). No GO enrichments were 
observed in the glucose candidate gene subset. However, the fatty acid beta-oxidation 
GO category was enriched in the mucus candidate gene subset (Fig 4.1C), indicating that 
genes related to beta-oxidation are found in the mucus condition more often than would 
be expected. These genes include fadL, fadE, fadB, and fadJ, all of which have been 
shown to be important for the pathway through which long chain fatty acids are 
transported into the cell and metabolized via beta-oxidation [26, 27]. The result of beta-
oxidation is several acetyl-CoA molecules, which can then enter into the citric acid cycle. 
These data indicate that the bacteria metabolized long chain fatty acids during the Tn-
seq mucus experiment. 
 
Many candidate genes are plasmid-encoded 
There was a striking predominance of candidate genes in both the mucus and 
glucose conditions that are likely located on a large plasmid that is very similar to the 
pUTI89 plasmid carried by the cystitis isolate UTI89 [28]. There are 5 F11 contigs that 
closely align to the pUTI89 plasmid at the nucleotide level, with relatively small gaps 
between contigs (Fig 4.S1A). Several genes located on these 5 contigs met the 
requirements of candidate genes in both mucus and glucose. Expanding the analysis to 
all insertion sites found on pUTI89 demonstrated that transposon insertions in the 
plasmid led to reduced fitness in general (Fig 4.S1B). The median fitness score of 
plasmid localized insertion sites was -1.46 in the mucus broth, in comparison with 0.04 
for chromosomal sites. Similar median fitness scores were observed for the glucose 
condition, with -1.14 for plasmid sites and 0.05 for chromosomal sites. These data 
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suggest that carriage of a fully-functional pUTI89 plasmid contributed to fitness in the 
Tn-seq experiment. 
 
The fadL, fbp, and glpG genes are important for growth in mucus 
In order to study genes important for growth in mucus, various genes were 
chosen from the mucus-specific candidate list, including appA, fadL, fbp, and glpG. 
Each of these genes was knocked out and retested in competition with the WT strain in 
the mucus and glucose growth assay. AppA is a periplasmic phosphatase whose 
expression is increased in anaerobic conditions [29]. The fadL gene encodes the outer 
membrane localized transporter of long chain fatty acids [30]. Fbp mediates the rate-
limiting step of gluconeogenesis, which is important for several biosynthetic pathways 
when glucose is absent [31]. Finally, glpG is a part of the glpEGR operon and encodes a 
membrane localized protease whose substrate is unknown [32]. When each of these 
mutants was competed against WT in the in vitro growth assay, the ΔappA strain did not 
exhibit a growth defect, whereas the others did (Figs 4.2A-B). The ΔfadL mutant 
demonstrated the most striking defect as it had a competitive index (CI) near -0.7 
(roughly a 5-fold decrease in fitness) at 48 h in mucus, but a CI that did not differ 
significantly from 0 in the glucose condition. The Δfbp and ΔglpG mutants grew worse 
than WT in both the glucose and mucus conditions, but with a more pronounced defect 
in the mucus media (Figs 4.2A-B). The ΔfadL, Δfbp, and ΔglpG mutants grew similar to 
WT when their respective genes or operons were returned to them on a plasmid (Fig 
4.2C), further solidifying the role of these genes in mucus broth growth. 
Disruptions to the beta-oxidation pathway lead to reduced growth on minimal 
media plates supplemented with the long chain fatty acid oleate [30]. As expected, the 
ΔfadL mutant grew poorly on oleate, but was rescued when the fadL gene was included 
















Figure 4.2. Mucus-specific candidate genes are important for growth on the 
LCFA oleate. Four genes were chosen from the Tn-seq mucus candidate gene list, 
knocked out, and tested in various assays. (A) Each of the four mutants was competed 
against WT during microaerobic growth in M9-glucose media. Each mixture was grown 
for 24 h, then subcultured 1:100 and grown for another 24 h, with titering at both 24 and 
48 h. The Log10 competitive index (CI) was calculated by dividing the mutant titers by 
the WT titers. * indicates that the CI is significantly different from 0 by the one-sample t-
test, P ≤ 0.05. (B) Bacteria were grown and titered as in A, except in M9-mucus media. * 
indicates that the CI is significantly different from 0 by the one-sample t-test, P ≤ 0.05. 
(C) Those mutants that exhibited a defect in the M9-mucus media in B were grown as in 
B in competition against the WT strain carrying an empty vector plasmid (pCWR40). 
The mutants carried either the empty vector plasmid or a complementation plasmid 
expressing the gene or operon under their native promoters. The ΔfadL mutant was 
complemented by pCWR37, the Δfbp mutant was complemented by pCWR38, and the 
ΔglpG mutant was complemented by pCWR39 which expresses the entire glpEGR 
operon. ** P ≤ 0.01, **** P ≤ 0.0001 by unpaired Student’s t-test. Experiments in A, B, 
and C were performed in triplicate, three times. (D) The ΔfadL, Δfbp, and ΔglpG 
mutants carrying either an empty vector control or a complementation plasmid as in C 































































































ΔfadL mutant on the oleate plates, whereas the ΔglpG strain exhibited a subtler growth 
defect (Fig 4.2D). Neither Fbp nor GlpG have a previously described connection to beta-
oxidation. Importantly, all of the strains grew similarly on a plate supplemented with 
glucose (Fig 4.2E). 
 
GlpG is required for gut colonization, whereas FadL and Fbp are not 
As the mucus layer is thought to be a source of nutrients for E. coli during gut 
colonization, and since the ΔfadL, Δfbp, and ΔglpG mutants exhibited a growth defect 
during mucus metabolism in vitro, we tested their ability to colonize the mouse gut. 
Each mutant was competed 1:1 against WT bacteria in mouse gut colonization. When 
either the ΔfadL or Δfbp mutants were competed against WT, the median competitive 
index was relatively close to 0 throughout the experiment, being 0.4 and -0.29 at day 14, 
respectively (Figs 4.3A-B). In contrast, when the ΔglpG mutant was competed against 
WT, the median competitive index dipped to -1.96 by day 14, which indicates 90-fold 
fewer mutant bacterial numbers in comparison to WT (Fig 4.3C). These data 
demonstrate that a disruption in glpG reduces bacterial fitness in the gut, whereas a 
mutation in fadL or fbp has no effect. 
 
Mutation of glpG has polar effects on the downstream gene glpR 
The glpG gene is the second gene of a three gene operon that includes glpE and 
glpR (Fig 4.4A). GlpE is a thiosulfate sulfurtransferase that is capable of transferring 
sulfur from thiosulfate to a recipient compound such as thioredoxin, but its biological 
role is not known [33]. GlpR is a transcriptional repressor of several genes that are 
involved with glycerol degradation [34]. There are multiple promoters that drive 
expression of the genes in the glpEGR operon, including two promoters inside of glpG 
that drive transcription of glpR [35]. It was possible that transposon insertions into glpG 





Figure 4.3. GlpG contributes to fitness during mouse gut colonization. WT 
and mutant bacteria were mixed 1:1 and were gavaged into mice at a dose of 109 CFUs. At 
various time points post inoculation, feces were collected, homogenized, and serially 
diluted onto LB containing either kanamycin to count the WT strain or chloramphenicol 
to count the mutant strain. For each mouse at each time point, a competitive index was 
calculated as the Log10(mutant CFUs/WT CFUs). * indicates P ≤ 0.05 using one sample t 
test with hypothetical mean set to 0. n=14-17 mice, utilized over three experiments. (A) 





















































Figure 4.4. The ΔglpG mutant exhibits a defect in the downstream gene 
glpR. (A) A schematic of the glpEGR operon, with each gene indicated as a blue box. 
Promoter locations are indicated by black arrows above the operon. Below the operon 
are listed the fitness scores (“FS”) and P values (“P”) for each gene in the mucus growth 
condition in the Tn-seq experiment. (B) Each glp mutant carrying the empty vector 
control, a plasmid expressing glpEGR, or a plasmid expressing glpEG, was grown in 
competition with WT carrying the control plasmid. The bacteria were grown in M9-
mucus media for 24 h microaerobically, and then subcultured into fresh media and 
grown for an additional 24 h. After 48 h of growth, each culture was titered to enumerate 
WT and mutant levels. * P ≤ 0.05, **** P ≤ 0.0001 by unpaired Student’s t-test. The 
experiment was performed in triplicate, three times. (C) The WT and ΔglpEGR mutant 
strain carrying various expression constructs was grown on minimal media agar 





















































disrupt its function. To test this possibility, the ΔglpEGR, ΔglpG, and ΔglpR mutants 
were transformed with a plasmid encoding either the entire glpEGR operon, or simply 
glpEG. Each of the mutants was then competed against the WT strain in a mucus growth 
assay (Fig 4.4B). At 24 h, all of the mutants carrying the empty vector control exhibited a 
similar growth defect, with a CI of about –0.4. With the addition of the glpEGR 
expression plasmid, the mutants' fitness improved. In contrast, the glpEG expression 
plasmid appeared to worsen the glp mutants' defect. This pattern of growth was 
mirrored on oleate plates for the ΔglpEGR strain (Fig 4.4C). Whereas the ΔglpEGR 
mutant carrying either the control plasmid or the glpEG expression plasmid grew more 
slowly than the WT control strain, mutant growth was rescued with addition of the 
glpEGR plasmid. In contrast, all of the strains grew equally well on glucose media (Fig 
4.4D). Altogether, these data suggest that the reduced fitness of the various glp mutants 
is due to a lack of glpR. 
 
The glp mutants are rescued during growth on oleate with the  
addition of glycerol-3-phosphate 
As GlpR is a transcriptional repressor, its absence leads to hyperactivation of the 
glyercol degradation pathway, which can deplete intermediates such as glycerol-3-
phosphate (G3P). G3P can be further modified in this pathway to dihydroxyacetone 
phosphate (DHAP) which can then be utilized in glycolysis or gluconeogenesis [36]. 
Additionally, G3P is an important starting substrate for membrane biogenesis [37]. 
Therefore, the depletion of G3P could lead to multiple detrimental downstream effects in 
a ΔglpR mutant. Indeed, it was previously observed that a ΔglpR mutant defect could be 
rescued by the addition of exogenous G3P [38]. 
To test whether the defect during growth on oleate could be rescued by the 
addition of G3P, the ΔglpR, ΔglpG, and ΔglpEGR mutants were grown on various 
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minimal medium plates. Nothing grew on the control plate that was supplemented with 
G3P alone (Fig 4.5A). As observed earlier, the glp mutants grew slower than WT on the 
oleate-supplemented plates (Fig 4.5B). When G3P was added in combination with the 
oleate, the mutants grew similarly to WT (Fig 4.5C), indicating that the mutants’ growth 
defect could be rescued with exogenous G3P. These data indicate that the glp mutants 




To better understand how ExPEC colonizes the gut, we performed a Tn-seq 
experiment with the aim of defining the genes important for metabolism of intestinal 
mucus. Mucus is thought to be a source of nutrients for ExPEC in the gut environment 
given the association of commensal E. coli with the mucus layer in the streptomycin-
treated mouse model [14, 15] and the observation that for a given strain, there is often a 
correlation between in vitro growth in mucus and fitness in vivo [15, 16]. By comparing 
the growth of individual mutants in our F11 transposon mutant library in M9-mucus 
with that of M9-glucose, we aimed to focus on mucus-specific factors, as opposed to 
general growth factors. Based on various parameters, we created a list of 112 mucus-
specific candidate genes (Fig 4.1B). Four of these genes were retested in the same 
conditions as the Tn-seq experiment, and three of the mutants (ΔfadL, Δfbp, and ΔglpG) 
recapitulated the Tn-seq data (Fig 4.2B). We found that the fatty acid degradation 
pathway was significantly enriched in the mucus specific gene set (Fig 4.1C). This finding 
was extended by the observation that the genes that we verified to have growth defects in 
mucus broth also exhibited a growth defect when oleic acid was the only carbon source 
(Fig 4.2D), suggesting that there may be several genes on the mucus candidate gene list 





Figure 4.5. Exogenous glycerol-3-phosphate rescues the glp mutants’ growth 
defects. The WT, ΔglpR, ΔglpG, and ΔglpEGR strains were streaked onto minimal 
medium plates supplemented with (A) glycerol-3-phosphate, (B) oleate, or (C) both 





























explicitly a part of that GO category. 
It is interesting to note that sugar utilization pathways were not prominent in the 
mucus candidate gene list, despite the mucin protein being heavily glycosylated. This 
may be due to the lack of the microbiota in the Tn-seq experiment, including bacteria 
that would be capable of releasing sugars from mucin [13]. However, the fact that lipids 
are utilized in our system is not surprising. A previous study found that E. coli (including 
an ExPEC isolate) and Salmonella strains were capable of growing on lipids extracted 
from mucus, although the lipid fraction did not support growth to the same extent as 
whole mucus [39]. Additionally, a microarray of MG1655 genes expressed in vitro during 
growth on mouse cecal mucus demonstrated induction of genes important for utilization 
of the lipid phosphatidylethanolamine [18]. These studies support the notion that lipids 
are an edible portion of the mucus layer for bacteria. 
Of the three mutants with a fitness defect in vitro in mucus broth, only the ΔglpG 
mutant had a defect during mouse gut colonization. Our results demonstrate that 
mutants defective in mucus growth in vitro are not always deficient during mouse gut 
colonization. This idea is supported by evidence that genes that are transcriptionally 
induced during growth on mucus in vitro are not necessarily required for growth in vivo 
[18]. The likely reason for this imperfect correlation is that there are several niches found 
within the gut, both physically and nutritionally, and some of these could support 
colonization in a manner independent of mucus-derived nutrients. Evidence for multiple 
nutritional niches during E. coli gut colonization comes from studies determining which 
E. coli strains can simultaneously colonize the gut [40, 41]. The extent to which two E. 
coli strains can coexist in the gut is dependent on the overlap between their respective 
metabolic capabilities. If the contributions of the microbiota are also considered, it is 
clear that there are multiple ways to obtain nutrients in the gut depending on the 
context, and scavenging mucus-derived products is likely only one strategy. 
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Why the ΔglpG mutant has a defect in vivo is not clear, although we believe it to 
be attributable to the polar effects that a glpG mutation has on glpR (Fig 4.4). Polar 
effects are assumed based on the observations that the ΔglpG and ΔglpR mutants 
phenocopy in the mucus broth experiment, and that they are both rescued by a plasmid 
carrying glpEGR, but not a plasmid expressing glpEG (Fig 4.4B). As GlpR is a 
transcriptional repressor of the glycerol degradation pathway, a ΔglpR mutant has a 
hyperactive glycerol degradation pathway which can act as a double-edged sword. On 
one hand, a ΔglpR mutation allows for improved growth on glycerol and is thought to be 
the reason that many K-12 strains have acquired spontaneous glpR mutations [42]. 
However, increased glycerol degradation can deplete glycerol-3-phosphate, an 
intermediate in the pathway that is also important for membrane biogenesis [38]. 
Therefore, as the ΔglpG mutant exhibits a defect in mouse gut colonization, it is clear 
that ExPEC needs to carefully modulate the levels of glycerol degradation in vivo. A 
BLAST search found that the glpEGR genes appear to be restricted to the 
Enterobacteriaceae family, suggesting that these findings may be applicable to other 
genera including Klebsiella, Shigella, and Salmonella. 
In this work we set out to find genes required for ExPEC gut colonization, as the 
gut is believed to be the primary ExPEC niche. Using data from an in vitro Tn-seq 
experiment, we endeavored to find mutants with gut colonization defects. Through these 
efforts it was found that proper regulation of the glycerol degradation pathway is 
required for persistence of ExPEC in the intestine. Future work to delineate gut 
colonization by ExPEC will be invaluable for obtaining a broader view of the ExPEC life 




Materials and Methods 
Creation of bacterial strains and plasmids 
The cystitis isolate F11 was genetically altered using strains carrying pKM208, 
which facilitates creation of knockouts and knockins via lambda-red recombination [43]. 
Knockout and knockin constructs were created by PCR using either pKD3 or pKD4 as 
template to make a chloramphenicol or kanamycin resistance cassette, respectively, 
along with ~40 bps of flanking overhang with homology to the genomic insertion site. 
All plasmids utilized in this study are derived from pACYC177 [44]. All of the 
expression vectors were created by traditional cloning techniques, with insertion of the 
PCR product at the BamHI and NheI sites, which removes the kanamycin resistance 
cassette. The control plasmid pCWR40 was created by digestion of pACYC177 with 
BamHI and NheI, followed by a reaction with the Klenow fragment to create blunt ends 
prior to re-ligation. 
 
Media 
While creating knockout, knockin, and complemented strains, bacteria were 
grown in Luria-Bertani (LB) broth. All growth in petri dishes was done using LB agar 
supplemented with chloramphenicol (20 µg/mL), kanamycin (50 µg/mL), or ampicillin 
(100 µg/mL). When growing bacteria for mouse experiments, a modified M9 medium 
was utilized. It contains MgSO4•7H2O (1 mM), CaCl2•2H2O (0.1 mM), D-(+)-Glucose 
(0.1%), Nicotinic Acid (0.00125%), Thiamine HCl (0.00165%), Casamino Acids (0.2%), 
Na2HPO4 (6g/L), KH2PO4 (3 g/L), NH4Cl (1 g/L), and NaCl (0.5 g/L), all dissolved in 
water. For in vitro growth experiments in “M9-glucose” or “M9-mucus”, the above recipe 
was used, except that Casamino Acids were excluded. Additionally, for the M9-mucus 
media, 0.5% mucus (Sigma M1778) was used in place of the glucose. To make M9-
mucus, the mucus was dissolved in water by autoclaving for 20 min at 121° C. 
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Mucus and glucose Tn-seq experiment 
Three independently-derived transposon mutant pools that were used previously 
[20] were utilized in this experiment. Briefly, these pools were created by conjugative 
transfer to F11 of the pSAM-Ec plasmid, which contains a himar1C9 transposase and a 
mariner transposon with a kanamycin resistance cassette. Transposon mutants were 
selected by plating on LB supplemented with kanamycin, and further analysis indicated 
few ampicillin resistant bacteria, indicating that whole plasmid insertion occurred 
infrequently. 
Each of the transposon mutant pools was expanded in LB broth, and then 
subcultured 1:100 into M9-mucus or M9-glucose, and grown at 37° C for 24 h shaking at 
180 rpm in a jar containing an AnaeroPack-MicroAero sachet. Each culture was then 
subcultured into fresh media and grown for another 24 h. After 48 h of growth, cells 
were collected for DNA purification. 
DNA was prepared for sequencing via HTML-PCR as described [45], with some 
modifications. DNA from the “input” (LB) and “output” (M9-glucose and M9-mucus) 
samples was isolated using a Wizard Genomic DNA Purification Kit (Promega). Thirty µg 
of genomic DNA were diluted in 50 µl of water and sonicated using a Diagenode 
Sonicator, using 30 cycles of 30 seconds ON, 60 seconds OFF. This treatment led to 
sheared DNA being mostly less than 600 bps. The DNA was purified and concentrated 
using the GeneJet PCR Purificaiton Kit (Fermentas), which removes DNA pieces below 
the size of 100 bps. Poly-dC tails were added to the 3’ ends of the sheared DNA pieces by 
incubation of 1.5 µg of DNA with Terminal Deoxynucleotidyl Transferase (TdT from 
NEB) at 37° C for 1 h, followed by heat inactivation at 75° C for 20 minutes. The TdT 
reaction was purified using a DTR Gel Filtration Cartridge (Performa) following the 
directions provided by the manufacturer. Two PCR reactions were performed in 
succession using the Easy A Cloning Enzyme. The first reaction contained primers olj376 
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and tn_rev1-2, while the second contained primers tn_rev2-2 and the appropriate 
indexing primer. The reactions were purified and were sent for sequencing by the Tufts 
University Genomics Core Facility using the “pSAM-Ec Illumina seq” primer. 
Sequencing was done on the HiSeq 2500, high output v4, with single-end reads 
produced over 50 cycles. 
 
Bioinformatic analysis 
Reads were initially processed using a custom Python script to remove adaptor 
sequences, trim low quality bases from the 3’ end of the read (minimum phred score of 
20 required), trim strings of C nucleotides that may have originated from the TdT 
reaction from the 3’ end, as well as to filter out reads with low quality 5’ ends (minimum 
phred score of 20 required). After trimming, any read with a length less than 28 
nucleotides was removed. On average, these requirements led to ~3% of reads being 
removed. 
The trimmed reads were then aligned to the F11 genome using Bowtie2, and the 
resulting SAM files were sorted using SAMtools. Custom Python scripts were used to 
analyze the sorted SAM files, including identification of transposon insertion locations, 
and quantification of the number of reads for each insertion location. Lower quality 
alignments were filtered out by requiring that each alignment have a Mapq score of at 
least 35, no more than 2 mismatches, and that it not align equally well to more than one 
location on the genome. Additionally, alignments were required to correspond to a TA 
dinucleotide, the preferred insertion location of the mariner transposon. These 
thresholds resulted in an additional ~3% of the reads being filtered at this step. During 
this process, forward and reverse insertion events that occurred at the same location 
were pooled together and considered as one insertion site. 
In order to calculate fitness scores for individual transposon insertion sites, a 
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table was created for each input-output sample pair that included the read counts for 
only those insertion sites that were detected in both samples. Insertion sites were 
required to have at least 10 reads in the input sample to be included. Transposon 
mutants that were completely lost from the output sample were added to the table if the 
number of reads at that insertion site in the input sample was very high, within the top 
1% of input sites. In this case, the output read count was set to 1, the limit of detection. 
This practice allowed for analysis of mutants with very low fitness in the growth 
conditions. The input-output pair tables were then normalized using geometric mean 
normalization, similar to the normalization strategy utilized by DESeq2 [46]. The 
normalized reads were then used to calculate a fitness score for each insertion site in 
each sample, which was calculated as Log2(output sample reads/input sample reads). 
The fitness scores for all of the insertion sites in a given gene across the three replicates 
were used to calculate a median fitness score, which was designated the fitness score for 
that gene. A P value was calculated using a Wilcoxon Signed Rank Test with the 
hypothetical median set to 0. 
A list of candidate genes was created with the genes that met certain criteria, 
which included a fitness score of -2.0 or lower (i.e. at least a 4-fold reduction in fitness 
from input to output) and a P value of 0.05 or lower. The candidate gene lists were 
analyzed using gene ontology via PANTHER [25]. 
 
Mouse gut colonization 
Mice were handled in accordance with protocols approved by the Institutional 
Animal Care and Use Committee at the University of Utah (Protocol number 15-12015), 
following US federal guidelines indicated by the Office of Laboratory Animal Welfare 




For mouse gut colonization experiments, female Balb/c mice, aged 7-8 weeks, 
were intragastrically gavaged with 50 µl of PBS containing 109 CFUs of bacteria. The 
mice were housed 3-5 per cage, and were allowed to eat (Teklad Global Soy Protein-Free 
Extruded, irradiated, 2920x) and drink ad libitum. Feces were collected at various time 
points, homogenized in 1 mL of 0.7% NaCl, and briefly centrifuged at a low speed to 
pellet any insoluble debris. Supernatants were then serially diluted and plated onto LB 
plates containing either chloramphenicol (20 µg/mL) or kanamycin (50 µg/mL) to select 
for the relevant strains. Fecal samples were also collected and plated prior to gavage to 
ensure that the microbiota did not contain any bacteria that could be cultured on 
chloramphenicol or kanamycin. 
The bacteria for the mouse gut experiments were grown statically in 20 mL 
modified M9 in a 250 mL flask for 24 h at 37° C. For noncompetitive experiments, 12 mL 
of culture was centrifuged at 8,000 r.c.f. for 10 minutes, and the pellet was washed and 
resuspended in 0.5 mL of PBS. For competitive experiments, 6 mL of culture for each 
strain were mixed prior to centrifugation. 
 
Growth on oleate plates 
To make M9-oleate plates, the reagents for the modified M9 media as outlined in 
the “Media” section were mixed, with the exception of casamino acids and glucose. 
Triton X-100 (0.6%) and oleate (0.1%) were also added, and everything was allowed to 
rock at room temperature for 20 minutes to facilitate mixture of the oleate with the 
Triton X. Molten agar was added to the mixture and the plate was poured. Control plates 
were made by adding glucose (0.5%) or glycerol-3-phosphate (1 mM) instead of oleate. 
Once the plates were made, 1 µl of overnight culture from each strain was streaked out 




Statistical analysis for the Tn-seq experiment was performed using the NumPy 
package. All other analysis was done in GraphPad Prism. The specific statistical test used 
in each case is indicated in the figure legend. 
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Figure 4.S1. Transposon insertions in pUTI89 reduce fitness in vitro. (A) A 
schematic of the F11 contigs that align with pUTI89. The F11 contig number is indicated 
at top. (B) Fitness scores for the insertion sites that are located on the F11 contigs that 
align with pUTI89, the sites that are on contigs that do not align with pUTI89, and all of 
the sites. The whiskers extend to minimum and maximum values. 
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Escherichia coli is a frequent member of the human microbiota that can exert 
diverse effects on the gut ecosystem. One subset of the E. coli species is extraintestinal 
pathogenic E. coli (ExPEC), which acts as a commensal within the gut, but induces 
pathology upon dissemination to other niches such as the urinary tract and bloodstream. 
Given that ExPEC spends the majority of its time within the gut, it is likely that it has 
been mostly shaped by the evolutionary pressures found in this environment, provoking 
the question of how its extraintestinal virulence arose. The principle of coincidental 
evolution, in which a factor that evolved in one niche happens to be useful in another, 
has been hypothesized to be applicable to the ExPEC life cycle, in that extraintestinal 
virulence factors in actuality arose for full gut fitness. To test this hypothesis, several 
mutants were made that lacked canonical ExPEC virulence factors, and their importance 
for gut colonization was assessed. We found that most of the factors—including Cnf1, 
Usp, colibactin, flagella, and the plasmid pUTI89—were dispensable for gut colonization. 
A couple of mutants, DpapG and DhlyA, exhibited transient defects that did not affect 
long-term persistence. Only FimH, the adhesin for type 1 pili, was found to be important 
for gut colonization. Importantly, type 1 pili were important for repopulation of the gut 
after a course of oral antibiotics, uncovering a possible mechanism of recurrent 
infections. As FimH was the only virulence factor that was important for gut 
colonization, it is clear that coincidental evolution cannot be applied to ExPEC 
wholesale, but may need to be tested on a gene-by-gene basis. 
 
Introduction 
The bacterium Escherichia coli was first described by Theodor Escherich in 1884, 
and has since become a critical model organism that has been used to understand the 
fundamentals of molecular biology [1]. E. coli is able to live in a variety of locations, 
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including the soil, water, and the human gut—in part because it is a facultative anaerobe, 
meaning that it is capable of switching between aerobic and anaerobic metabolism. 
Although it is a prominent member of the neonatal microbiota, it is quickly 
overshadowed by the burgeoning anaerobic population as oxygen becomes scarce within 
the gut shortly after birth [2, 3]. In adults, E. coli is present at about 107 to 109 CFUs/g 
feces, a level that is 100-10,000-fold lower than the resident anaerobes [4]. Despite 
being a minor member of the microbiota, the estimated number of E. coli cells that are 
transmitted via fecal matter from a human being to the environment in a single day is 
staggering: about 1011 CFUs [5]. 
Understanding the role of E. coli within the microbiota is complicated by the fact 
that E. coli is a very diverse species with a wide spectrum of phenotypes [1]. Some E. coli 
strains live harmlessly in the gut, while others act as pathogens in the gastrointestinal 
tract, causing diarrhea and hemorrhaging [6], or have even been associated with Crohn’s 
Disease [7]. One strain, Nissle 1917, acts as a probiotic that assuages inflammation in 
addition to inhibiting colonization by pathogens such as Salmonella [8, 9]. Finally, a 
group of strains known as extraintestinal pathogenic Escherichia coli (ExPEC) are 
generally commensals within the gut, but disseminate to and infect other host sites [10]. 
ExPEC includes uropathogenic E. coli (UPEC), which cause the overwhelming majority 
of urinary tract infections (UTIs), a bacterial infection that is especially prevalent among 
women, infecting about half of all women during their lifetime [11]. Other, more serious 
conditions can also be initiated by ExPEC, including neonatal sepsis, urosepsis, and 
neonatal meningitis [10]. 
The gut is thought to be one of the major ExPEC reservoirs that seeds 
extraintestinal infections. The majority of adults carry ExPEC within their gut, even in 
the absence of extraintestinal infection [12], indicating that the gut is capable of 
harboring ExPEC at a high frequency. Longitudinal studies indicate that the presence of 
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ExPEC within the gut is fairly stable, with the E. coli phylogenetic group that includes 
ExPEC being the most likely to reside long term when compared to other E. coli groups 
[13, 14]. Additionally, the gut ExPEC population is often difficult to clear with antibiotics, 
even when the urinary tract population is eradicated [15]. Together, these observations 
suggest that the gut is available to act as a source of ExPEC that could then travel to 
other host niches. More direct evidence for this notion is that the same strain can be 
isolated from the feces and urine of patients suffering from a UTI [16-19] indicating 
some sort of transit between the two niches. 
The idea that ExPEC spends most of its time within the gut with only occasional 
dissemination to extraintestinal niches provokes the question of how ExPEC virulence 
has arisen. Many hypotheses have been proposed to explain how virulence evolves in 
pathogens in general, especially in cases where high virulence leads to cessation of 
pathogen transmission, such as in the event of host death [20]. In the case of ExPEC, 
blood infection can be thought of as a dead-end as it often leads to host expiration, 
especially if left untreated. Urinary tract infections are typically not as severe, allowing 
urine to possibly serve as a route of transmission. However, the rate of transmission 
between hosts via urine when compared to feces is likely low due to the extremely high 
rate of bacterial shedding in the feces. The hypothesis of coincidental evolution has often 
been evoked to explain the evolution of ExPEC virulence [21]. In general terms, 
coincidental evolution is when a factor evolves in one context, but happens to be useful 
in another context as well [20]. When the hypothesis of coincidental evolution is applied 
to the ExPEC life cycle, the primary niche and main evolutionary arena is the gut. The 
implication is that factors that promote virulence in extraintestinal niches evolved in the 
gut for a function possibly unrelated to virulence. 
Little concrete evidence has been put forth to support or contradict coincidental 
evolution in the context of ExPEC infection, other than that known extraintestinal 
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virulence factors are often found in gut isolates [14, 21, 22]. One prediction of this 
hypothesis is that extraintestinal virulence factors should play a role in gut colonization, 
which has only been addressed by one study thus far [5]. It is clear that more 
experimental work needs to be done to determine to what extent coincidental evolution 
applies to ExPEC. 
Here, we take a systematic approach to test the hypothesis of coincidental 
evolution as applied to ExPEC by determining the role of individual virulence factors in 
gut colonization. Several canonical ExPEC virulence factors were deleted and the 
resulting mutant was tested for its ability to colonize the mouse gastrointestinal tract. 
Most of these virulence factors (HlyA, Cnf1, Usp, colibactin, flagella, pUTI89, and PapG) 
do not appear to play a role in persistence in the gut. Only FimH, the adhesin for type 1 
pili, is required for full fitness in the gut. The DfimH knockout mutant exhibits a defect in 
gut colonization that includes an increased frequency of clearance. This defect can be 
partially attributed to increased motility. We observe that the importance of FimH for 
gut persistence is especially prominent in the face of antibiotic treatment. Overall, these 
data indicate that coincidental evolution must be applied on a per-gene basis and may 
not apply to ExPEC as a whole. Furthermore, many of the canonical ExPEC virulence 
factors have no role in the gut, indicating that coincidental evolution may not be a 
reasonable explanation for their existence. 
 
Results 
ExPEC benignly colonizes the murine lower gastrointestinal tract  
in the presence of an intact microbiota  
In order to establish an in vivo model of ExPEC gut colonization, we tested how 
well ExPEC could persist within the mouse gut. Specific pathogen free (SPF) mice were 
intragastrically gavaged with 109 CFUs of the ExPEC cystitis isolate F11. At various time 
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points post gavage, feces were collected, and the number of viable ExPEC bacteria in the 
feces was enumerated. Throughout the course of the experiment, which lasted for 75 
days after gavage, the median CFU per gram of feces was between 106 and 107, with the 
exception of a higher bacterial load at 1 day after gavage (Fig 5.1A). These data 
demonstrate that ExPEC can efficiently initiate and maintain colonization of the SPF 
mouse gut, as we have observed previously [23, 24]. Consistent with the observation that 
nonpathogenic E. coli mostly resides within the large bowel [25], the cecum and colon 
appear to carry the largest load of ExPEC bacteria, although there was a considerable 
amount of bacteria in the small intestine as well (Fig 5.1B). 
It is of note that the SPF mice utilized in these experiments have not been treated 
with antibiotics and therefore carry an intact microbiota. This is in contrast to the 
streptomycin-treated mouse model, in which mice drink streptomycin water ad libitum 
prior to and during colonization [25]. The streptomycin-treated mouse model has been 
frequently used to study gut colonization by nonpathogenic E. coli strains, as it alters the 
microbiota in such a way as to clear a niche for a more consistent colonization 
phenotype. As streptomycin was not required for consistent ExPEC colonization, we 
wondered whether ExPEC is simply more adept at colonization than MG1655, a 
nonpathogenic E. coli strain commonly used with the streptomycin-treated mouse 
model. Indeed, when F11 and MG1655 were competed head-to-head in the mouse gut, 
the MG1655 bacteria were cleared from all of the mice by day 3, while F11 persisted (Fig 
5.1C). When mice were gavaged with MG1655 alone, 80% of the mice were no longer 
colonized by day 14 (Fig 5.1D). In contrast, all of the mice that were gavaged with F11 
alone remained colonized through day 14 (Fig 5.1D). 
To determine whether ExPEC colonization is marked by inflammation, the mice 
were weighed at several time points after colonization as weight loss frequently 












Figure 5.1. ExPEC colonizes the gut of SPF mice without causing serious 
pathology. Female Balb/c mice were gavaged at the age of 7-8 weeks with 109 CFUs of 
bacteria. (A) Mice were gavaged with F11, and fecal titers were determined at various 
time points. n=5 mice. (B) Mice were gavaged with F11, and the bacterial load for each 
organ of the gastrointestinal tract was determined. The mice were euthanized at 14 days 
post gavage and the stomach, small intestine (which was subsequently divided into three 
portions), the colon, and the cecum were removed from each mouse, homogenized, and 
serially diluted onto LB-clm plates. n=10 mice analyzed over two experiments. (C) Mice 
were gavaged with a 1:1 mixture of F11 and MG1655, and fecal titers were determined for 
both populations at various time points. ** P ≤ 0.01 by Wilcoxon Signed-Rank Test. (D) 
Mice were gavaged with either F11, F11ΔhlyA, or MG1655, and fecal titers were 
determined at various time points. *** P ≤ 0.001, **** P ≤ 0.0001 by Mann-Whitney U 
Test. n=10 mice per group, analyzed over two experiments. (E) The mice in D were 
weighed at various time points. The values are normalized to the mass of each mouse 
prior to gavage. *** P ≤ 0.001 when F11 is compared to F11ΔhlyA, or MG1655 by 
unpaired Student’s t-test. (F) Mice were gavaged with either F11 or MG1655, and the 
colon was removed from each mouse 14 days post gavage. The colons were fixed and 
stained with H&E, and then imaged at 20x magnification. The scale bar indicates 100 












































































































weight loss at 24 h in comparison to the mice colonized with MG1655 (Fig 5.1E). As the 
alpha-hemolysin toxin (HlyA) has been shown to induce inflammation in the gut in other 
mouse models [27, 28], we colonized mice with F11ΔhlyA. When mice were colonized 
with F11ΔhlyA, the bacterial load was lower at 1 and 3 days post inoculation, with a 10-
fold reduction in bacterial levels at day 1 (Fig 5.1D). Additionally, transient weight loss 
did not occur in mice colonized with F11ΔhlyA (Fig 5.1E), suggesting that HlyA is 
required for both full bacterial levels and short-term inflammation during the initiation 
of colonization. The idea that the effect of this inflammation is short-lived is supported 
by the observation that at day 14, the colons of mice colonized with F11 retain their 
normal crypt architecture, and do not contain infiltrating immune cells (Fig 5.1F). 
Altogether, these data suggest that F11 induces transient inflammation that manifests as 
temporary weight loss, a condition that is not sustained after 24 h of colonization. 
 
Various ExPEC toxins are not important for  
colonization of the mouse gut 
In light of the hypothesis of coincidental evolution, it is intriguing that a 
canonical ExPEC virulence factor, such as HlyA, is not required for sustained 
colonization of the mouse gut (Fig 5.1D). To test whether other ExPEC toxins could be 
involved in gut colonization, we examined cytotoxic necrotizing factor type 1 (Cnf1), 
uropathogenic specific protein (Usp), and colibactin. 
Cnf1 intoxicates host cells via deamidation of a specific glutamine amino acid of 
various Rho family GTPases such as RhoA, Rac, and Cdc42, which leads to constitutive 
activation of these proteins [29]. The activation of Rho GTPases by Cnf1 leads to 
rearrangements of the host cytoskeleton and multinucleation [30, 31]. The actions of 
Cnf1 induce an inflammatory response in both UTIs [32] and prostatitis [33]. Although 
Cnf1 mediates ExPEC virulence, the contribution of Cnf1 to bacterial fitness remains 
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unclear, as it is important for host colonization in some cases [34] but not others [32, 33, 
35]. Given the association of Cnf1 with ExPEC in epidemiological studies [31], and its 
potential as an ExPEC virulence and fitness factor, we tested whether it plays a role in 
the gut. After feeding mice either 109 CFUs of WT F11 or F11Dcnf1, bacterial colonization 
levels were tracked by homogenizing and plating feces at various time points. Median 
bacterial levels ranged between 105 and 106 CFU per gram of feces (Fig 5.2A). Overall, 
there was no change in colonization levels of the F11Dcnf1 strain in comparison to WT 
(Fig 5.2A), suggesting that Cnf1 does not contribute to the ability of F11 to colonize the 
mouse gut. 
Like many of the other ExPEC virulence factors, Usp has been linked to ExPEC 
epidemiologically, meaning that the usp gene is more often found in ExPEC isolates than 
in commensal isolates of E. coli [36, 37]. Usp was also associated with E. coli fecal 
isolates that were capable of persisting in the guts of infants and that carried other 
ExPEC markers [38]. The physiological function of Usp is not clear, although it has been 
proposed to be genotoxic, as it is a nuclease that can intoxicate host cells in vitro [39, 
40]. The sequence of Usp indicates that it could also act as a colicin, a toxin that will 
harm unrelated bacteria, which is strengthened by the observation that several genes 
downstream of usp have sequence similar to colicin immunity proteins [41]. Given that 
interbacterial competition is expected to occur in the gut, we tested whether Usp is 
important for ExPEC gut colonization. The F11Dusp mutant did not exhibit a defect 
during gut colonization, indicating that it is not required for this niche (Fig 5.2B). 
Another toxin that has been linked to ExPEC pathogenesis is colibactin, which is 
produced by the polyketide synthase (pks) genomic island. The pks island is not found in 
intestinal pathogenic E. coli strains, but is enriched in extraintestinal isolates in 
comparison to fecal commensal isolates [42]. Colibactin induces DNA damage and cell 






















Figure 5.2. Several ExPEC virulence factors are not required for gut 
colonization. Mice were gavaged with 109 CFUs of WT or mutant bacteria, including 
(A) Dcnf1, (B) Dusp, (C) DclbCDEFG, (D) DfliC, and (E) DpUTI89. Feces were collected at 
the indicated time points and titered to enumerate the bacterial load in the feces. n = 9-
11 mice per group. No statistical significance found by comparing WT and mutant titers 













































































































been linked to colorectal cancer [44]. In extraintestinal infections, colibactin-deficient 
bacterial strains are not as virulent as their WT counterparts. Mutation of the pks island 
reduces ExPEC translocation from the gut in neonatal rats [45] and reduces 
lymphopenia in septic mice [46]. Whether the pks island also plays a role in bacterial 
fitness during gut colonization is not clear. Whereas one study observed decreased gut 
colonization by colibactin mutants [45], another found no difference between the mutant 
and WT bacteria [47]. To test whether colibactin is important in our model of gut 
colonization, we colonized mice with either WT F11 or F11DclbCDEFG—removing the 
entirety of one of the pks island operons [48]—and tracked fecal titers over time. There 
was no difference in the colonization ability of the WT and mutant strains (Fig 5.2C), 
suggesting that colibactin does not contribute to bacterial fitness in this model of gut 
colonization. 
 
Flagella are not required for ExPEC gut colonization 
Flagella create motility through a membrane-localized motor that drives an 
extracellular filament composed mostly of FliC [49]. Several studies have provided 
evidence that flagella play an important role during ExPEC infection of the mouse 
urinary tract [50-53]. The expression of fliC, which encodes for the major flagellar 
protein, is spatiotemporally regulated during UTI. It is expressed early during infection 
in the bladder, but as the infection progresses, the expression in the bladder decreases 
while the expression in the kidneys increases, suggesting that flagellar expression is 
required for ascension of the urinary tract [53]. Although flagella are not important for 
gut colonization of the streptomycin-treated mouse by nonpathogenic E. coli [54], it was 
not known whether flagella are important for gut colonization by ExPEC in the face of an 
intact microbiota. The F11DfliC KO mutant was able to colonize the mouse gut as well as 
the WT strain (Fig 5.2D), suggesting that flagella do not play an important role for 
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ExPEC in the gut. 
 
The pUTI89 plasmid is not important for gut colonization 
The pUTI89 plasmid was first identified when the cystitis isolate UTI89 was 
sequenced [55]. It is roughly 114 kb in length, and encodes conjugation machinery, some 
virulence genes, and many hypothetical genes. A derivative of UTI89 that was cured of 
the plasmid had reduced fitness at early time points of urinary tract infection, in addition 
to a defect in invasion of host cells and formation of intracellular bacterial communities 
[56]. Other ExPEC strains have since been found to carry identical or closely-related 
plasmids [57], including F11, in which disruptions of several plasmid genes can lead to in 
vitro growth defects (see Chapter 3). To determine the role that pUTI89 plays during gut 
colonization, an F11 derivative cured of the plasmid was tested in our mouse model. The 
cured strain exhibited no defect when compared to the control WT strain (Fig 5.2E), 
suggesting that pUTI89 is not important for fitness within the gut. 
 
Type 1 Pili contribute to fitness in the gut, whereas the P pili adhesin  
is dispensable for gut colonization 
ExPEC encodes many types of pili, which are hair-like fibers that extend from the 
cell and terminate in an adhesin protein that interacts with its surrounding environment. 
For type 1 pili (T1P), this adhesin is FimH, while PapG is the adhesin for P pili. T1P have 
been shown to be important for many steps in the urinary tract infection process, 
including adherence to bladder epithelial cells, subsequent invasion into host cells, and 
formation of intracellular bacterial communities [58]. While T1P play a role in the 
bladder, P pili mediate binding to the kidney epithelium and are also important for 
ExPEC-mediated UTI [58]. 
To determine whether these adhesins are important for successful gut 
colonization, each adhesin was disrupted and the resulting mutants were tested in 
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competitive colonization experiments. The WT strain and either F11DfimH or F11DpapG 
were mixed in equal amounts and fed to mice, and bacterial titers were enumerated at 
various time points post inoculation. A control experiment was also performed to 
determine the relative fitness effects of the antibiotic resistance cassettes. In this control 
experiment, the kanR WT strain exhibited somewhat of a defect (about 3-fold with a 
median competitive index of -0.49) in comparison to the clmR WT strain at 14 days post 
inoculation (Fig 5.3A). Furthermore, 2 of the 13 mice cleared the WT-kan strain by day 
14, as indicated by the green data points (Fig 5.3A). The WT vs DpapG experiment 
demonstrated a transient defect at day 5 with a median competitive index of -0.83 (6.8-
fold mutant defect), but no defect was observed at later time points (Fig 5.3B). By day 14, 
one mouse had cleared the kanR DpapG mutant (green dot) while one mouse had cleared 
the clmR WT competitor (red dot). In contrast, the kanR DfimH mutant had significantly 
reduced fitness beginning at day 7 and continuing throughout the rest of the experiment 
(Fig 5.3C), with the greatest defect seen at day 10 (median competitive index of -2.55, 
indicating a ~350-fold mutant defect). The mice started clearing the DfimH mutant as 
early as day 3, with 6 of 13 mice clearing the mutant by day 10 (green dots). These data 
indicate that T1P may play a role in gut colonization, whereas P pili do not. 
These observations are supported by noncompetitive experiments in which WT 
and mutant strains were inoculated individually into separate groups of mice. The 
DpapG mutant strain colonized as well as WT (Fig 5.3D), whereas the DfimH mutant was 
cleared in 3 of the 10 mice (Fig 5.3E), a difference that did not reach statistical 
significance. 
 
Disruption of fimH or papG alters bacterial motility 
As alteration of T1P and P pili expression is known to lead to modifications in 




Figure 5.3. The DfimH mutant, but not a DpapG mutant, has a defect in the 
gut. Mice were gavaged with 109 CFUs of a mixture of (A) WT::kan and WT::clm, (B) WT 
and DpapG, (C) or WT and DfimH. n = 11-13 mice per competition. * P ≤ 0.05 by one 
sample t test. Mice were gavaged with WT bacteria and either (D) DpapG or (E) DfimH. 
No statistical significance found by comparing WT and mutant titers at every time point 















































































































agar. The DfimH mutant had increased motility when compared to the WT strain, 
whereas the DpapG strain exhibited decreased motility (Fig 5.4A). 
Aberrant overexpression of flagella can lead to a defect in gut colonization [5], 
and mutants expressing lower levels of flagella can spontaneously arise over the course 
of gut colonization experiments [62, 63]. To test whether the defect in the DfimH mutant 
strain was due to increased flagella, an F11DfimHDfliC double knockout strain was 
created. This strain exhibited no motility, similar to the single DfliC KO (Fig 5.4B). 
During competitive gut colonization, the clmR DfimHDfliC mutant strain exhibited a 
defect in comparison to the kanR WT strain (Fig 5.4C). By day 14, 5 of the 13 mice had 
cleared the mutant strain, and the median competitive index was -1.33. However, this 
defect did not appear to be as strong as was observed with the DfimH mutant, as the 
reduction in the competitive index was smaller and not statistically significant. Clearance 
of the DfimHDfliC also began later, at day 7 (Fig 5.4C), in comparison to the DfimH strain 
that began to be cleared by the mice at day 3 (Fig 5.3C). Considered together, these data 
suggest that the defect of the DfimH strain is due to both increased motility and the lack 
of T1P.  
 
The fim switch is mostly in the OFF state in feces-localized ExPEC 
There are many levels of regulation that modulate the expression of T1P. One 
aspect of T1P regulation is that the fim switch—a short span of DNA containing the 
promoter for the main fim operon—can be flipped back and forth by various 
recombinases [58]. In this manner, environmental cues can influence whether the fim 
switch is in the ON state and primed for transcription, or whether it is in the OFF state, 
in which transcription is impossible. To quantify the percentage of the ExPEC gut 





Figure 5.4. The increased motility of the DfimH mutant contributes to its gut 
colonization defect. Bacteria were inoculated into motility agar to observe their 
swimming ability. WT bacteria as well as (A) DfimH and DpapG, or (B) DfimH, DfliC, and 
DfimH DfliC, were tested. Images are representative of 3 experiments. (C) Mice were 
gavaged with a mixture of 109 CFUs of WT and DfimH DfliC bacteria. n = 13 mice. No 



































that were colonized with WT F11 (Fig 5.5). A PCR reaction that spans the fim switch was 
performed, followed by a restriction enzyme digest with HinfI, which cuts in one location 
within the fim switch and results in different sized products depending on the state of 
the switch. As expected, growing F11 in pure culture led to different switch states 
depending on the growth conditions (Fig 5.5). The majority of the population carried an 
ON switch when the bacteria were grown statically, whereas shaking incubation led to 
switches that were mostly OFF (Fig 5.5). Prior to gavage, no fimS was detected in the 
feces. At various points post gavage, this assay revealed that the majority of the 
population (~70%, on average) carried an OFF switch. The OFF state of the fim switch 
observed during ExPEC colonization of mice was recapitulated in a human fecal sample 
from a patient colonized with at least two ExPEC strains. These data indicate that only a 
portion of the ExPEC fecal population is capable of expressing T1P. 
 
T1P facilitate the resurgence of ExPEC after antibiotic treatment 
One roadblock for treatment of ExPEC-mediated UTI is the issue of recurrence. 
Frequently, women who suffer a UTI will contract another UTI relatively shortly after the 
initial infection is resolved [64]. It is thought that the gut may act as a reservoir that 
reseeds the urinary tract, therefore mediating the recurrent infection. An unsettling 
observation is that the ExPEC gut population can either rebound shortly after the 
termination of antibiotic treatment, or is never cleared by the antibiotic treatment in the 
first place [15]. How the ExPEC gut population is able to tolerate antibiotic treatment has 
not been studied, but a similar phenotype can be observed during bladder colonization. 
ExPEC is capable of utilizing T1P to invade into bladder epithelial cells, and within this 
intracellular niche, ExPEC is protected from membrane impermeable antibiotics [65]. 
To test whether antibiotic tolerance in the gut could also be mediated by T1P, we 





Figure 5.5. The fim switch is mostly OFF within the ExPEC fecal population. 
Mice were gavaged with WT F11 and fecal samples were acquired at various time points 
post gavage. As a control, fecal samples were also collected prior to gavage. DNA was 
isolated from each sample, and the fim switch status in the population was quantified 
using a PCR that spanned the switch, followed by HinfI digestion and measurement of 
ON and OFF bands on an agarose gel. For controls, the bacteria were grown in LB for 
either 72 h statically (ON), or shaking until exponential phase (OFF). Feces from a 




































treatment. Mice were gavaged with WT bacteria, the DfimH mutant, or PBS. At day 7 
post gavage, no ExPEC were detected in the PBS-gavaged mice as expected (Fig 5.6A), 
whereas similar amounts of WT and mutant F11 bacteria were observed (Figs 5.6B-5.6C). 
The membrane-impermeable antibiotic gentamicin was added to the drinking water at 
day 7, and after 3 days of treatment, no ExPEC bacteria were detected in any of the mice 
(Figs 5.6A-5.6C). Antibiotic treatment was halted on day 11, and 24 h later, the ExPEC 
population rebounded in all of the mice gavaged with WT bacteria (Fig 5.6B). In 
contrast, the DfimH mutant strain reemerged in only 1 of the 4 mice, and in that case, the 
bacteria became detectable 48 h after the removal of gentamicin (Fig 5.6C). Importantly, 
no ExPEC bacteria were detected in the PBS control mice at any time (Fig 5.6A). 
Furthermore, the mice drank equal amounts of water prior to and during gentamicin 
treatment (Fig 5.6D). These data indicate that T1P play a role in the ability of ExPEC to 
reestablish a population within the gut post antibiotic treatment. 
 
Discussion 
As the gastrointestinal tract is the major host niche for ExPEC, the gut 
environment could be the most prominent driver of ExPEC evolution. With this in mind, 
it has been hypothesized that the extraintestinal success of ExPEC is a by-product of its 
ability to colonize the gut [21]. This hypothesis would be supported by evidence that 
extraintestinal virulence or fitness factors also play a role in gut colonization. Therefore, 
we set out to test the relevance of several canonical ExPEC virulence factors in a mouse 
model of gut colonization. We found that several factors played no role during 
colonization, including Cnf1, Usp, colibactin, flagella, and the plasmid pUTI89 (Fig 5.2). 
Mutants lacking either papG or hlyA exhibited only transient colonization defects that 
did not affect overall gut survival (Figs 5.1D & 5.3B). In contrast, T1P were important for 




Figure 5.6. T1P contribute to the ability of ExPEC to reemerge after oral 
antibiotic treatment. Mice were gavaged with (A) PBS, or 109 of either (B) WT F11 or 
(C) F11DfimH bacteria. At several time points post gavage, feces were collected, 
homogenized, and plated onto MacConkey agar in order to enumerate the ExPEC 
population. Collection was done prior to, during, and after gentamicin treatment, which 
began on day 7 and ended on day 11, and which is indicated by the gray box. PBS, n = 5 
mice. WT, n = 3 mice. DfimH, n = 4 mice. (D) The amount of water consumed per day by 
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ExPEC virulence factors are important for gut colonization, while others are not. 
 
Therefore, it is reasonable to apply the principle of coincidental evolution to 
individual genes, but there are likely many forces from various niches that have shaped 
ExPEC genetics over time. For example, one study found a correlation between 
extraintestinal virulence and the ability to resist killing by amoebae, highlighting that 
diverse environmental situations could have influenced extraintestinal pathogenesis 
[66]. 
A previous study examined ExPEC coincidental evolution by testing the 
importance of the 7 major pathogenicity islands of the cystitis isolate 536 during 
extraintestinal infection and gut colonization [5]. It was found that a mutant that lacked 
the 7 pathogenicity islands had reduced virulence in a mouse model of sepsis as well as 
in gut colonization. However, the gut colonization defect was attributed to aberrantly 
increased flagellar expression, a condition that is detrimental to E. coli fitness in the gut 
[62, 63]. This is similar to our observation that the gut colonization defect of the DfimH 
mutant could be partially attributed to its increased motility (Fig 5.4A). Importantly, the 
DfimH DfliC double knockout strain continued to have a gut colonization defect (Fig 
5.4C), although it was more modest than that exhibited by the DfimH mutant (Fig 5.3C). 
In addition to being important for persistence in the gut, T1P also play a role in 
the reestablishment of the ExPEC population after an antibiotic treatment (Fig 5.6C). 
This has implications in the realm of recurrent UTIs (rUTIs), which can be a major 
challenge in UTI treatments [67]. These rUTIs are often thought to be due to a reservoir 
of ExPEC within the gut that repeatedly supplies bacteria to the urinary tract. This 
hypothesis assumes that the gut ExPEC reservoir is either not efficiently cleared by the 
antibiotic used to treat the UTI, or that gut colonization is easily occurring multiple 
times. The former possibility is supported by a study indicating that ExPEC can be 
detected within the gut between two UTI episodes [15]. In that study, two patterns were 
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observed, one in which the ExPEC population was unaltered by the antibiotic treatment, 
and another in which the population was cleared but later reemerged. In our mouse 
model, we observed that the bacteria became undetectable after 3 days of oral 
gentamicin treatment, but quickly rebounded (Fig 5.6). Why T1P contributed to this 
phenotype remains unclear, but it could be related to the ability of the bacteria to access 
a niche that would otherwise be unavailable. For example, in the urinary tract, T1P allow 
the bacteria to invade into the bladder epithelial cells, and within this intracellular 
compartment, the bacteria are less affected by antibiotics [65]. Whether invasion of host 
cells also occurs in the gut is not currently clear, but such a niche would allow a subset of 
the bacteria to survive the gentamicin treatment and repopulate the gut. 
Another interesting possibility that could explain the role of T1P in the gut is a 
scenario in which T1P and secretory IgA (sIgA) interact to create an ExPEC biofilm that 
is resistant to antibiotics. This idea is supported by the fact that T1P can bind to the 
heavily glycosylated sIgA proteins [68], and that this interaction can enhance biofilm 
formation in vitro [69]. Interestingly, there is a correlation between the production of 
sIgA in humans and the presence of E. coli that is capable of T1P-mediated adherence 
[70]. E. coli isolated from individuals that are deficient in sIgA has a reduced capacity for 
T1P-mediated adherence in comparison to E. coli from healthy volunteers. This 
difference can be attributed to many factors, including fewer bacteria carrying the fim 
genes, a reduced ability to switch to the ON phase, and possibly ineffective fimH alleles 
[70];Nowrouzian, 2007 #60}. These data suggest that there is an association of T1P+ 
bacteria with sIgA-producing individuals, while T1P- bacteria are more often found with 
sIgA-deficient individuals. The co-occurrence of T1P and sIgA could also be a clue for the 
function of T1P in the absence of antibiotics. 
A striking feature of our mouse model is that ExPEC is able to colonize SPF mice 
that carry an intact microbiota, which has also been observed by others [71]. However, E. 
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coli gut colonization is traditionally studied using mice that have been treated with 
streptomycin in order to provide an open niche [72]. Disturbance of the microbiota has 
been commonly utilized as E. coli is unable to experimentally colonize a gut with an 
intact microbiota. For example, when volunteers ingested a marked derivative of E. coli 
isolated from their own guts, the strains were unable to persist [73]. This failure to 
colonize can be attributed to colonization resistance, which is due—in part—to the 
microbiota reducing niche availability and restricting colonization by incoming bacteria 
[74]. It therefore seems likely that as microbiota composition varies from one facility to 
the another [75], some mice are amenable to ExPEC colonization due to the specific 
makeup of their microbiota. Indeed, the mice in our facility do not appear to be 
colonized with E. coli prior to beginning our experiments, which may indicate a niche is 
available for ExPEC to fill. 
The results of this work indicate that T1P are important for gut colonization, and 
for repopulating the gut after antibiotic treatment. Furthermore, we found that 
coincidental evolution was a feasible explanation for the existence of only one of several 
ExPEC virulence factors, indicating that piecing together the evolutionary history of 
these bacteria is a complicated task. Future work to label genes as gut-specific, 
extraintestinal-specific, environment-related, or multi-niche—especially in a high-
throughput manner—will better paint a picture of the pressures experienced by ExPEC. 
 
Methods 
Bacterial strain creation 
The cystitis isolate F11 and the K-12 strain MG1655 were genetically modified 
using lambda-red recombination that was facilitated by the pKM208 plasmid [76]. Most 
of the constructs used for recombination were created by PCR using either pKD4 or 
pKD3 as a template to make a kanamycin or chloramphenicol resistance cassette, 
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respectively, flanked with ~40 bps of homology to the insertion site. In some cases, 
longer homology regions were required, and three-part PCR was performed. This was 
done by PCR of the upstream region, the resistance cassette, and the downstream region, 
all with some homology to the adjacent piece. The three pieces were then stitched 
together in a single reaction. 
The pCP20 plasmid was used to remove the resistance cassette when needed [77]. 
To cure F11 of the pUTI89 plasmid, the ccdAB toxin-antitoxin system was replaced with 
a tetA-sacB construct and spontaneous loss of the plasmid was selected for on LB plates 
containing fusaric acid and sucrose, as explained before [78]. 
 
Media 
Prior to lambda-red recombination, bacteria were grown in LB broth. All growth 
in petri dishes was done using LB agar supplemented with chloramphenicol (20 µg/mL) 
or kanamycin (50 µg/mL). Prior to experiments, bacteria were grown in a modified M9 
medium, which contains the following in water: MgSO4•7H2O (1 mM), CaCl2•2H2O (0.1 
mM), D-(+)-Glucose (0.1%), Nicotinic Acid (0.00125%), Thiamine HCl (0.00165%), 
Casamino Acids (0.2%), Na2HPO4 (6g/L), KH2PO4 (3 g/L), NH4Cl (1 g/L), and NaCl (0.5 
g/L). 
 
Mouse gut colonization 
Mice were handled in accordance with protocols approved by the Institutional 
Animal Care and Use Committee at the University of Utah (Protocol number 15-12015), 
following US federal guidelines indicated by the Office of Laboratory Animal Welfare 
(OLAW) and described in the Guide for the Care and Use of Laboratory Animals, 8th 
Edition. 
To prepare bacteria for inoculation into mice, the bacteria were grown in 20 mL 
of modified M9 media in a 250 mL flask for 24 h at 37° C, without shaking. A total of 12 
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mL of culture (6 mL of each culture for competitive experiments) was centrifuged at 
8,000 r.c.f. for 10 min, and the pellet was washed and resuspended in 0.5 mL of PBS. To 
colonize the mouse gastrointestinal tract, 7-8-week-old female Balb/c mice were 
intragastrically gavaged with 109 CFUs of bacteria in a volume of 50 µl. At various time 
points post inoculation, mice were placed individually into unused takeout boxes for 
weighing and feces collection. Feces were homogenized in 1 mL of 0.7% NaCl, briefly 
centrifuged to pellet insoluble debris, and the supernatants were serially diluted and 
spread onto LB plates containing either chloramphenicol (20 µg/mL) or kanamycin (50 
µg/mL) to select for the relevant strains. Prior to gavage, fecal samples were analyzed to 
make sure there were no endogenous bacteria resistant to chloramphenicol or 
kanamycin. The mice were housed 3-5 per cage, and were allowed to eat (Teklad Global 
Soy Protein-Free Extruded, irradiated, 2920x) and drink antibiotic-free water ad 
libitum. 
To acquire a count of the bacterial burden in various organs of the 
gastrointestinal tract, the mice were anaesthetized via isoflurane and euthanized by 
cervical dislocation. The cecum, colon, small intestine, and stomach were removed. The 
small intestine was divided into thirds, with the portion closest to the stomach labeled 
“proximal”, and the portion closest to the cecum labeled “distal”. A part of each organ 
was then weighed and placed into a Safe-Lock tube (Eppendorf) with three 3.2 mm 
stainless steel beads, and homogenized using the Bullet Blender (Next Advance). The 
homogenate was then serially diluted and plated onto LB plates containing 
chloramphenicol (20 µg/mL) to quantify the levels of F11::clm bacteria. For histology, a 
portion of the colon was removed, placed into a cassette, and fixed in 10% neutral 
buffered formalin and submitted to the University of Utah Research Histology group for 




Gentamicin treatment assay 
Mice were gavaged as described above with either 109 CFUs of WT F11 or 
F11DfimH, or with PBS. Seven days post inoculation, the feces were titered onto 
MacConkey agar to quantify the bacterial load. On day 7, gentamicin (Sigma #G1264) 
was added to the water at 1 g/L, and was removed on day 11 after confirming clearance of 
ExPEC on day 10. More fecal samples were analyzed at later time points to observe 
whether the bacterial population grew out again. 
 
Quantification of the fim switch status 
Mice were gavaged as described above with 109 CFUs of WT F11. Fecal samples 
were collected prior to gavage and at various time points post gavage, and DNA was 
isolated using the ZR Fecal DNA MiniPrep by Zymo Research. The patient fecal sample 
was processed in parallel with the same kit. As a control for a population with the 
majority of the switch ON, WT F11 was grown in LB statically for 72 h, with 1:100 
subculturing done at 24 and 48 h. As an OFF control, WT F11 was grown shaking in LB 
to exponential phase. For both controls, DNA was isolated using the Promega Wizard 
Genomic DNA Purification Kit. For each sample, a PCR reaction was run using primers 
that spanned the fim switch (F: 5’-TACCGCCAGTAATGCTGCTC-3’, R: 5’-
GTCCCACCATTAACCGTCGT-3’). The extension portion of the reaction lasted for 25 
cycles, with a Tm of 56º C. Each reaction was purified, and then digested with HinfI for 
1.5 h at 37º C, after which each reaction was run on a 2% agarose gel. The intensities of 
the ~560 bp (ON) and ~430 bp (OFF) bands were analyzed in ImageJ. 
 
Motility assay 
To test the swimming ability of particular strains, motility agar plates were made 
by pouring 25 mL of LB soft agar (0.1% agar) into a petri dish. A small volume of bacteria 
(1.5 µl) from an overnight culture was dispensed just below the surface of the plate. The 
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All analyses were done in GraphPad Prism. The specific statistical test used in 
each case is indicated in the figure legend. 
 
References 
1. Blount ZD. The unexhausted potential of E. coli. Elife. 2015;4. doi: 
10.7554/eLife.05826. PubMed PMID: 25807083; PubMed Central PMCID: 
PMCPMC4373459. 
2. Bezirtzoglou E. The intestinal microflora during the first weeks of life. Anaerobe. 
1997;3(2-3):173-7. doi: 10.1006/anae.1997.0102. PubMed PMID: 16887585. 
3. Human Microbiome Project C. Structure, function and diversity of the healthy 
human microbiome. Nature. 2012;486(7402):207-14. doi: 10.1038/nature11234. 
PubMed PMID: 22699609; PubMed Central PMCID: PMCPMC3564958. 
4. Tenaillon O, Skurnik D, Picard B, Denamur E. The population genetics of commensal 
Escherichia coli. Nat Rev Microbiol. 2010;8(3):207-17. doi: 10.1038/nrmicro2298. 
PubMed PMID: 20157339. 
5. Diard M, Garry L, Selva M, Mosser T, Denamur E, Matic I. Pathogenicity-associated 
islands in extraintestinal pathogenic Escherichia coli are fitness elements involved in 
intestinal colonization. J Bacteriol. 2010;192(19):4885-93. doi: 10.1128/JB.00804-
10. PubMed PMID: 20656906; PubMed Central PMCID: PMCPMC2944530. 
6. Karpman D, Stahl AL. Enterohemorrhagic Escherichia coli Pathogenesis and the 
Host Response. Microbiol Spectr. 2014;2(5). doi: 10.1128/microbiolspec.EHEC-
0009-2013. PubMed PMID: 26104359. 
7. Rolhion N, Darfeuille-Michaud A. Adherent-invasive Escherichia coli in 
inflammatory bowel disease. Inflamm Bowel Dis. 2007;13(10):1277-83. doi: 
10.1002/ibd.20176. PubMed PMID: 17476674. 
8. Schultz M, Strauch UG, Linde HJ, Watzl S, Obermeier F, Gottl C, et al. Preventive 
effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal 
inflammation in two different murine models of colitis. Clin Diagn Lab Immunol. 
2004;11(2):372-8. PubMed PMID: 15013990; PubMed Central PMCID: 
PMCPMC371200. 
9. Deriu E, Liu JZ, Pezeshki M, Edwards RA, Ochoa RJ, Contreras H, et al. Probiotic 
bacteria reduce salmonella typhimurium intestinal colonization by competing for 
iron. Cell Host Microbe. 2013;14(1):26-37. doi: 10.1016/j.chom.2013.06.007. 
 	
142 
PubMed PMID: 23870311; PubMed Central PMCID: PMCPMC3752295. 
10. Vila J, Saez-Lopez E, Johnson JR, Romling U, Dobrindt U, Canton R, et al. 
Escherichia coli: an old friend with new tidings. FEMS Microbiol Rev. 2016. doi: 
10.1093/femsre/fuw005. PubMed PMID: 26961094. 
11. Barber AE, Norton JP, Spivak AM, Mulvey MA. Urinary tract infections: current and 
emerging management strategies. Clin Infect Dis. 2013;57(5):719-24. doi: 
10.1093/cid/cit284. PubMed PMID: 23645845; PubMed Central PMCID: 
PMCPMC3739462. 
12. Smati M, Clermont O, Le Gal F, Schichmanoff O, Jaureguy F, Eddi A, et al. Real-time 
PCR for quantitative analysis of human commensal Escherichia coli populations 
reveals a high frequency of subdominant phylogroups. Appl Environ Microbiol. 
2013;79(16):5005-12. doi: 10.1128/AEM.01423-13. PubMed PMID: 23770894; 
PubMed Central PMCID: PMCPMC3754702. 
13. Nowrouzian FL, Wold AE, Adlerberth I. Escherichia coli strains belonging to 
phylogenetic group B2 have superior capacity to persist in the intestinal microflora of 
infants. J Infect Dis. 2005;191(7):1078-83. doi: 10.1086/427996. PubMed PMID: 
15747243. 
14. Nowrouzian FL, Adlerberth I, Wold AE. Enhanced persistence in the colonic 
microbiota of Escherichia coli strains belonging to phylogenetic group B2: role of 
virulence factors and adherence to colonic cells. Microbes Infect. 2006;8(3):834-40. 
doi: 10.1016/j.micinf.2005.10.011. PubMed PMID: 16483819. 
15. Russo TA, Stapleton A, Wenderoth S, Hooton TM, Stamm WE. Chromosomal 
restriction fragment length polymorphism analysis of Escherichia coli strains causing 
recurrent urinary tract infections in young women. The Journal of infectious 
diseases. 1995;172(2):440-5. Epub 1995/08/01. PubMed PMID: 7622887. 
16. Moreno E, Andreu A, Pigrau C, Kuskowski MA, Johnson JR, Prats G. Relationship 
between Escherichia coli strains causing acute cystitis in women and the fecal E. coli 
population of the host. J Clin Microbiol. 2008;46(8):2529-34. doi: 
10.1128/JCM.00813-08. PubMed PMID: 18495863; PubMed Central PMCID: 
PMCPMC2519474. 
17. Chen SL, Wu M, Henderson JP, Hooton TM, Hibbing ME, Hultgren SJ, et al. 
Genomic diversity and fitness of E. coli strains recovered from the intestinal and 
urinary tracts of women with recurrent urinary tract infection. Sci Transl Med. 
2013;5(184):184ra60. doi: 10.1126/scitranslmed.3005497. PubMed PMID: 
23658245; PubMed Central PMCID: PMCPMC3695744. 
18. Foxman B, Manning SD, Tallman P, Bauer R, Zhang L, Koopman JS, et al. 
Uropathogenic Escherichia coli are more likely than commensal E. coli to be shared 
between heterosexual sex partners. Am J Epidemiol. 2002;156(12):1133-40. PubMed 
PMID: 12480658. 
19. Yamamoto S, Tsukamoto T, Terai A, Kurazono H, Takeda Y, Yoshida O. Genetic 
evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by 
Escherichia coli. J Urol. 1997;157(3):1127-9. PubMed PMID: 9072556. 
 	
143 
20. Levin BR. The evolution and maintenance of virulence in microparasites. Emerg 
Infect Dis. 1996;2(2):93-102. doi: 10.3201/eid0202.960203. PubMed PMID: 
8903208; PubMed Central PMCID: PMCPMC2639826. 
21. Le Gall T, Clermont O, Gouriou S, Picard B, Nassif X, Denamur E, et al. 
Extraintestinal virulence is a coincidental by-product of commensalism in B2 
phylogenetic group Escherichia coli strains. Mol Biol Evol. 2007;24(11):2373-84. doi: 
10.1093/molbev/msm172. PubMed PMID: 17709333. 
22. Wold AE, Caugant DA, Lidin-Janson G, de Man P, Svanborg C. Resident colonic 
Escherichia coli strains frequently display uropathogenic characteristics. J Infect Dis. 
1992;165(1):46-52. PubMed PMID: 1727897. 
23. Norton JP, Mulvey MA. Toxin-antitoxin systems are important for niche-specific 
colonization and stress resistance of uropathogenic Escherichia coli. PLoS Pathog. 
2012;8(10):e1002954. doi: 10.1371/journal.ppat.1002954. PubMed PMID: 
23055930; PubMed Central PMCID: PMCPMC3464220. 
24. Russell CW, Mulvey MA. The Extraintestinal Pathogenic Escherichia coli Factor RqlI 
Constrains the Genotoxic Effects of the RecQ-Like Helicase RqlH. PLoS Pathog. 
2015;11(12):e1005317. doi: 10.1371/journal.ppat.1005317. PubMed PMID: 26636713; 
PubMed Central PMCID: PMCPMC4670107. 
25. Myhal ML, Laux DC, Cohen PS. Relative colonizing abilities of human fecal and K 12 
strains of Escherichia coli in the large intestines of streptomycin-treated mice. Eur J 
Clin Microbiol. 1982;1(3):186-92. PubMed PMID: 6756909. 
26. Rosen MJ, Dhawan A, Saeed SA. Inflammatory Bowel Disease in Children and 
Adolescents. JAMA Pediatr. 2015;169(11):1053-60. doi: 
10.1001/jamapediatrics.2015.1982. PubMed PMID: 26414706; PubMed Central 
PMCID: PMCPMC4702263. 
27. Troeger H, Richter JF, Beutin L, Gunzel D, Dobrindt U, Epple HJ, et al. Escherichia 
coli alpha-haemolysin induces focal leaks in colonic epithelium: a novel mechanism 
of bacterial translocation. Cell Microbiol. 2007;9(10):2530-40. doi: 10.1111/j.1462-
5822.2007.00978.x. PubMed PMID: 17587334. 
28. Bucker R, Schulz E, Gunzel D, Bojarski C, Lee IF, John LJ, et al. alpha-Haemolysin of 
Escherichia coli in IBD: a potentiator of inflammatory activity in the colon. Gut. 
2014;63(12):1893-901. doi: 10.1136/gutjnl-2013-306099. PubMed PMID: 24534723. 
29. Welch RA. Uropathogenic Escherichia coli-Associated Exotoxins. Microbiol Spectr. 
2016;4(3). doi: 10.1128/microbiolspec.UTI-0011-2012. PubMed PMID: 27337488; 
PubMed Central PMCID: PMCPMC4920080. 
30. Fiorentini C, Arancia G, Caprioli A, Falbo V, Ruggeri FM, Donelli G. Cytoskeletal 
changes induced in HEp-2 cells by the cytotoxic necrotizing factor of Escherichia coli. 
Toxicon. 1988;26(11):1047-56. PubMed PMID: 3072687. 
31. Caprioli A, Falbo V, Roda LG, Ruggeri FM, Zona C. Partial purification and 
characterization of an escherichia coli toxic factor that induces morphological cell 
alterations. Infect Immun. 1983;39(3):1300-6. PubMed PMID: 6341235; PubMed 
 	
144 
Central PMCID: PMCPMC348099. 
32. Smith YC, Rasmussen SB, Grande KK, Conran RM, O'Brien AD. Hemolysin of 
uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and 
hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation 
of mice. Infect Immun. 2008;76(7):2978-90. doi: 10.1128/IAI.00075-08. PubMed 
PMID: 18443089; PubMed Central PMCID: PMCPMC2446707. 
33. Rippere-Lampe KE, Lang M, Ceri H, Olson M, Lockman HA, O'Brien AD. Cytotoxic 
necrotizing factor type 1-positive Escherichia coli causes increased inflammation and 
tissue damage to the prostate in a rat prostatitis model. Infect Immun. 
2001;69(10):6515-9. doi: 10.1128/IAI.69.10.6515-6519.2001. PubMed PMID: 
11553597; PubMed Central PMCID: PMCPMC98788. 
34. Rippere-Lampe KE, O'Brien AD, Conran R, Lockman HA. Mutation of the gene 
encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of 
uropathogenic Escherichia coli. Infect Immun. 2001;69(6):3954-64. doi: 
10.1128/IAI.69.6.3954-3964.2001. PubMed PMID: 11349064; PubMed Central 
PMCID: PMCPMC98434. 
35. Johnson DE, Drachenberg C, Lockatell CV, Island MD, Warren JW, Donnenberg MS. 
The role of cytotoxic necrotizing factor-1 in colonization and tissue injury in a murine 
model of urinary tract infection. FEMS Immunol Med Microbiol. 2000;28(1):37-41. 
PubMed PMID: 10767605. 
36. Kanamaru S, Kurazono H, Ishitoya S, Terai A, Habuchi T, Nakano M, et al. 
Distribution and genetic association of putative uropathogenic virulence factors iroN, 
iha, kpsMT, ompT and usp in Escherichia coli isolated from urinary tract infections 
in Japan. J Urol. 2003;170(6 Pt 1):2490-3. doi: 
10.1097/01.ju.0000094185.48467.dc. PubMed PMID: 14634457. 
37. Bauer RJ, Zhang L, Foxman B, Siitonen A, Jantunen ME, Saxen H, et al. Molecular 
epidemiology of 3 putative virulence genes for Escherichia coli urinary tract 
infection-usp, iha, and iroN(E. coli). J Infect Dis. 2002;185(10):1521-4. doi: 
10.1086/340206. PubMed PMID: 11992291. 
38. Ostblom A, Adlerberth I, Wold AE, Nowrouzian FL. Pathogenicity island markers, 
virulence determinants malX and usp, and the capacity of Escherichia coli to persist 
in infants' commensal microbiotas. Appl Environ Microbiol. 2011;77(7):2303-8. doi: 
10.1128/AEM.02405-10. PubMed PMID: 21317254; PubMed Central PMCID: 
PMCPMC3067437. 
39. Nipic D, Podlesek Z, Budic M, Crnigoj M, Zgur-Bertok D. Escherichia coli 
uropathogenic-specific protein, Usp, is a bacteriocin-like genotoxin. J Infect Dis. 
2013;208(10):1545-52. doi: 10.1093/infdis/jit480. PubMed PMID: 23997234. 
40. Zaw MT, Yamasaki E, Yamamoto S, Nair GB, Kawamoto K, Kurazono H. 
Uropathogenic specific protein gene, highly distributed in extraintestinal 
uropathogenic Escherichia coli, encodes a new member of H-N-H nuclease 
superfamily. Gut Pathog. 2013;5(1):13. doi: 10.1186/1757-4749-5-13. PubMed PMID: 
23759109; PubMed Central PMCID: PMCPMC3685522. 
 	
145 
41. Kurazono H, Yamamoto S, Nakano M, Nair GB, Terai A, Chaicumpa W, et al. 
Characterization of a putative virulence island in the chromosome of uropathogenic 
Escherichia coli possessing a gene encoding a uropathogenic-specific protein. Microb 
Pathog. 2000;28(3):183-9. doi: 10.1006/mpat.1999.0331. PubMed PMID: 10702359. 
42. Nougayrede JP, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, et al. 
Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 
2006;313(5788):848-51. doi: 10.1126/science.1127059. PubMed PMID: 16902142. 
43. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrede JP. Escherichia 
coli induces DNA damage in vivo and triggers genomic instability in mammalian 
cells. Proc Natl Acad Sci U S A. 2010;107(25):11537-42. doi: 
10.1073/pnas.1001261107. PubMed PMID: 20534522; PubMed Central PMCID: 
PMCPMC2895108. 
44. Taieb F, Petit C, Nougayrede JP, Oswald E. The Enterobacterial Genotoxins: 
Cytolethal Distending Toxin and Colibactin. EcoSal Plus. 2016;7(1). doi: 
10.1128/ecosalplus.ESP-0008-2016. PubMed PMID: 27419387. 
45. McCarthy AJ, Martin P, Cloup E, Stabler RA, Oswald E, Taylor PW. The Genotoxin 
Colibactin Is a Determinant of Virulence in Escherichia coli K1 Experimental 
Neonatal Systemic Infection. Infect Immun. 2015;83(9):3704-11. doi: 
10.1128/IAI.00716-15. PubMed PMID: 26150540; PubMed Central PMCID: 
PMCPMC4534652. 
46. Marcq I, Martin P, Payros D, Cuevas-Ramos G, Boury M, Watrin C, et al. The 
genotoxin colibactin exacerbates lymphopenia and decreases survival rate in mice 
infected with septicemic Escherichia coli. J Infect Dis. 2014;210(2):285-94. doi: 
10.1093/infdis/jiu071. PubMed PMID: 24489107. 
47. Payros D, Secher T, Boury M, Brehin C, Menard S, Salvador-Cartier C, et al. 
Maternally acquired genotoxic Escherichia coli alters offspring's intestinal 
homeostasis. Gut Microbes. 2014;5(3):313-25. doi: 10.4161/gmic.28932. PubMed 
PMID: 24971581; PubMed Central PMCID: PMCPMC4153768. 
48. Homburg S, Oswald E, Hacker J, Dobrindt U. Expression analysis of the colibactin 
gene cluster coding for a novel polyketide in Escherichia coli. FEMS Microbiol Lett. 
2007;275(2):255-62. doi: 10.1111/j.1574-6968.2007.00889.x. PubMed PMID: 
17714479. 
49. Morimoto YV, Minamino T. Structure and function of the bi-directional bacterial 
flagellar motor. Biomolecules. 2014;4(1):217-34. doi: 10.3390/biom4010217. 
PubMed PMID: 24970213; PubMed Central PMCID: PMCPMC4030992. 
50. Haugen BJ, Pellett S, Redford P, Hamilton HL, Roesch PL, Welch RA. In vivo gene 
expression analysis identifies genes required for enhanced colonization of the mouse 
urinary tract by uropathogenic Escherichia coli strain CFT073 dsdA. Infect Immun. 
2007;75(1):278-89. doi: 10.1128/IAI.01319-06. PubMed PMID: 17074858; PubMed 
Central PMCID: PMCPMC1828413. 
51. Wright KJ, Seed PC, Hultgren SJ. Uropathogenic Escherichia coli flagella aid in 
efficient urinary tract colonization. Infect Immun. 2005;73(11):7657-68. doi: 
 	
146 
10.1128/IAI.73.11.7657-7668.2005. PubMed PMID: 16239570; PubMed Central 
PMCID: PMCPMC1273872. 
52. Lane MC, Lockatell V, Monterosso G, Lamphier D, Weinert J, Hebel JR, et al. Role of 
motility in the colonization of uropathogenic Escherichia coli in the urinary tract. 
Infect Immun. 2005;73(11):7644-56. doi: 10.1128/IAI.73.11.7644-7656.2005. 
PubMed PMID: 16239569; PubMed Central PMCID: PMCPMC1273871. 
53. Lane MC, Alteri CJ, Smith SN, Mobley HL. Expression of flagella is coincident with 
uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad 
Sci U S A. 2007;104(42):16669-74. doi: 10.1073/pnas.0607898104. PubMed PMID: 
17925449; PubMed Central PMCID: PMCPMC2034267. 
54. McCormick BA, Laux DC, Cohen PS. Neither motility nor chemotaxis plays a role in 
the ability of Escherichia coli F-18 to colonize the streptomycin-treated mouse large 
intestine. Infect Immun. 1990;58(9):2957-61. PubMed PMID: 2201640; PubMed 
Central PMCID: PMCPMC313594. 
55. Chen SL, Hung CS, Xu J, Reigstad CS, Magrini V, Sabo A, et al. Identification of 
genes subject to positive selection in uropathogenic strains of Escherichia coli: a 
comparative genomics approach. Proc Natl Acad Sci U S A. 2006;103(15):5977-82. 
doi: 10.1073/pnas.0600938103. PubMed PMID: 16585510; PubMed Central PMCID: 
PMCPMC1424661. 
56. Cusumano CK, Hung CS, Chen SL, Hultgren SJ. Virulence plasmid harbored by 
uropathogenic Escherichia coli functions in acute stages of pathogenesis. Infect 
Immun. 2010;78(4):1457-67. doi: 10.1128/IAI.01260-09. PubMed PMID: 20123719; 
PubMed Central PMCID: PMCPMC2849428. 
57. Wijetunge DS, Karunathilake KH, Chaudhari A, Katani R, Dudley EG, Kapur V, et al. 
Complete nucleotide sequence of pRS218, a large virulence plasmid, that augments 
pathogenic potential of meningitis-associated Escherichia coli strain RS218. BMC 
Microbiol. 2014;14:203. doi: 10.1186/s12866-014-0203-9. PubMed PMID: 
25164788; PubMed Central PMCID: PMCPMC4155114. 
58. Russell CW, Mulvey MA. Type 1 and P pili of uropathogenic Escherichia coli. In: 
Barocchi MA, Telford JL, editors. Bacterial pili: structure, synthesis and role in 
disease. 1 ed. Wallingford, UK: CAB International; 2014. p. 49-70. 
59. Lane MC, Simms AN, Mobley HL. complex interplay between type 1 fimbrial 
expression and flagellum-mediated motility of uropathogenic Escherichia coli. J 
Bacteriol. 2007;189(15):5523-33. doi: 10.1128/JB.00434-07. PubMed PMID: 
17513470; PubMed Central PMCID: PMC1951814. 
60. Simms AN, Mobley HL. Multiple genes repress motility in uropathogenic Escherichia 
coli constitutively expressing type 1 fimbriae. J Bacteriol. 2008;190(10):3747-56. doi: 
10.1128/JB.01870-07. PubMed PMID: 18359812; PubMed Central PMCID: 
PMC2395009. 
61. Cooper LA, Simmons LA, Mobley HL. Involvement of mismatch repair in the 
reciprocal control of motility and adherence of uropathogenic Escherichia coli. Infect 
Immun. 2012;80(6):1969-79. doi: 10.1128/IAI.00043-12. PubMed PMID: 22473602; 
 	
147 
PubMed Central PMCID: PMC3370570. 
62. Leatham MP, Stevenson SJ, Gauger EJ, Krogfelt KA, Lins JJ, Haddock TL, et al. 
Mouse intestine selects nonmotile flhDC mutants of Escherichia coli MG1655 with 
increased colonizing ability and better utilization of carbon sources. Infect Immun. 
2005;73(12):8039-49. doi: 10.1128/IAI.73.12.8039-8049.2005. PubMed PMID: 
16299298; PubMed Central PMCID: PMCPMC1307065. 
63. Giraud A, Arous S, De Paepe M, Gaboriau-Routhiau V, Bambou JC, Rakotobe S, et al. 
Dissecting the genetic components of adaptation of Escherichia coli to the mouse gut. 
PLoS Genet. 2008;4(1):e2. doi: 10.1371/journal.pgen.0040002. PubMed PMID: 
18193944; PubMed Central PMCID: PMCPMC2174974. 
64. Vosti KL. Infections of the urinary tract in women: a prospective, longitudinal study 
of 235 women observed for 1-19 years. Medicine (Baltimore). 2002;81(5):369-87. 
PubMed PMID: 12352632. 
65. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, et al. 
Induction and Evasion of Host Defenses by Type 1-Piliated Uropathogenic 
Escherichia coli. Science. 1998;282(5393):1494-7. doi: 
10.1126/science.282.5393.1494. 
66. Adiba S, Nizak C, van Baalen M, Denamur E, Depaulis F. From grazing resistance to 
pathogenesis: the coincidental evolution of virulence factors. PLoS One. 
2010;5(8):e11882. doi: 10.1371/journal.pone.0011882. PubMed PMID: 20711443; 
PubMed Central PMCID: PMC2920306. 
67. Nickel JC. Practical management of recurrent urinary tract infections in 
premenopausal women. Rev Urol. 2005;7(1):11-7. PubMed PMID: 16985802; 
PubMed Central PMCID: PMCPMC1477561. 
68. Wold AE, Mestecky J, Tomana M, Kobata A, Ohbayashi H, Endo T, et al. Secretory 
immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 
fimbrial lectin. Infection and immunity. 1990;58(9):3073-7. Epub 1990/09/01. 
PubMed PMID: 2201644; PubMed Central PMCID: PMC313613. 
69. Bollinger RR, Everett ML, Wahl SD, Lee YH, Orndorff PE, Parker W. Secretory IgA 
and mucin-mediated biofilm formation by environmental strains of Escherichia coli: 
role of type 1 pili. Mol Immunol. 2006;43(4):378-87. doi: 
10.1016/j.molimm.2005.02.013. PubMed PMID: 16310051. 
70. Friman V, Adlerberth I, Connell H, Svanborg C, Hanson LA, Wold AE. Decreased 
expression of mannose-specific adhesins by Escherichia coli in the colonic microflora 
of immunoglobulin A-deficient individuals. Infect Immun. 1996;64(7):2794-8. 
PubMed PMID: 8698510; PubMed Central PMCID: PMCPMC174141. 
71. Green SI, Ajami NJ, Ma L, Poole NM, Price RE, Petrosino JF, et al. Murine model of 
chemotherapy-induced extraintestinal pathogenic Escherichia coli translocation. 
Infect Immun. 2015;83(8):3243-56. doi: 10.1128/IAI.00684-15. PubMed PMID: 
26034214; PubMed Central PMCID: PMCPMC4496622. 
72. Wadolkowski EA, Laux DC, Cohen PS. Colonization of the streptomycin-treated 
 	
148 
mouse large intestine by a human fecal Escherichia coli strain: role of growth in 
mucus. Infect Immun. 1988;56(5):1030-5. PubMed PMID: 3281898; PubMed 
Central PMCID: PMCPMC259757. 
73. Anderson JD, Gillespie WA, Richmond MH. Chemotherapy and antibiotic-resistance 
transfer between Enterobacteria in the human gastro-intestinal tract. J Med 
Microbiol. 1973;6(4):461-73. doi: 10.1099/00222615-6-4-461. PubMed PMID: 
4587394. 
74. Lawley TD, Walker AW. Intestinal colonization resistance. Immunology. 
2013;138(1):1-11. doi: 10.1111/j.1365-2567.2012.03616.x. PubMed PMID: 23240815; 
PubMed Central PMCID: PMCPMC3533696. 
75. Rausch P, Basic M, Batra A, Bischoff SC, Blaut M, Clavel T, et al. Analysis of factors 
contributing to variation in the C57BL/6J fecal microbiota across German animal 
facilities. Int J Med Microbiol. 2016. doi: 10.1016/j.ijmm.2016.03.004. PubMed 
PMID: 27053239. 
76. Murphy KC, Campellone KG. Lambda Red-mediated recombinogenic engineering of 
enterohemorrhagic and enteropathogenic E. coli. BMC Mol Biol. 2003;4:11. doi: 
10.1186/1471-2199-4-11. PubMed PMID: 14672541; PubMed Central PMCID: 
PMCPMC317293. 
77. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in 
Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A. 
2000;97(12):6640-5. doi: 10.1073/pnas.120163297. PubMed PMID: 10829079; 
PubMed Central PMCID: PMCPMC18686. 
78. Li XT, Thomason LC, Sawitzke JA, Costantino N, Court DL. Positive and negative 
selection using the tetA-sacB cassette: recombineering and P1 transduction in 
Escherichia coli. Nucleic Acids Res. 2013;41(22):e204. doi: 10.1093/nar/gkt1075. 














The Beginning of the End 
 
This dissertation has focused on the various factors that ExPEC requires to 
colonize the host, including adhesins, toxins, plasmids, metabolism, and protection of 
bacterial DNA, with a special emphasis on how ExPEC colonizes the gut. In addition to 
being a simple hunt for bacterial fitness factors, this work touches on broader matters, 
including how the gut can act as a reservoir for recurring infections, the difficulty of 
selecting an appropriate mouse model, and the evolution of pathogenesis, which are 
discussed below. 
 
ExPEC Reservoirs for Recurrent UTIs 
Although antibiotic treatment is effective for resolving a urinary tract infection in 
most patients, a major challenge for some patients is the issue of recurrence. One study 
that followed over 1,000 women for a decade found a wide range of UTI frequency, with 
10.6% of patients experiencing no infection, to ~52% of patients suffering from 2-6 
infections, and one patient with 42 UTI episodes [1]. A critical question surrounding 
recurrent UTIs (rUTIs) has been whether the ExPEC strain that causes the initial 
infection is the same strain responsible for subsequent infections. Unfortunately, the 
answer to that question appears to depend on the study [2]. However, it is clear that 
many patients are infected by a new strain at each episode, indicating that host 
susceptibility may be an important factor that determines rUTI frequency. In many other 
patients, the same strain can be isolated during multiple UTI episodes [2, 3], suggesting 
that in these cases, a reservoir of ExPEC exists either in the patient or within their 
environment that continues to supply bacteria even after the initial UTI episode is 
resolved. 
There could be many sources of ExPEC in the case of patients that are infected 
with the same strain multiple times. A likely reservoir is the gut as it is home to relatively 
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high levels of ExPEC bacteria. This possibility is strengthened by an analysis of 6 patients 
that collectively experienced 13 rUTI episodes [3]. It was observed that the infecting 
strain could be detected in the feces between episodes in 12 (92%) of the cases. In 3 of 
these patients, antibiotic treatment only temporarily made the strain undetectable in the 
feces, whereas in the other 3 patients, the antibiotic treatment did not alter fecal levels of 
the pathogen at all. Therefore, it is possible that during antibiotic treatment for an 
ongoing UTI, the gut-localized population of the infecting strain is not successfully 
cleared, and that it is capable of reseeding the urinary tract for a subsequent infection. 
In addition to the gut, there are other possible ExPEC reservoirs that could be 
driving rUTIs. For example, during bladder infection, ExPEC bacteria are capable of 
invading into the bladder epithelial cells and living intracellularly, sheltered from 
antibiotic treatment [4]. Within the superficial host cells, the bacteria quickly replicate 
and form intracellular bacterial communities, which can exit the host cell into the 
bladder lumen. Within deeper layers of the epithelium, the bacteria can remain 
quiescent for longer periods of time, but later resurge and potentially reinitiate 
symptoms. Other reservoirs are also possible, including within pets, a sexual partner, or 
the environment [5, 6]. 
The treatment of rUTIs is challenging, as a delicate balance must be maintained 
between helping the patient and avoiding selection for antibiotic resistance or disruption 
of the gut microbiota. For women with 2-4 UTIs per year, an economical and practical 
strategy is patient-initiated antimicrobial treatment [7]. This strategy allows the patient 
to keep antibiotics on hand and begin treatment immediately upon the appearance of 
symptoms without having to wait for an appointment and a prescription. For women 
with more frequent UTIs, a prophylactic approach can be taken through either 
continuous administration of low-dose antibiotics, or a single dose taken immediately 
after intercourse [7]. 
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An attractive future treatment option for rUTI would be to remove the ExPEC 
reservoir in addition to treating the UTI. For example, combining antibiotic treatment 
with administration of chitosan—a chemical that facilitates exfoliation of the bladder 
epithelium—can reduce overall bacterial titers in infected mice, presumably by removing 
intracellular reservoirs [8]. A more difficult task would be to remove ExPEC from the gut 
reservoir without pathologic disruption of the microbiota. However, such a strategy 
could possibly reduce rUTIs in patients that are in desperate need of an effective 
treatment. The work presented in this dissertation could perhaps be used in the future to 
design such a treatment, as many possible therapeutic targets have been identified, 
including RqlI, GlpR, and type 1 pili. Unfortunately, like most antimicrobial treatments, 
it is fairly easy to imagine resistance evolving. For example, a simple loss-of-function 
mutation in rqlH would render an RqlI-targeted therapy useless. Due to the 
interconnectedness of metabolism, it is likely that there are mutations that would also 
nullify targeting the glycerol degradation pathway. In contrast, attacking type 1 pili with 
mannosides has already been shown to be effective at clearing ExPEC from the gut 
(Spaulding, et al., personal communication). 
 
Limitations of the Mouse Model of Gut Colonization 
One major factor that influences the outcome and interpretation of gut 
colonization experiments is the choice of mouse model. The most common protocol for 
E. coli gut colonization has been the streptomycin-treated mouse model, in which the 
antibiotic streptomycin is added to the water prior to inoculation, and is continuously 
administered throughout the experiment [9]. This model is convenient due to the ease of 
antibiotic administration and the consistency with which the mice are colonized. The 
major drawback for this method is the necessary disruption of the microbiota. Another 
system utilizes germ-free mice, which allows for easy colonization by E. coli, and which 
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has the advantage of simplifying interpretation of the results as the complexity of the 
microbiota is sidestepped. However, germ-free mice exhibit many phenotypes that differ 
from conventional mice [10]. 
In this work, we chose to colonize conventional mice without any antibiotic 
treatment, allowing us to observe gut colonization by ExPEC in the presence of a 
complete microbiota and a normal host environment. The mice were colonized at a high 
frequency, and the bacteria persisted for long periods of time. This is contrary to 
expectations put forth in studies utilizing the streptomycin-treated mouse model, a 
model that is based on the observation that antibiotic treatment is generally required to 
provide a niche for E. coli to inhabit. Furthermore, through personal communications, 
we have learned that other ExPEC researchers have failed to colonize conventional mice 
with ExPEC in the absence of streptomycin. There appears to be something unique about 
our mouse colony that allows the mice to be readily colonized by ExPEC. We hypothesize 
that the susceptibility of our mice to ExPEC colonization is likely due to differences in 
microbiota composition, as the microbiota is known to differ among animal facilities 
[11]. For example, we have never detected any E. coli in our mice prior to colonization by 
ExPEC, neither by plating feces onto MacConkey agar nor by 16S sequencing, whereas 
others have isolated endogenous ExPEC strains from their colonies [12]. The lack of 
endogenous E. coli may facilitate ExPEC gut colonization in our experiments, but there 
are still E. coli strains that do not colonize well in our model, such as MG1655, a non-
pathogenic K12 derivative that is frequently used in gut colonization experiments. 
Therefore, this model of colonization allows us to test aspects of ExPEC gut colonization 
in the face of an undisturbed microbiota, with the drawback of not being easily repeated 
at other facilities. However, this limitation itself is interesting. Future work to define the 
differences in ExPEC gut persistence between facilities could be invaluable to 




Another limitation of our in vivo model is the relatively high amount of deviation 
in the data, especially when two bacterial strains are competed. The “spread” in data 
points tends to increase over the course of the experiment and complicate interpretation. 
For example, when the ∆rqlHI strain was competed against the WT strain in the mouse 
gut, the standard deviation rose from 0.25 at day 5 to 1.49 at day 50 (Fig 3.8C). At day 
50, the competitive index ranged from -3.34 (2,200-fold more WT than mutant) to 2.24 
(170-fold more mutant than WT). However, the median competitive index steadily held 
close to 0, and most of the indices were smaller values between 1 and -1, making it easier 
to conclude that there was no difference between the WT and mutant strain. Another 
group made similar observations when competing two E. coli strains with equal fitness 
[13]. Two derivatives of MG1655 were created in which either YFP or CFP were 
expressed, but which were otherwise identical. When these two strains were competed in 
streptomycin-treated mice, the expectation that the ratio between the two strains would 
remain at 1:1 throughout the experiment did not hold true in many of the mice. In 
several mice, the YFP strain became a minor part of the total MG1655 population, while 
in other mice, it dominated by the end of the experiment. As several other studies have 
reported that E. coli can acquire consequential mutations during gut colonization 
experiments [14-18], the authors tested whether evolution was occurring in their study. 
Indeed, over the course of the experiment, the strains developed increased gut fitness, 
and were able to outcompete the ancestral strain in subsequent assays. By sequencing 
these derivatives, many loss-of-function mutations in the gat operon were observed, 
which would eliminate the ability of the strain to utilize galactitol, but are hypothesized 
to improve its ability to utilize other sugars. The alteration of metabolism is a common 
result of the short-term evolution occurring in these studies [15-17]. We believe that such 
evolution is occurring in our experiments, and is leading to increased noise in the data. 
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Unfortunately, various attempts to reduce the deviation in the data failed. Future work to 
define the beneficial mutations could allow us to mitigate the effects of this phenomenon 
and make the data easier to interpret. 
 
The Evolution of Extraintestinal Pathogenesis 
A major question that remains in ExPEC research is how extraintestinal 
pathogenesis came to be, and why it might be beneficial to the bacteria. To answer these 
questions, the selective pressures that ExPEC has experienced need to be defined. It is 
often assumed that ExPEC evolution has been mostly driven by the gut environment 
[19]. This assumption is derived from the argument that the gut is the major ExPEC 
niche, and that extraintestinal infections tend to be shorter in duration in comparison to 
the time that ExPEC spends within the gut. The shorter duration limits the transmission 
of selected clones to other hosts. At its extreme, infection of an extraintestinal niche can 
be a dead-end, as in the case of lethal bacteremia or meningitis where transmission from 
one host to another is unlikely. However, whether infection of the urinary tract is also a 
dead-end is debatable, especially when the pre-antibiotic era is considered. One study 
tracked nonpregnant women suffering from cystitis who received a placebo pill instead 
of an antibiotic [20]. A little over 70% of the women had cleared the infection 
spontaneously within 4 weeks. Although in most cases the infection was resolved 
relatively quickly, a substantial proportion (~30%) continued to exhibit symptoms and 
shed bacteria in their urine 1 month after infection. This suggests that prior to antibiotics 
(or even today in situations where antibiotics are not readily available), there existed a 
larger window of opportunity for ExPEC transmission from the urine of one individual to 
another individual or the environment. Although transmission via this route is 
substantially more modest than through the fecal route, and probably even less frequent 
now than in the past, it may not strictly be a dead-end. To my knowledge, a comparison 
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of the rate at which ExPEC is transmitted from one individual to another, or to the 
environment, via feces and urine has not been determined. 
If one operates under the assumption that the gut is the major host-associated 
evolutionary arena for ExPEC—and that other niches, such as the urinary tract, play a 
minor role—then the mechanism driving evolution of extraintestinal virulence factors is 
a puzzle. How could a gene evolve to be used specifically in the blood, for example, when 
that niche is rarely encountered, and selected clones are passed on very infrequently? 
Three hypotheses explaining the evolution of virulence in general [21] can been 
considered in the context of ExPEC pathogenesis. First, the “conventional wisdom” 
hypothesis is that the coevolution of host and pathogen is always moving towards a 
commensal relationship. Therefore, a pathogenic interaction is a relatively young host-
microbe association that will become less antagonistic over time. The drift from 
pathogen to commensal has been observed in various isolates such as Nissle 1917 and 
ABU 83972, which both exhibit degradation of pathogen-associated genes [22], but it is 
unclear whether this process is occurring for all ExPEC strains. 
A second evolutionary idea is the trade-off hypothesis, which says that if the rate 
of transmission of a pathogen between individuals is higher than the rate of pathogen-
mediated mortality, then virulence could be favored, especially if increased virulence 
translates to increased transmission [21]. One could imagine this balance coming into 
play during UTIs, in which the infection increases the frequency at which the individual 
urinates, which could possibly increase the transmission rate of the pathogen. 
The third (and generally favored) evolutionary principle that is frequently applied 
to ExPEC is that of coincidental evolution. The idea is that extraintestinal virulence 
factors were actually shaped by selective pressures found in the gut, but that they happen 
to be useful in other niches, such as the urinary tract or blood [21]. Our data seem to 
indicate that this is not always true, as there are several canonical ExPEC virulence 
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factors that appear to play no role in bacterial fitness within the gut (see Chapter 5). 
Although it is difficult to extrapolate these findings to describe the entire evolutionary 
story of a pathogen, it is safe to say that evolutionary principles such as coincidental 
evolution may not apply to the entire genetic content of a bacterium. Rather, 
coincidental evolution could apply to some genes but not others. Furthermore, there are 
many other niches (e.g. the environment) and situations that need to be considered. For 
example, one study found a correlation between the ability of a given E. coli strain to 
resist being eating by amoeba and the extraintestinal virulence of that strain [23]. It may 
be that the ability of ExPEC to withstand attacks from amoeba both inside the gut and in 




The data presented in this dissertation begin to paint a picture of the required 
genes for ExPEC host colonization, especially within the gut. A lot of work is needed to 
better understand the colonization process, especially with an eye towards possible 
future therapies. The first major challenge in this endeavor is to simply identify genes 
important for gut colonization. The second—and possibly more difficult—task is to 
understand the functions of those genes. As a deeper knowledge of ExPEC host 
colonization is formed, therapeutic strategies to combat extraintestinal infections, rUTIs, 
and antibiotic resistance will improve. 
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Abstract
Strains of Extraintestinal Pathogenic Escherichia coli (ExPEC) exhibit an array of virulence strategies and are a major cause of
urinary tract infections, sepsis and meningitis. Efforts to understand ExPEC pathogenesis are challenged by the high degree
of genetic and phenotypic variation that exists among isolates. Determining which virulence traits are widespread and
which are strain-specific will greatly benefit the design of more effective therapies. Towards this goal, we utilized a
quantitative genetic footprinting technique known as transposon insertion sequencing (Tn-seq) in conjunction with
comparative pathogenomics to functionally dissect the genetic repertoire of a reference ExPEC isolate. Using Tn-seq and
high-throughput zebrafish infection models, we tracked changes in the abundance of ExPEC variants within saturated
transposon mutant libraries following selection within distinct host niches. Nine hundred and seventy bacterial genes (18%
of the genome) were found to promote pathogen fitness in either a niche-dependent or independent manner. To identify
genes with the highest therapeutic and diagnostic potential, a novel Trait Enrichment Analysis (TEA) algorithm was
developed to ascertain the phylogenetic distribution of candidate genes. TEA revealed that a significant portion of the 970
genes identified by Tn-seq have homologues more often contained within the genomes of ExPEC and other known
pathogens, which, as suggested by the first axiom of molecular Koch’s postulates, is considered to be a key feature of true
virulence determinants. Three of these Tn-seq-derived pathogen-associated genes—a transcriptional repressor, a putative
metalloendopeptidase toxin and a hypothetical DNA binding protein—were deleted and shown to independently affect
ExPEC fitness in zebrafish and mouse models of infection. Together, the approaches and observations reported herein
provide a resource for future pathogenomics-based research and highlight the diversity of factors required by a single
ExPEC isolate to survive within varying host environments.
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Introduction
Within the Escherichia coli lineage there are several distinct
virulent subgroups that are principally classified by an ability to
cause a common set of diseases. One specific subgroup,
Extraintestinal Pathogenic E. coli (ExPEC), is typically thought
to be a benign inhabitant of the lower intestinal tract of warm-
blooded vertebrates. However, outside this niche, ExPEC strains
have the ability to persist in an array of secondary host-associated
habitats where they can cause urinary tract infections (UTIs),
meningitis, bacteremia and sepsis in both humans and domesti-
cated animals [1,2,3,4]. The combined medical, agricultural and
economic burden of ExPEC-related diseases is likely to increase as
antibiotic resistance spreads [1,5,6]. Delineation of the genetic
elements utilized by ExPEC to infect such a diverse spectrum of
host niches and cause disease promises to advance our
understanding of pathogen evolution and behavior while also
highlighting more effective strategies to combat these pervasive
opportunistic pathogens.
Despite colonizing similar ecological niches, ExPEC isolates can
differ by 20–30% of their respective gene inventories and to date, a
specific and ubiquitous molecular trait or function exclusive to this
cohort has not been characterized [7,8]. Without knowledge of a
unifying ExPEC-associated feature, the development of broad-
spectrum therapeutic strategies is made exceptionally difficult [9].
Previous work indicates that individual ExPEC strains appear to
have evolved distinct genetic repertoires that promote unique and
at times subtle fitness advantages during colonization of specific
host environments [10,11]. It is becoming clear that the working
definition of ExPEC is more multigenic in nature. Further
complicating the search for ExPEC-associated traits is the 30–
40% of genes within their genomes that still require functional
annotation [7]. This problem will likely persist as genome
sequencing continues to outstrip rates of experimental character-
ization. Consequently, there is a pressing need to develop methods
that mesh high-throughput genomics with context-based function-
al observations—a notion that is becoming increasingly appreci-
ated [12,13]. To this end, we adapted a previously described








transposon mutagenesis technique known as ‘Tn-seq’ to identify
genes that promote pathogen fitness during colonization of a
vertebrate host [14,15].
The use of transposons to conduct unbiased forward genetic
screens in bacteria has provided many avenues for investigation
over the last two decades [16,17,18]. However, these approaches
are, for the most part, time and labor intensive and often lack
reliable quantitative metrics and sampling depth to identify genes
of interest for retrospective follow-up. On the other hand,
transposon mutagenesis as a tool is quite amenable to innovation
[19,20,21]. Tn-seq, also known as ‘INSeq’, utilizes deep sequenc-
ing to monitor the composition of insertion variants within bulk
mutant pools [14,15]. This is accomplished through use of a
modified mariner transposon that contains recognition sites within
the two distal inverted repeats that are specific for the restriction
enzyme MmeI. Cleavage of DNA by this enzyme occurs 18–20
base pairs from its recognition site, such that excision of the
transposon by MmeI captures flanking genomic sequences. These
sequences serve as tags that can be used to track the relative
abundance of distinct insertion variants within heterogenetic
mutant libraries. This technique ultimately allows the fitness of
thousands of mutant variants to be quantified simultaneously
following exposure to specific selective pressures. By comparing
the composition and abundance of mutants before and after
passage through selective conditions, such as within a host
organism, a genome-wide map of loci that are important for
bacterial fitness can be assembled.
The screening approach reported here involved injection of 48 h
post-fertilization (hpf) zebrafish embryos with transposon-mutagen-
ized pools of ExPEC derived from a single parent isolate.
Embryonic zebrafish are particularly useful for this type of selection
screen because their vertebrate physiology closely matches that of
humans, and they have proven useful for the identification and
characterization of virulence determinants that enable ExPEC to
survive within host niches [10,11,22,23]. Of particular importance,
zebrafish embryos possess many of the same innate defenses that
mammalian hosts rely upon to resist ExPEC (e.g. phagocytes,
complement and antimicrobial peptides) [10,24,25,26]. This
attribute underscores the ability of the zebrafish host to mirror a
set of overlapping selective pressures that ExPEC naturally
encounter. Zebrafish embryos can be used to model both localized
and systemic infections and the complete recovery and enumeration
of bacteria from within the entire host is relatively straightforward
[10,11]. Through three independent biological experiments em-
ploying Tn-seq we identified 970 genes (,18% of gene content) that
promote the competitive fitness of ExPEC during either localized or
systemic infections. A large number of these genes have unknown
functions, while many others have reported roles in iron transport,
bacterial secretion, two-component signaling and metabolism. To
focus on genes that are likely important to ExPEC pathogenesis
specifically, we devised a gene ontology-like method called ‘TEA’
(Trait Enrichment Analysis), that enabled us to organize candidate
genes according to their association with certain bacterial lineages
or groups of bacteria that are phenotypically similar. The data
presented in this report indicate that TEA, in combination with Tn-
seq, provides an effective, streamlined approach for identifying
biologically relevant fitness and virulence determinants that are
employed by ExPEC within various host environments. Datasets
generated in this study have been made freely available through a
curated and searchable web-based data viewer (http://
pathogenomics.path.utah.edu/F11_TnSeq/).
Results
Mutant library construction and screen design
We previously described the use of the embryonic zebrafish as a
surrogate host to study genotype-phenotype relationships of a
variety of human and non-human ExPEC isolates [10,11]. During
this initial work we observed that the human cystitis (bladder
infection) isolate F11 is particularly adept at growing within and
eliciting death of zebrafish during either localized or systemic
infections. Elucidation of the virulence gene repertoire (i.e. genetic
determinants that promote pathogenic behaviors such as coloni-
zation or destruction of host tissues) of this ExPEC strain using Tn-
seq provides a starting point for future comparative pathoge-
nomics studies. Figure 1 presents an outline detailing the negative
selection screen carried out in this study.
Transposon mutagenesis was accomplished by using the
previously described pSAM vector and conjugation [15]. This
plasmid, which contains a mariner transposon flanked by MmeI
modified inverted repeats and the himar1C9 transposase, was
retrofitted with an E. coli compatible antibiotic resistance cassette
and promoter elements to generate pSAM-Ec (Figure S1).
Multiple, independent mating events were performed to assemble
three transposon mutant libraries to be used in three separate
replicate screens (Figure 1A). It was determined that each pool
contained a minimum of 50,000 distinct insertion variants by
enumerating selectable, transposon positive colonies immediately
following conjugation when mutant siblings are minimal. Success-
ful transposition of single inserts into individual bacterial
chromosomes was verified by detection of the transposon by
Southern blot analysis (Figure S2). Because the cost of a pre-screen
sequence analysis was prohibitive, we utilized a more economical
means to confirm the diversity and saturation of mutant pools.
The frequency of variants defective for lactose utilization, curli
production and glycogen storage was determined using standard
colorimetric plating assays (Figure S2), which demonstrated that
our transposon mutant libraries were sufficiently saturated and
ready for in vivo screening. Post-hoc sequencing later confirmed
that our libraries contained 60,000 to 80,000 mutant variants
each, corresponding to an insertion event approximately every
75 bp within the F11 chromosome (Table S1).
Author Summary
Antibiotic resistance is an increasingly serious problem,
especially among pathogenic strains of Escherichia coli that
cause urinary tract infections, sepsis and meningitis. It is
important to obtain a more comprehensive genome-wide
understanding of bacterial virulence because it has the
potential to uncover novel and alternative therapeutic
targets. Therefore, we probed the genome of a pathogenic
E. coli isolate using transposon mutagenesis, deep
sequencing and comparative pathogenomics in an effort
to define its virulence gene repertoire. Using this multi-
layered approach in combination with high-throughput
zebrafish infection models, we identified hundreds of
genes that affect pathogen fitness during localized and/or
blood-borne infections. We also developed a bioinfor-
matics-based method to systematically sift through our
datasets for genes that are broadly conserved among an
assortment of pathogenic species. Follow-up analysis of
several pathogen-associated candidate genes using zebra-
fish and mouse infection models highlighted the capacity
of our approach to identify novel fitness determinants. The
results from this study are available via an interactive
online data viewer (http://pathogenomics.path.utah.edu/
F11_TnSeq/) so that investigators can more effectively
search and utilize these findings.
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For each independent biological experiment, a single mutant
library was cultivated from a frozen stock in M9 minimal media
overnight at 37uC (Figure 1B). During this initial outgrowth period,
variants with insertions that disabled genes critical for normal
replication within broth culture were likely reduced in abundance or
completely eliminated. Prior to injection of 48 hpf zebrafish
embryos, a 1 ml aliquot of each overnight culture was pelleted,
washed and suspended in phosphate buffered saline (PBS) at the
desired density. A second aliquot was pelleted and stored as a
reference ‘input’ population for later sequencing and comparative
analyses with ‘output’ populations. A dose of approximately 3,000
colony forming units (CFU) from each mutant library was injected
into either the pericardial cavity (PC) or into the blood via the
circulation valley (CV) of zebrafish embryos (200 embryos per niche
per experiment were used to ensure adequate sampling of mutant
variants) (Figure S3). Injection of the PC provides a model of
localized tissue infection, whereas injection into the CV results in
rapid dissemination of ExPEC via the bloodstream, modeling
bacteremia or sepsis-like infections [10,11]. We previously deter-
mined that a variety of ExPEC isolates have the capacity to grow
unchecked within the PC, while only a subset are able to persist and
multiply within the bloodstream. Presumably, the microenviron-
ments encountered by ExPEC following injection into the zebrafish
circulatory system are more challenging than the PC with respect to
nutrient availability, host defenses or other as-yet-undefined factors
[10,11]. F11 is able to survive and replicate within both the PC and
blood. Once injected, selection proceeded for 18 to 20 h—a
timeframe in which the mutant F11 population grows to between
104 and 106 CFU/embryo and elicits death in ,40–60% of the
animals (Figure S4). Total genomic DNA of the surviving F11
variants was recovered from batch-homogenized fish (alive and
dead) to produce output pools. In parallel, equal amounts of
genomic material from input and corresponding output pools were
digested using theMmeI restriction enzyme followed by enrichment
of transposon-containing fragments with flanking genomic sequenc-
es via gel electrophoresis. The fragments were then excised and
prepared for indexed sequencing on a single lane of an Illumina
HiSeq 2000. General sequence-based features of each mutant pool,
including number of detected mutant variants, sequencing depth,
saturation and insertional bias, are summarized in Table S1.
Genetic footprinting by Tn-seq reveals distinguishable
gene sets that have distinct functional compositions
within the ExPEC genome
Gene insertion tolerance after passage in broth
culture. Beyond targeting T+A dinucleotides, transposable
Figure 1. Schematic of the Tn-seq selection screen used to identify genes necessary for fitness in a zebrafish infection model. (A)
Three selection screens were performed (green, grey and blue tracks) using three ‘input’ pools to generate a total of six ‘output’ pools. (B) For each
replicate screen, an independent transposon mutant library was created. Expansion of mutant libraries from frozen stocks was done at 37uC for 24 h
to produce input pools and starting inoculum. Approximately 200 zebrafish embryos were injected in the pericardial cavity (PC) or circulation valley
(CV, blood) with approximately 3,000 mutant bacteria. After a selection period of 20 h, zebrafish were homogenized to facilitate recovery and
extraction of total DNA. The restriction enzyme MmeI was used to excise transposons and flanking F11 genomic DNA for analysis by deep
sequencing.
doi:10.1371/journal.pgen.1003716.g001
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mariner elements have a relatively low insertional bias (Table S1
and Figure 2: F11 genome) [27]. Using sequence data from the
three input samples exclusively, the number of insertion sequences
mapped per 100 bp for all annotated regions was calculated to
determine an insertion frequency (Table S2, Methods). As
anticipated, we observed that transposon insertion rates within
our mutant libraries mostly occurred at a steady rate independent
of chromosomal region. An approach akin to traditional genetic
footprinting was used to determine the specific insertional
tolerance of each gene within the F11 genome [28,29]. Gene
insertion rates that were more than 1 standard deviation below the
genome-wide mean were considered hypo-tolerant (,2.1 inserts/
100 bp, n=609, Figure 2: hypo-tolerant), those within +/21
standard deviation were tolerant (2.1 , inserts/100 bp ,4.5,
n=4,272) and those that were more than 1 standard deviation
above the genome-wide mean were hyper-tolerant (.4.5 inserts/
100 bp, n=431, Figure 2: hyper-tolerant). Genes assigned to the
hypo-tolerant gene set presumably provide ‘essential’ or ‘core’
physiological functions. In contrast, genes within the hyper-
tolerant gene set are likely not required during growth in broth
culture and/or exhibit certain genetic features that support high
rates of transposon insertion. Using the Kyoto Encyclopedia of
Genes and Genomes (KEGG) functional hierarchies, the hypo-
tolerant gene set, as expected, was found to be significantly
enriched for informational functions related to transcription and
translation and included various noncoding RNAs (ncRNA) and
transfer RNAs (tRNA) (Figure 3A and B). The hyper-tolerant gene
set contained a significantly elevated proportion of ribosomal
RNAs, ncRNAs and genes annotated as ‘hypothetical’ (Figure 3B
and F).
Genes required for in vivo fitness. To identify genes
necessary for in vivo fitness, a modified genetic footprinting
approach was used (Figure S5). For input-output pairs in each
experimental replicate (i.e. insertion mutants present in cognate
input and output pools), a normalized occurrence frequency
reflecting their abundance was calculated. This approach relies on
an ability to count the number of specific mutant variants in
corresponding input and output pools. However, strong negative
selection within the zebrafish host may have completely purged
variants with disruptions in genes critical for fitness. Therefore, we
established criteria to determine which mutant variants were likely
lost due to selection and not by chance through experimental
bottlenecks (Figure S5 and Methods). Missing variants that met
these criteria were assigned a value equal to the limit of detection.
Within each replicate experiment, we employed a Wilcoxon
signed-rank test on the collection of inserts for each gene to
determine if the distribution of insert occurrence frequencies
between input and output samples was significantly different. This
is a conservative approach that requires consistency between
insertion variants across a given gene for it to be identified as a
fitness determinant. Genes with 10 or more measured inserts, a
Wilcoxon p value less than 0.05 and an average decrease in variant
abundance of at least 2-fold were considered to have a significant
influence on in vivo fitness (FDR ,10%). Of the 970 genes
identified across all replicates and niches, only 21 overlapped with
the hypo-tolerant gene set, suggesting that the vast majority of
genes identified are specifically required by F11 to survive within
the zebrafish embryo (Figure 2: in piscis, http://pathogenomics.
path.utah.edu/F11_TnSeq/). This ‘in piscis’ gene set represents
,18% of the annotated regions within the F11 chromosome and is
enriched for genes with functions that fall under the KEGG
category ‘environmental interactions’ and the subcategories
membrane and iron transport (Figure 3C). Additionally, metabolic
functions were also highly represented, encompassing genes
involved in glycan biosynthesis and the metabolism of amino
acids and carbohydrates (Figure 3E). The proportion of candidate
fitness genes that were identified within each of the three mutant
libraries is visualized in Figure S6. Genes within the six different in
Figure 2. Transposon insertion rates for loci within different gene sets. From each input pool (1, 2 and 3) an average number of insertions
detected per 100 bp was calculated for each annotated region within the F11 genome. Box plots indicate median and interquartile ranges with
whiskers extending to the 1st and 99th percentiles. Dashed lines mark the upper and lower boundaries for hypo and hyper-tolerant gene sets,
respectively. Gene set sizes: F11 genome - 5,312; hypo-tolerant - 609; hyper-tolerant - 431; in piscis - 970; multi-niche - 76; blood - 772; PC - 122;
advantageous - 227. Note, the insertion rates reported here are expected to be overestimated—please refer to Methods section ‘Candidate
Identification’ for a complete description of how the number of transposon insertion events was determined.
doi:10.1371/journal.pgen.1003716.g002
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piscis gene sets showed only weak, though still in some cases
significant, overlap (denoted in Figure S6), suggesting that the
screening of multiple libraries was important for a more thorough
enumeration of regions that influence in vivo fitness. Of note, we
speculate that we did not fully reach a level of experimental
saturation that matched the mutagenic saturation of our libraries.
This observation may indicate a point of consideration for future
Tn-seq-based screens using high-throughput surrogate hosts such
as zebrafish where initial inoculum doses are relatively small and
the stochastic nature of infection can influence the resolution of
more subtle phenotypes. However, based on the findings presented
in the following sections, we conclude that this perceived
experimental noise did not compromise our ability to accurately
identify and confirm genes of importance to ExPEC fitness and
virulence.
Niche-dependent gene requirements. Seventy-six genes
(1.4% of total gene content) were found to be necessary for fitness
during both localized (PC) and systemic (blood) infections (http://
pathogenomics.path.utah.edu/F11_TnSeq/). This ‘multi-niche’
gene set appears to collectively encode functions that directly
influence gene expression and membrane architecture, both of
which are known to be critical for pathogen fitness. Indeed, a
number of the multi-niche genes have already been recognized for
their role in bacterial stress resistance, regulation of virulence
genes and pathogenesis (Table 1). Transposon inserts within
several of the multi-niche genes resulted in some of the most
dramatic declines in F11 fitness in vivo (Table 1). Notable
candidates include EcF11_3256/bipA, EcF11_1255/lrhA and
EcF11_2271/rfaH [30,31,32]. This gene set is also remarkably
enriched for factors that function in glycan biosynthesis, including
several genes involved in the production of capsular polysaccha-
rides, which is a well-documented ExPEC-associated virulence
trait (Figure 3E) [33,34].
As noted above, the zebrafish PC is more permissive to ExPEC
growth than the bloodstream [10,11]. Corroborating this obser-
vation, we found 772 genes to be exclusively required for blood-
borne fitness while only 122 genes were exclusive to the PC
(http://pathogenomics.path.utah.edu/F11_TnSeq/). This blood-
specific gene set was enriched for 7 different KEGG functional
categories, whereas the PC-specific gene set was enriched for only
1 (Figure 3, p,0.05). Iron transport, the sole category enriched
within the PC gene set, was also enriched within the blood set
(Figure 3C). Additional categories that were enriched among
blood-borne fitness genes covered signal transduction, membrane
transport and the metabolism of amino acids, carbohydrates and
lipids (Figure 3C and E). These observations indicate that the
ability of ExPEC to survive and grow systemically within the
zebrafish is, in part, dictated by a functionally diverse set of genes
that facilitate the utilization of nutrients that are likely scavenged
from the host.
Retrospective validation of a Tn-seq-derived fitness
determinant. We chose the candidate gene EcF11_3256/
bipA—which has not been previously reported to play a part in
the virulence potential of ExPEC—to experimentally confirm the
proficiency of our Tn-seq approach. An insertion map of this gene,
depicting the reduction in fitness for each variant across all six
pools, is presented in Figure 4A. The average changes in fitness for
bipA and neighboring genes were also examined and indicated that
the disruption of only bipA correlated with the observed fitness
defect (Figure 4B). BipA is conserved across several bacterial phyla
and has previously been shown to be a ribosome-associated
GTPase that can coordinate the expression of virulence and stress
response genes [30,35,36]. A targeted deletion of the EcF11_3256/
bipA allele was generated and the resulting mutant derivative
injected into the zebrafish PC and CV at a one-to-one ratio with
wild type F11. F11D3256 exhibited a significant reduction in
fitness compared to the wild type strain in both environments
(Figure 4C). Independent challenges within the PC and blood-
stream revealed that F11D3256 also exhibits significantly attenu-
ated killing kinetics compared to wild type (Figure 4D). These
results confirm that EcF11_3256/bipA is a critical component of
F11’s genetic repertoire and promotes both the fitness and
virulence of this ExPEC strain within distinct host environments.
Collectively, the identification of genes with known roles in
bacterial pathogenesis (Table 1) and our observations with the Tn-
seq-derived in piscis candidate gene EcF11_3256/bipA validate the
Tn-seq protocol described here as a viable approach for detecting
fitness and virulence determinants of ExPEC.
Disruptions that confer an in vivo fitness advantage. We
identified 227 genes (,4% of gene content), that when disrupted
conferred a fitness advantage to F11 within the zebrafish host
(http://pathogenomics.path.utah.edu/F11_TnSeq/). Twenty of
these gene disruptions were advantageous in both the PC and
blood, 124 were advantageous only in the PC and 84 conveyed
significant advantages in only the blood. KEGG functional
categories enriched within the ‘advantageous’ gene set include
cell motility, nucleotide metabolism and biosynthesis of vitamins
and cofactors (Figure 3D and E). This indicates that motility is
likely dispensable for survival within zebrafish and agrees with
previous work showing that loss of this trait can provide bacteria
with a fitness advantage in some host settings [37]. Other factors
encoded within the advantageous gene set may control processes
that are easily trans-complemented by neighboring bacterial cells
through the production of ‘common goods’ or represent negative
regulators of virulence determinants that promote competitive
growth [38]. Thirteen of the 227 advantageous genes were hyper-
tolerant to transposon insertion, suggesting that the inactivation of
these genes may have provided a growth advantage prior to in
piscis selection (Figure 2: advantageous).
Trait Enrichment Analysis (TEA) is used to filter Tn-seq-
derived candidate genes for putative virulence
determinants
To focus the list of Tn-seq-derived candidate genes for further
study, we developed a qualitative ranking system using a
customized algorithm referred to as Trait Enrichment Analysis
(TEA). The underlying premise of TEA was inspired by molecular
Koch’s postulates, which are a widely acknowledged set of
guidelines used by investigators to critically assess the contributions
made by certain genetic elements to the virulent nature of
pathogenic organisms [39]. In particular, TEA draws on the first
Figure 3. Functional KEGG categories enriched within gene sets. To orient the reader to graph organization and symbols, a key is provided in
the lower right corner. The cumulative percent of genes (y-axis) within each Tn-seq-derived gene set (x-axis) belonging to the functional categories
(A) informational, (B) RNA (C) environmental interactions, (D) cellular processes, (E) metabolism and (F) hypothetical is depicted. The proportion of
genes contributed by specific sub-KEGG categories is represented by stacked elements within each column. Significant enrichments for KEGG and
sub-KEGG categories are denoted with asterisks and white circles, respectively. Gene set abbreviations: hypo-tol. = hypo-tolerant; hyper-tol. = hyper-
tolerant; advant. = advantageous. Theoretical KEGG category compositions for Tn-seq gene sets and p values were determined using 10,000 Monte
Carlo simulations (Methods).
doi:10.1371/journal.pgen.1003716.g003
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axiom of these postulates, which states that, ‘‘The phenotype or
property under investigation should be associated with pathogenic members of a
genus or pathogenic strains of a species.’’ [40]. Thus, the primary goal of
TEA is to identify correlations between bacterial genes and
bacterial traits (i.e. genotype-phenotype relationships).
TEA was carried out as outlined in Figure 5. Briefly, protein
sequences were acquired from an ecologically diverse, manually
curated collection of 165 bacteria representing six phyla and
assembled to form the TEA metaproteome database (TEA-MD,
Table S3). Each bacterial strain was annotated with ‘trait
categories’ defining habitat, niche of isolation, taxonomic lineage
and phenotype (i.e. pathogen or non-pathogen). Homologues were
retrieved for each of the 5,146 protein-coding genes contained
within the F11 chromosome using the Basic Local Alignment
Search Tool: BLASTp (Methods) [41]. Because proteins in the
TEA-MD are linked to a set of traits defined by their source
bacterium, homologue collections associated with F11 proteins can
be appraised for the presence of a universal characteristic in a
similar fashion to traditional gene ontology and KEGG enrich-
ment analyses. As a result, hypotheses can then be generated
regarding a protein’s evolutionary origins (i.e. horizontal vs.
vertical inheritance or homoplasy) and possible influence on
bacterial physiology or behavior based on its combination of trait
associations. A complete description of the TEA-MD, including
the number of organisms and proteins comprising each trait
category and the relative proportions of phyla compared to
sequenced isolates in GenBank, is provided as supporting
information (Figures S7 and S8).
Pathogen-associated genes within Tn-seq gene
sets. TEA, as it was employed here, aimed to assign ‘trait
identities’ to F11 genes, with particular attention being paid to
genes that are common to known pathogens and therefore,
putative virulence determinants (Figure 5). It was found that
approximately 22% of the F11 genome is made up of genes with
pathogenic identity—1,166 F11 genes are significantly more
associated with pathogen genomes (Methods). Considering Tn-
seq-derived candidate genes, it was anticipated that the in piscis
gene set be enriched for these types of genes. Indeed, a significant
portion of the 970 in piscis genes had pathogenic identity (246
genes, 25% of gene set, p=0.009) (Table S4 and http://
pathogenomics.path.utah.edu/F11_TnSeq/). The enrichment of
pathogen-associated genes within the in piscis gene set was largely
attributed to the composition of both the PC and blood gene sets,
which also had a significant number of genes with pathogenic
identity as determined by TEA (PC: 39 genes, ,32% of gene set,
p=0.008; blood: 192 genes, ,25% of gene set, p=0.0485).
Interestingly, the multi-niche gene set was not enriched for
pathogen-associated genes (15 genes, ,20% of gene set,
p=0.786).
We conclude from these data that genes required for F11 fitness
in multiple niches are likely to encode more basic ‘core’ type
functions that may enable both pathogenic and non-pathogenic
strains alike to better deal with general stresses encountered within
varied host environments, but not necessarily in broth culture. In
contrast, the niche-specific genes, which are more likely to be
pathogen-associated, may endow bacteria like F11 with salient,
pathoadaptive traits that are perhaps contextually regulated.
Along these lines, we unexpectedly found that the advantageous
gene set was also enriched for pathogen-associated genes (Table
S4, 69 genes, ,30% of gene set, p=0.004). We hypothesize that
the disruption of these particular genes during the Tn-seq selection
screen alleviated fitness costs associated with their maintenance
and/or expression within the zebrafish host. Future investigation
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that are incurred by the acquisition and retention of these loci by
pathogens as they traverse different host-associated environments.
Examination of Tn-seq candidates filtered by TEA. To
investigate the effectiveness of TEA to help identify previously
uncharacterized genes important for ExPEC fitness in vivo, we
selected 3 from the subset of 246 pathogen-associated Tn-seq-
derived in piscis genes for closer examination. EcF11_3082,
EcF11_2628 and EcF11_3933 were individually deleted from the
F11 chromosome and tested in competitive infection assays against
wild type F11 within the zebrafish PC and blood. These genes
were chosen based on their performance in the initial Tn-seq
selection screen and their association with known pathogens, as
determined by TEA. Trait identities for each gene are illustrated
in Figure 6 along with the results from competitive infection
assays.
The EcF11_3082 gene product is homologous to the transcrip-
tional repressor MprA/EmrR. In E. coli lab strains, MprA/EmrR
has been shown to negatively regulate biosynthesis of the microcin
B17 antibiotic and a multidrug efflux pump encoded by emrA and
emrB [42,43]. Fifty-six strains within the TEA-MD harbor an
EcF11_3082-like gene, 34 (61%) of which are pathogens
(Figure 6A, significance of pathogenic identity: p=0.034). Tn-
seq indicated that EcF11_3082 promotes the fitness of F11 in both
the PC and bloodstream in all three replicates. Average fitness
deficits observed through Tn-seq for EcF11_3082 insertion
mutants ranged from 5 to 21-fold. This was confirmed by one-
to-one competitive assays in which survival of the EcF11_3082
deletion mutant was markedly diminished relative to wild type F11
following inoculation of the PC and blood (Figure 6B).
Transposon insertions into the EcF11_2628 locus decreased the
fitness of F11 within the blood by an average of 15-fold, as assessed
by Tn-seq. The TEA-MD contains 7 homologues of EcF11_2628,
6 of which belong to ExPEC strains that were isolated from a
variety of host-associated niches (Figure 6C, significance of
Figure 4. Retrospective deletion of the candidate gene EcF11_3256/bipA confirms Tn-seq as a useful tool for the identification of loci
required for fitness and virulence. (A) Inserts found within the locus EcF11_3256/bipA are plotted with respect to their position of integration (x-
axis). Magnitude and direction of bars represent the change in fitness of F11 (y-axis) that correlated with a given insertion event. Color of bars
denotes pool of origin. Changes in fitness are presented as log2 of the ratio of occurrence frequencies observed between output and input pools
(output/input). (B) The average of insert-based fitness changes in (A) is plotted on the x-axis (shaded bar, bipA). For comparison, the average
alterations in occurrence frequency ratios for proximal genes are also plotted. (C) Equal numbers (1,000–2,000 CFU total) of wild type and F11D3256
were inoculated into the PC (left) or bloodstream (right) of zebrafish embryos. Fish were sacrificed and bacterial loads enumerated ,20 h post-
inoculation by differential plating (n= 9 to 10 zebrafish). Dashed line marks the limit of quantification; p values were determined using a paired t-test,
bars indicate medians. (D) The pericardial cavity (PC, top) and blood (bottom) of 48 hpf embryos were inoculated with approximately 3,000 CFU. Fish
were scored for death at 0, 12, 24, 36, 48, 60 and 72 h post-inoculation (hpi). Data are presented as Kaplan-Meier survival plots and p values were
calculated using a log-rank (Mantel-Cox) test (n.45 for each survival curve).
doi:10.1371/journal.pgen.1003716.g004
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pathogenic identity: p=0.035). EcF11_2628 encodes a hypothet-
ical protein that is predicted by PHYRE (Protein Homology/
analogY Recognition Engine) to function as a toxic extracellular
metalloendopeptidase [44]. A structurally similar toxin, AsaP1,
was recently described as a critical virulence factor encoded by the
natural fish pathogen Aeromonas salmonicida subsp. Achromogenes [45].
Deletion of this gene from F11 resulted in decreased fitness within
the PC and surprisingly, had no discernible effects in the
bloodstream during one-to-one competition assays with the wild
type strain (Figure 6D). These results run counter to those
obtained with Tn-seq, where disruption of EcF11_2628 reduced
the fitness of F11 within the blood. This discrepancy may be
attributable to the fact that Tn-seq is in effect a one-to-3,000
competitive assay among transposon insertion mutants within each
fish, whereas in our follow-up assays specific gene knockout
mutants are tested in one-to-one competition with wild type.
Within these different experiments, individual mutants may be
subject to very different pressures and frequency-dependent
selection events.
Tn-seq results indicated that disruption of a third pathogen-
associated gene, EcF11_3933, attenuates the fitness of F11 about
4-fold within the PC. Fifteen of the 18 EcF11_3933 homologues
(83%) found in the TEA-MD are encoded by known pathogens,
including multiple ExPEC strains, E. coli O157:H7, Neisseria
gonorrhoeae, Vibrio cholera, Haemophilus influenza, Photorhabdus lumines-
cens and Erwinia amylovora (Figure 6E, significance of pathogenic
identity: p=0.001). EcF11_3933 is uncharacterized and annotated
as a homologue of the broadly conserved DNA protecting protein
DprA. A related but distinct protein, DprA/Smf, has been
suggested to confer competence for the uptake of foreign DNA by
various bacterial species [46,47], though it is presumed to function
differently in lab strains of E. coli [48]. In competitive assays,
deletion of EcF11_3933 rendered F11 significantly less fit than the
wild type strain in both the PC and bloodstream of zebrafish
(Figure 6F).
Tn-seq and TEA-derived in piscis candidate genes
contribute to pathogen fitness within mouse models of
bacteremia and urinary tract infection
To extend our experimental and sequence-based observations
with the candidate genes EcF11_3256/bipA, EcF11_3082,
EcF11_2628 and EcF11_3933, we employed a more traditional
host organism for investigating ExPEC pathogenicity—the labo-
ratory mouse [49,50]. Evaluating Tn-seq and TEA-derived in piscis
candidate genes using a murine model provided an opportunity to
further establish the biological relevance of our multilayered
approach. Murine models of bacteremia are an established means
to assess the general capacity of ExPEC isolates to replicate and
cause disease within a host [50,51,52]. One-to-one mixtures of
wild type F11 and each mutant strain (108 total CFU) were
subcutaneously injected into adult female Swiss Webster mice.
Approximately 12 to 15 h later, bacterial titers within the spleen
and liver were determined (Figure 7). Mutants lacking
Figure 5. Diagrammatic workflow of ‘Trait Enrichment Analysis’ (TEA). This visualization depicts the TEA method and describes the
relationships between various data types. Bottom track: linear representation of steps followed in the execution of TEA. Protein alignments are made
between F11 proteins and the TEA-MD to identify homologues. Microbes within the TEA-MD are annotated with four separate traits contained within
the trait categories: habitat (1 of 3), niche (1 of 16), phylum (1 of 6) and phenotype (1 of 2). The composition of traits associated with homologue sets
for each F11 protein is assessed for enriched traits in order to assign trait identities. Trait groups, which are F11 genes that share a particular trait
identity, are used to organize Tn-seq-derived candidate genes. TEA-MD=TEA-metaproteome database; BLASTp= Basic Local Alignment Search Tool
used to align protein sequences.
doi:10.1371/journal.pgen.1003716.g005
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EcF11_3256/bipA (Figure 7A), EcF11_3082 (Figure 7B) and
EcF11_3933 (Figure 7D) were significantly outcompeted by the
wild type F11 parent strain. However, F11D3256 exhibited a more
modest defect in the spleen (p=0.0828). In contrast, there was no
observable competitive difference between wild type and
F11D2628 in either organ (Figure 7C).
Of note, we found that F11D3256 displayed a cold sensitivity
phenotype when grown at 20uC in broth culture, which is
consistent with reports on BipA function in other bacteria (Figure
S9A) [53]. Therefore, we were initially concerned that the growth
rate of this mutant at 28.5uC—the temperature used to raise
zebrafish embryos—was compromising our ability to distinguish
its temperature and host-dependent phenotypes. However,
F11D3256, like the other mutants, grew similar to the wild type
strain at both at 28.5uC and 37uC (Figure S9). We conclude that
the attenuated fitness phenotypes observed with F11D3256 in
competitive assays in both zebrafish and mice are independent of
temperature effects.
We next tested the fitness contributions made by each of the
four candidate genes above within the murine urinary tract, which
is another commonly used model system for understanding
ExPEC pathogenicity. Three days after inoculation of one-to-
one mixtures of wild type and mutant derivatives (107 total CFU)
into the urinary tract of adult female CBA/J mice, kidneys and
bladders were harvested and bacterial titers determined. Of the
four genes assayed, only EcF11_3933 was critical for the
competitive fitness of F11 within the bladder and kidneys
(Figure 7E).
Our ability to identify candidate genes necessary for ExPEC
fitness within mammalian host niches through initial prescreening
in embryonic zebrafish highlight the utility of this teleost host to
model overlapping aspects of ExPEC biology. By comparing the
specific host and niche-specific phenotypes of various ExPEC
isolates and mutant strains in futures investigations, we will be able
to gain a deeper understanding of the host-pathogen interactions
engaged by ExPEC.
Discussion
Application of Tn-seq to investigate the multigenic basis
of ExPEC pathogenicity
The genetic and phenotypic plasticity of ExPEC isolates, which
is in part due to horizontal transfer of pathoadpative accessory
genes, presumably enables these pathogens to traverse a wide
range of environmental and host-associated niches [7,8,10,11]. It
will be important to decipher how ExPEC employ their genetic
repertoires so that more specific and efficacious therapeutic
strategies can be developed. Moreover, knowledge of key events
that occur during the evolutionary assembly of pathogen genomes
will likely be gleaned as genotype-phenotype relationships are
mapped. To this end, we functionally dissected the contents of an
ExPEC reference genome using the recently described transposon-
based screening technique Tn-seq (Figure 1) [14,15]. With mutant
pools derived from the ExPEC reference isolate F11 and multi-
niche zebrafish infection models, we found that ,18% of the F11
genome significantly affected bacterial fitness under the patho-
genic conditions tested. These fitness determinants can be grouped
based on the niches where they were required, which in some
instances correlated with particular functions like iron transport
and amino acid metabolism (Figure 3). Gene set and gene-based
contributions to fitness can be explored through an online and
curated data viewer (http://pathogenomics.path.utah.edu/
F11_TnSeq/). Going forward, it is our intent that this work will
expedite future comparative and functional pathogenomic anal-
yses focused on elucidating the genetic basis of pathogen behavior
and evolution.
Seventy-six genes (1.4% of genome content) were found to
significantly influence the fitness of F11 in both the PC and blood
of zebrafish. We suggest that these multi-niche genes largely
provide core functions that are critical, but not necessarily specific,
to pathogen physiology. It was not surprising that several of these
genes were recognizable and annotated as being involved in the
regulation of gene expression and membrane architecture—two
functions that are important to pathogens and non-pathogens alike
(Table 1). In addition to the translational regulator EcF11_3256/
BipA, which we validated in follow up experiments using a
targeted deletion mutant and multiple in vivo host model systems
(Figure 4 and 7A), several other informational genes, including
hdeD, lrhA, rfaH and nhaR, were also identified by our Tn-seq
screens as being important to the fitness of F11 within multiple
niches. These genes have been shown to affect acid stress
resistance, toxin expression, adhesion to host tissues and virulence
gene regulation in a diverse array of pathogens, including
enterohemorrhagic E. coli (O157:H7), Xenorhabdus nematophila,
Proteus mirabilis and a sub-group of ExPEC isolates like F11 known
as uropathogenic E. coli (UPEC) (Table 1) [31,32,54,55,56].
Additionally, genes responsible for the production of capsule—
which is a well-established virulence feature that serves as a
protective polysaccharide barrier surrounding the bacterial cell
wall—were also important in both the PC and blood (Table 1)
[57]. Further identification and, importantly, functional charac-
terization of multi-niche genes will lead to a deeper understanding
of the general fitness and virulence gene networks employed by
ExPEC and other virulent bacteria within varying host environ-
ments.
Aside from multi-niche genes, we observed a striking numerical
imbalance of genes that are exclusively required for either blood-
borne or tissue-localized PC fitness (772 and 122 genes,
respectively). The large number of genes and variety of enriched
KEGG functional categories within the blood-specific gene set
corroborated previous experimental observations that indicated
the blood of embryonic zebrafish is a hostile environment and
highly restrictive to bacterial growth [10,11]. Specifically, genes
involved in nutrient acquisition and utilization made up a
significant portion of the blood-specific genes (Figure 3). These
results provide evidence that during systemic infections nutrients
are more limiting than during localized infection of the PC,
requiring ExPEC to employ a greater portion of their genetic
repertoire to maintain fitness in the blood. However, additional
factors could also account for the discrepancy between the PC and
blood-specific gene sets, including instances of trans-complemen-
tation. Once injected into the PC, bacteria remain confined until
Figure 6. Targeted deletion of candidate genes with pathogenic identity attenuates the fitness of F11 within zebrafish. The
composition of traits (bottom KEY) represented among bacteria encoding homologues of (A) EcF11_3082, (C) EcF11_2628, or (E) EcF11_3933 are
presented for the trait categories habitat of isolation, niche of isolation, phylum and phenotype. For reference, segmented outer rings bordering each
pie graph depict the composition of traits of all genes contained within the TEA-MD. Equal numbers (1,000–2,000 CFU total) of wild type and (B)
F11D3082, (D) F11D2628, or (F) F11D3933 were inoculated into the PC (left) or bloodstream (right) of embryos. Fish were sacrificed and bacterial
counts determined ,20 h post-inoculation by differential plating (n= 9 to 14 zebrafish). Dashed line marks the limit of quantification; p values were
determined using a paired t-test, bars indicate medians.
doi:10.1371/journal.pgen.1003716.g006
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Figure 7. Tn-seq and TEA-derived candidate genes promote the fitness of F11 within murine models of bacteremia and urinary
tract infection. Equal numbers (108 total CFU) of wild type F11 and (A) F11D3256, (B) F11D3082, (C) F11D2628, or (D) F11D3933, were
subcutaneously injected into the nape of the neck of adult female Swiss Webster mice. Approximately 12 to 15 h later, bacterial titers within the
spleen (left) and liver (right) were determined by differential plating. (E) Equal numbers (107 total CFU) of wild type F11 and F11D3933 were
transurethrally inoculated into the urinary tract of adult female CBA/J mice. Bacterial titers present in the bladder (left) and kidneys (right) were
determined 3 d post-inoculation by differential plating. Dashed line marks the limit of quantification. n=7 to 14 mice; p values were determined
using a paired t-test, bars indicate medians.
doi:10.1371/journal.pgen.1003716.g007
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the embryo succumbs to the infection [10]. Because bacteria stay
in close proximity to one another within the PC, the chances for
trans-complementation and the sharing of common goods are high
and may result in relaxed selection. A recent study demonstrated
that extensive trans-complementation can occur within mixed
mutant populations of Yersinia pestis in a mouse model of
pneumonic plague [58]. However, the authors noted that this
appears to be a unique characteristic of Y. pestis, as other pathogens
with tropism for lung tissue do not exhibit such a high degree of
wild type-to-mutant rescue. In our assays, trans-complementation
effects within the PC were apparently limited as we were able to
identify genes required for ExPEC survival within this niche.
Ultimately, this initial genome-wide analysis of the components
necessary for ExPEC fitness within pathogenic environments
garnered two key insights: (i) the number of genes that influence
fitness in multiple niches is relatively small and (ii) there are distinct
subsets of genes employed by ExPEC within different host
environments. This suggests that do-it-all genes do not necessarily
dictate the generalist and plastic nature of ExPEC. Instead,
ExPEC may evolutionarily maintain sets of context-specific genes
that can be employed, possibly in different combinations, to
respond in a highly specific-manner to a variety of conditions. This
characteristic likely contributes to the seemingly redundant
composition and versatility of contemporary ExPEC genomes.
Further functional dissection of ExPEC genomes by Tn-seq-based
approaches will help clarify which genes underlie the salient traits
of this lineage and inform the design of broad-spectrum therapies
that target only ExPEC while leaving beneficial or benign E. coli
strains within the normal microbiota unperturbed.
Refinement of candidate gene sets by TEA
A longstanding challenge associated with unbiased, high-
throughput functional genomics techniques like Tn-seq has been
the need to develop methods that provide an effective transition to
focused follow-up studies. Much work has been done to
quantitatively filter datasets using sophisticated determinations of
statistical significance and false discovery control procedures.
Analysis of the molecular pathways represented within functional
genomics gene sets has also been addressed extensively. However,
less attention has been given to systematic methods that exploit the
qualitative features of individual genes and how such consider-
ations can streamline candidate gene vetting. To address this issue,
we developed a Trait Enrichment Analysis (TEA) tool to organize
Tn-seq-derived candidate genes in a biologically meaningful way
(Figure 5). With a manually curated set of 165 microbial
proteomes, TEA is able to assign meta-features to F11 genes
based on their association with specific bacterial traits (i.e. habitat,
niche of isolation, phylum and phenotype). In this way, TEA
provides a tractable method to categorize Tn-seq candidate genes
into a more focused subset—something not easily accomplished
using larger microbial sequence databases like GenBank and
BioCyc or functional annotation platforms such as DAVID. TEA
uncovered several genes with previously unappreciated roles in
ExPEC pathogenicity, thus creating new opportunities to further
understand the genetic underpinnings of this lineage.
For the purposes of our investigation, we used TEA to identify
F11 genes with homologues that are more often associated with
the genomes of known pathogens. We describe such genes as
having ‘pathogenic identity’ and reason that, because of their
affiliation with pathogens, they are more likely to contribute to
pathogenic behavior—a principal tenet of molecular Koch’s
postulates [39,40]. In considering the overlap between Tn-seq-
derived in piscis genes and the TEA-derived gene set made up of
F11 genes with pathogenic identity, we were able to identify 246
genes that potentially influence the in vivo fitness capacity of F11
specifically. We selected three of these pathogen-associated
candidate genes for closer inspection.
The candidate gene EcF11_3082 was identified by Tn-seq and
confirmed during one-to-one co-challenge experiments to be
important for the fitness of F11 within the blood and PC of
zebrafish and spleen and liver of mice (Figure 6B and 7B). This gene
appears to be relatively widespread within the TEA-MD, being
found in 56 genomes, 61% of which are classified as pathogens. The
range of bacteria encoding homologues of EcF11_3082 includes
isolates from 12 (out of 16) different niches and 3 (out of 6) phyla
represented in the TEA-MD (Figure 6A). These observations
suggest that EcF11_3082 may play a broad role in bacterial fitness
within a variety of pathogenic and non-pathogenic contexts.
EcF11_3082 is predicted to encode an MprA/EmrR-like transcrip-
tional repressor, which was shown to regulate the expression of a
downstream multidrug efflux pump encoded by emrA and emrB.
Although our Tn-seq selection screen and co-challenge experiments
identified EcF11_3082 as a fitness determinant, disruption of the
emrA and emrB genes present in F11 did not appreciably affect fitness
within the zebrafish host, as determined by Tn-seq. This suggests
that either disruption of EcF11_3082 led to aberrant and deleterious
expression of emrAB that resulted in attenuation of the EcF11_3082
mutant, or the particular MprA/EmrR allele harbored by F11
influences other aspects of bacterial physiology not yet defined.
Further investigation is required to determine the exact influence of
EcF11_3082 on pathogenicity.
EcF11_2628, which encodes a ‘conserved hypothetical protein’
that has some homology to a secreted metalloendopeptidase toxin,
was also identified by Tn-seq and confirmed as an important
fitness determinant using a targeted knockout strain (Figure 6D).
However, we were unable to ascertain if this gene is required
during colonization of a mammalian host. The F11D2628 mutant
variant did not exhibit any statistically significant decline in
competitive fitness during systemic or urinary tract infection of
mice (Figure 7C and data not shown). Further investigation is
required to determine the physiological context in which this
putative toxin promotes ExPEC fitness. Nonetheless, homologues
of EcF11_2628 were found in only 7 proteobacterial genomes
within the TEA-MD (Figure 6C and D). Of these, 5 are ExPEC
strains that were isolated from human patients with either
meningitis (strain S88) or UTI (strains CFT073, UTI89, 536
and UMN026). Another ExPEC strain (APEC01) harboring an
EcF11_2628 homologue came from a case of avian sepsis that
occurred subsequent to respiratory tract infection. The sole non-
pathogen that carried an EcF11_2628 homologue was ED1a, a
commensal isolate from the human gut that is classified as
belonging to the B2 phylogenetic group—the E. coli lineage that
encompasses the vast majority of human ExPEC strains [7]. This
observation is intriguing because the EcF11_2628 allele carried by
ED1a could represent either a genetic vestige from a pathogenic
past or a new acquisition that is edging ED1a down an
evolutionary path towards a more ExPEC-like countenance.
Elucidating the function of this hypothetical gene should help
explain its seemingly restricted distribution within a phylogenet-
ically narrow range of bacteria.
The final pathogen-associated gene that we examined,
EcF11_3933, encodes a variant of the DNA protection protein
DprA [46,47]. However, this particular dprA allele is distinct from
those previously characterized in other bacteria. Within the TEA-
MD, 83% of the EcF11_3933 homologues were found in the
genomes of known pathogens. Interestingly, pathogens harboring
an EcF11_3933-like gene included ExPEC isolates as well as other
members of Proteobacteria and species within the phyla Bacter-
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oidetes and Firmicutes (Figure 6E). In our Tn-seq selection
screens, EcF11_3933 was initially identified because it appeared to
affect fitness within the PC, but subsequent analyses revealed that
EcF11_3933 could also promote pathogen fitness within the
bloodstream of both zebrafish and mice (Figure 6F and 7D).
Indeed, there were indications that EcF11_3933 contributed to
blood-borne fitness, but it was filtered out of the final Tn-seq-
derived blood gene set because it did not meet all of the
predetermined cutoffs, though only by a thin margin. These results
identify limits to Tn-seq as it is applied here, but also highlight the
value of using multiple infection models to discover and assess the
roles of fitness and virulence determinants.
Additional work using a murine UTI infection model demon-
strated that EcF11_3933 is also important for competitive fitness
within the murine bladder and kidneys (Figure 7E). This is in
contrast to EcF11_3256, EcF11_3082 and EcF11_2628, which we
found to be dispensable for colonization of the urinary tract (data
not shown). Interestingly, alleles of c4222, which is a homologue of
EcF11_3933 harbored by the UPEC strain CFT073, were shown
by microarray to be transcriptionally induced within a panel of
UPEC isolates during active infection of the human urinary tract
[59]. Together, previous observations and those presented here
indicate that EcF11_3933 is of broad importance to the pathogenic
potential of F11 and other ExPEC isolates within a variety host-
associated niches. Moreover, the distribution of EcF11_3933-like
genes among a diverse array of pathogens (e.g. ExPEC, the enteric
pathogen E. coli O157:H7, Neisseria gonorrhoeae, Vibrio cholera,
Haemophilus influenza, Photorhabdus luminescens and Erwinia amylovora),
which can colonize and cause disease within a broad range of
animal, insect and plant hosts, suggests that EcF11_3933 also
represents a multi-lineage virulence determinant. Further analysis
of EcF11_3933 and its pathogen-associated homologues may
prove useful in defining common virulence strategies employed by
ExPEC as well as other more distantly related bacterial species.
Concluding remarks
Cumulatively, this investigation demonstrates that the application
of Tn-seq, coupled with TEA, provides an efficient means to identify
novel or previously unappreciated fitness and virulence determi-
nants. The utility of TEA could easily be enhanced through
expansion of the TEA-MD by, for example, the addition of metadata
obtained from other host-microbe experimental systems. TEA serves
as an accelerated annotation layer for bridging high-throughput
sequencing experiments and functional characterization. In moving
forward, it will be important to continue the careful curation of
pertinent biological information associated with the rapidly expand-
ing and often redundant and ill-defined collections of microbial
genomics data so that meaningful connections can be mined.
Ultimately, the use of Tn-seq and TEA with an expanded number of
bacterial isolates and host systems may provide a detailed map of the
gene families and signaling cascades employed by ExPEC and other
pathogens to colonize host-associated environments.
Methods
Ethics statement
Animals used in this study were handled in accordance with
University of Utah approved IACUC protocols that followed the
standard guidelines described at www.zfin.org and in the Guide
for the Care and Use of Laboratory Animals, 8th Edition.
Bacterial strains and plasmids
All bacterial strains and plasmids used in this study are listed in
Table S5. Unless specified otherwise, bacteria were cultured
statically at 37uC for 24 h in 20 ml of a defined M9 minimal
medium (6 g/L Na2HPO4, 3 g/L KH2PO4, 1 g/L NH4Cl, 0.5 g/
L NaCl, 1 mM MgSO4, 0.1 mM CaCl2, 0.1% glucose, 0.0025%
nicotinic acid, 0.2% casein amino acids and 16.5 mg/ml thiamine
in H2O) prior to injection into zebrafish embryos or mice.
Antibiotics (kanamycin or ampicillin) were added to the growth
medium when necessary to maintain recombinant plasmids or
select for mutants.
Targeted gene knockouts of Tn-seq-derived candidate genes
were generated in ExPEC strain F11 using the lambda Red-
mediated linear transformation system [60,61]. Briefly, a kana-
mycin resistance gene was amplified using polymerase chain
reaction (PCR) from the pKD4 plasmid with 40-base pair
overhangs specific to the 59 and 39 ends of each targeted locus.
PCR products were introduced via electroporation into F11
carrying pKM208, which encodes an IPTG (isopropyl-b-D-
thiogalactopyranoside)-inducible lambda red recombinase.
Knockouts were confirmed by PCR. Primer sets used are listed
in Table S6.
Retrofitting of the previously constructed pSAM_Bt vector to be
used for the transposon mutagenesis of ExPEC isolate F11 was
accomplished using source vectors and primers as listed in Tables
S5 and S6, respectively. The Plac promoter from pGFP-Mut3.1
(Clonetech), along with its associated ribosome binding sequence,
was amplified via PCR. Engineered 59 BamHI and 39 NdeI
restriction sites were used to sub-clone the resulting fragment into
a BamHI/NdeI (New England Biolabs) double digested pSAM_Bt
vector upstream of the himar1C9 transposase gene. The kanamycin
resistance gene from pKD4 was amplified and ligated using the
restriction sites MfeI and XbaI, replacing the erythromycin
resistance gene ermG in pSAM_Bt. The resulting transposon
mutagenesis vector, pSAM-Ec, was stored and propagated in the
pir+ E. coli strain EcS17.
Zebrafish embryos
*AB wild-type zebrafish embryos were collected from a
laboratory-breeding colony that was maintained on a 14 h/10 h
light/dark cycle. Embryos were grown at 28.5uC in E3 medium
(5 mM NaCl, 0.17 mM KCl, 0.4 mM CaCl2, 0.16 mM MgSO4)
containing 0.000016% methylene blue as an anti-fungal agent.
Infection of zebrafish
One ml from a 24-h bacterial culture of each transposon mutant
library or isogenic bacterial strain was pelleted, washed once with
1 ml sterile PBS (Hyclone) and re-suspended in approximately
1 ml PBS to obtain appropriate bacterial densities for microinjec-
tion. Prior to injection, 48 h post-fertilization (hpf) embryos were
manually dechorionated, briefly anesthetized using 0.77 mM ethyl
3-aminobenzoate methanesulfonate salt (tricaine) (Sigma-Aldrich)
and embedded in 0.8% low-melt agarose (MO BIO Laboratories)
without tricaine. Approximately 1 nl of bacteria was injected
directly into the pericardial cavity (PC) or the blood via the
circulation valley (CV) located ventral to the yolk sac using a
YOU-1 micromanipulator (Narishige), a Narishige IM-200
microinjector and a JUN-AIR model 3-compressor setup. For
each experiment, average colony forming units (CFU) introduced
per injection were determined by adding 10 nl of the inoculum
into 1 ml 0.7% NaCl that was then serially diluted and plated on
Luria-Bertani (LB) agar plates. For co-challenge experiments,
input doses were plated on LB agar +/2 kanamycin (50 mg/mL)
to determine relative numbers of the wild type and mutant strains
present. After injection, embryos were carefully extracted from
agar and placed in either a 10 cm petri dish containing E3
medium for transposon screening or, individually into wells of a
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96-well microtiter plate (Nunc) containing E3 medium for co-
challenge experiments. The E3 medium used during this
incubation period lacked both tricaine and methylene blue.
To harvest DNA from embryos infected with transposon
mutant libraries at the end of the selection period, all infected
fish were collected (both alive and dead) in a 1.6 ml tube, being
careful to remove as much E3 medium as possible by gently
pulsing the tube in a microfuge to facilitate separation. Embryos
were suspended in 500 ml of 0.5% Triton X-100 in PBS and
homogenized using a mechanical PRO 250 homogenizer (PRO
Scientific). Homogenates were then centrifuged at 18,000 g for
5 minutes to sediment bacteria away from host cellular compo-
nents released during Triton X-100-mediated lysis. The resulting
pellet, which appears black because of remaining zebrafish debris,
served as the starting material for DNA extraction using the
Wizard Genomic DNA Purification Kit (Promega) as per the
manufacturer’s protocol with a brief modification: the duration of
the initial lysis step was extended as needed to dissolve the tough
pellet.
To quantify bacterial numbers at the completion of co-challenge
experiments, embryos were homogenized at the indicated time
points in 500 mL PBS containing 0.5% Triton X-100 using a
mechanical PRO 250 homogenizer. Homogenates were then
serially diluted and plated on LB agar +/2 kanamycin (50 mg/
mL) to determine relative numbers of wild type and mutant
bacteria. For co-challenge assays, only embryos where the total
bacterial CFU recovered was equal to or greater than the limit of
quantification (i.e. at least 20 CFU counted on the lowest serial
dilution, which corresponds to 100 CFU per embryo) are
reported. For lethality assays, fish were inspected for death at
the indicated time points over a 72 h period. Death is defined here
as the complete absence of heart rhythm and blood flow. Survival
graphs depict total pooled results from at least 3 independent
experiments in which groups of approximately 15 to 20 embryos
were injected at a time.
Mouse infections
For bacteremic co-challenge experiments, seven to eight-week
old female Swiss Webster mice (Charles River) were anesthetized
using isoflurane inhalation and injected subcutaneously via the
nape of the neck with 200 ml of a 1:1 wild type to mutant bacterial
suspension containing a total of 108 bacteria in sterile PBS. Spleens
and livers recovered 12 to 15 h later were weighed and
homogenized in 500 ml sterile PBS. Homogenization was done
with a Bullet Blender Storm 24 (Next Advance) using three SSB32
3.2 mm stainless steel beads for 5 minutes on power level 6.
Homogenates were serially diluted and plated on LB agar +/2
kanamycin (50 mg/mL) to determine the number of both wild type
and mutant bacteria. Bacteremic co-challenge experiments were
repeated at least twice. For these assays, only organs where the
total bacterial CFU recovered was equal to or greater than the
limit of quantification (i.e. at least 20 CFU counted on the lowest
serial dilution, which corresponds to approximately 200 to
600 CFU per g organ) are reported.
For co-challenge experiments within the murine urinary tract
infection, seven- to nine-week old female CBA/J mice (Jackson
Labs) mice were anesthetized using isoflurane inhalation and
inoculated via transurethral catheterization with 50 ml of a 1:1
wild type to mutant bacterial suspension containing a total of 107
bacteria suspended in PBS. Bladders and kidneys were recovered 3
days later and each was weighed and homogenized in 1 ml
containing 0.025% Triton X-100. Homogenates were serially
diluted and plated on LB agar +/2 kanamycin (50 mg/mL) to
determine number of both wild type and mutant bacteria.
Statistical analysis of zebrafish and mouse infections
For co-challenge experiments, numbers of wild type and mutant
bacteria present in the inoculum and recovered from host tissues
were enumerated by differential plating on selective media as
described above. To determine if bacterial counts differed between
wild type and mutant-infected animals, a paired t-test was
performed on log10-transformed values. Graphs and statistics were
generated using GraphPad Prism 5.
Transposon library generation
Transposon mutagenesis. A detailed protocol for the
transposon mutagenesis of ExPEC strain F11 using the E. coli
donor strain EcS17 carrying pSAM-Ec and the methods to verify
and sequence mutant libraries is provided in Protocol S1. Briefly,
EcS17/pSAM-Ec and F11 were mixed 2:1 (donor:recipient),
deposited onto nitrocellulose 0.45 mm filter discs (Millipore) and
incubated for 5 h on agar plates at 37uC. Because the Plac
promoter allows for constitutive low-level expression of the
himar1C9 transposase, no induction was required. Bacteria from
individual mating discs were recovered in 2 ml of 16M9 salts by
vortexing. A 100 ml aliquot was serially diluted and plated on
selective agar plates to determine mutagenesis frequency. The
remaining 1.9 ml of mating mixture was added to 20 ml of
selective media and allowed to grow shaking at 37uC until an
optical density at 600 nm (OD600) of ,0.5 was reached. One ml
aliquots from individual matings were then store at 280uC until
used in selection screening. In the event a mutant library did not
contain a satisfactory number of mutants, for example, ,50,000
mutants, frozen axillary stocks were briefly thawed, combined and
refrozen.
Bioinformatic analysis
Sequence alignment. Sequence reads were trimmed to
remove transposon sequence and the remaining 12 bp sequences
were aligned to the F11 genome consisting of 119 contigs
(GenBank: AAJU00000000). The alignment was preformed with
Bowtie [62], allowing no mismatches to the trimmed 12-mers. The
number of times each 12-mer was observed (abundance) and the
insertion position were tracked in a relational database. Because
our strategy for determining candidate regions relied on the
Wilcoxon signed-rank test, which is relatively resistant to spurious
observations, there was no limit to how many times a given 12-mer
was allowed to align to the genome.
Candidate identification. To distinguish loci within the F11
genome that were hypo or hyper-tolerant to transposon insertion,
the average number of inserts observed within each annotated
region, considering input pools 1, 2 and 3 alone, was calculated. A
Z-test was performed on the population of 5,312 loci—those that
fell below a standard score of 21 were considered hypo-tolerant
and those that were above a standard score of +1 were considered
hyper-tolerant. Standard scores were used here as an intuitive
demarcation within the distribution of insertion tolerances and are
not necessarily used to indicate any particular statistical signifi-
cance. Of note, because we allowed reads to be aligned to the
genome multiple times, we acknowledge that the specific values
calculated for insertion tolerances for each annotated F11 region is
overestimated. Indeed, we found that on average, reads could be
aligned approximately twice to the F11 chromosome (distribution
median = 2). This accounts for the elevated insertion rates
reported in Figure 2 and Table S2, which are approximately
two times greater than the inferred genome-wide insertion rate of
1 in 75 bp that is reported in the results section. Although this
approach added a source of noise, it also allowed us to quantify
and rank regions that would have otherwise been assigned a ‘0’
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(i.e. putative essential genes). The design of future Tn-seq
experiments should evaluate the pros and cons of such an
approach.
To calculate changes in fitness in vivo due to transposon insertion,
occurrence frequencies for insertion variants were first determined
by normalizing insert abundance. The normalized occurrence rate
of each insertion was obtained by dividing the number of times an
insert was observed by the sum of insert counts for the insert
positions that were detected in both the input and output pools of
the replicate screen in question. Next, a Wilcoxon signed-rank test
was performed on each F11 locus to compare the distribution of
occurrence frequencies of inserts found within both input and
respective output pools. Because this basic approach did not
immediately account for inserts that were absent from output pools,
which possibly indicates a strong negative selection event, we
assigned the limit of detection (1/sequencing depth) to lost inserts
that were present within a cognate input pool and within the top 1%
of occurrence frequencies of all inserts that were lost. By
incorporating these lost inserts prior to performing the Wilcoxon
signed-rank test, we could more confidently account for inserts that
likely represented a true negative selection signal while not
considering inserts that were absent due to sampling error or
passive loss. Regions having significantly altered frequency distri-
butions (p,0.05) and at least 10 measured inserts were assigned to
the in piscis gene set if the average occurrence frequency of inserts
within the output samples was reduced by at least 2-fold, or assigned
to the advantageous gene set if the average occurrence frequency of
inserts within the output samples was greater than that of the input
by at least 2-fold. Using these orthogonal vetting parameters we
calculated that the false discovery rate (FDR), as defined by
Benjamini and Hochberg, 1995, for the collection of observations
with a maximal p value of 0.05 to be 0.096 and 0.094 for the in piscis
and advantageous gene sets, respectively [63]. Figure S5 provides a
diagrammatic summary of the bioinformatic pipeline used above to
determine Tn-seq candidate genes and gene sets. Table S7, along
with an online data viewer (http://pathogenomics.path.utah.edu/
F11_TnSeq/), can be used to anonymously access and browse final
metric-based data that were generated using these methods. Data
analyses were done using custom software written in Python and the
open source math tool SciPy.
KEGG-based functional analysis of gene sets. Kyoto
Encyclopedia of Genes and Genomes (KEGG) orthologies (KO)
were assigned to genes within the F11 genome using the KEGG
automatic annotation server (KAAS) [64,65,66]. Genes without
KO assignments were considered to have a ‘hypothetical’ function
and genes encoding RNAs (e.g. tRNAs, non-coding RNAs and
ribosomal RNAs) were manually assembled into a custom ‘RNA’
orthology. To test for enrichment of a particular KEGG functional
category within a gene set, Monte Carlo simulations were
performed by sampling an equivalent number of genes from the
F11 genome at random 10,000 times without replacement. The
functional composition of observed gene sets was then compared
to theoretical sample sets using a Z-test. If a particular functional
category was significantly overrepresented compared to chance
(p,0.05) it was considered enriched. Data analyses were done
using custom software written in Python and the open source math
tool SciPy.
Trait enrichment analysis (TEA). 165 bacterial proteomes
were downloaded from the National Center for Biotechnology
Information’s (NCBI) microbial genome sequence collection and
assembled into the TEA metaproteome database (TEA-MD)
(Table S3). Each strain included in the TEA-MD was annotated
for habitat, niche of isolation, phylum and phenotype. Annotations
were retrieved manually by referring to original sequencing project
resources. Homologues within the TEA-MD were identified for
each protein-coding gene within the F11 genome using the Basic
Local Alignment Search Tool BLASTp [41]. Homologue
assignment was conferred if bi-directional alignments produced
an E value,1026 with similarity over 50% of query length. The
resulting set of TEA-MD microbes harboring homologues of
specific F11 proteins were then used to determine particular trait
associations. For each F11 protein, 1,000 Monte Carlo simulations
were performed by sampling an equivalent number of bacterial
genomes from the TEA-MD without replacement. Genes that
were found to have significant trait enrichments (p,0.05) were also
required to have at least 5 TEA-MD homologues, 60% of which
belonged to pathogen genomes, to be further considered and
placed into trait groups. TEA was performed in parallel and
independent of Tn-seq. Cross-referencing of several well-known
bacterial virulence factors, in addition to broadly conserved genes
involved in basic bacterial physiology, confirmed that our TEA
approach could reliably distinguish pathogenic identity between
these two gene classes (Table S8). Data analyses were done using
custom software written in Python and the open source math tool
SciPy.
Supporting Information
Figure S1 Plasmids used in this study. A) pSAM_Bt was
originally constructed to express the himar1C9 transposase (light
green open reading frame) within Bacteroides thetaiotaomicron,
facilitating insertion of the ermG erythromycin resistance gene
(blue open reading frame) into the chromosome this bacterium. (B)
pSAM_Bt was retrofitted using the indicated restriction sites with a
kanamycin resistance gene (purple open reading frame) and a Plac
promoter to drive expression of the himar1C9 transposase within E.
coli. This plasmid, pSAM-Ec, was then transferred into E. coli
strain F11 via conjugation. Other pSAM-Ec features include: two
transcriptional terminators downstream of the kanamycin resis-
tance gene (red stop signs), P7 priming sites for Illumina
sequencing (dark green blocks), MmeI-modified restriction sites
(red blocks) flanking the transposon (grey), a b-lactamase gene for
donor selection (red open reading frame) and an RP4 oriT/
oriR6K origin of replication (orange block) for specific propaga-
tion in pir-positive donor strains.
(PDF)
Figure S2 Assessment of transposon mutant pool diversity and
saturation. (A) E. coli F11 transposon mutants were randomly
isolated and subjected to Southern blot analysis. Genomic DNA
was isolated, digested with the restriction enzyme HindIII,
resolved by gel electrophoresis and probed with a digoxigenin-
labeled probe specific for the kanamycin resistance gene within the
transposon. (B to D) Representative colorimetric microbiological
agar plates were used to estimate mutant occurrence frequency
within mutant pools. (B) E. coli F11 transposon mutants grown on
MacConkey agar to assay for the presence of mutants deficient for
lactose utilization (white colony within inset). (C) Agar plates
containing the dye Congo red were used to determine the
frequency of insertion variants that disrupted normal curli
production. Inset shows a white colony (not able to bind Congo
red due to the presumed absence of curli) surrounded by curli
producing mutant variants (red colonies). (D) Mutant colonies
grown on Kornberg agar and subsequently exposed to iodine
vapor to stain for the presence of glycogen. Normal colonies
exhibit a brown coloration, colonies lacking glycogen synthesis are
yellow-white (left inset) and colonies overloaded with glycogen are
dark brown or black (right inset).
(PDF)
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Figure S3 Diagram of a 48 h post-fertilization zebrafish embryo.
E. coli F11 transposon mutants were delivered into zebrafish
embryos via one of two injections sites. The pericardial cavity (PC)
simulates a localized infection—bacteria are restricted to the
indicated area (green). The circulation valley (CV) is used to
deliver bacteria systemically throughout the bloodstream (red).
(PDF)
Figure S4 Virulence of E. coli F11 within zebrafish embryos. (A)
Approximately 2,000 colony-forming units of E. coli F11 were
delivered into the pericardial cavity (PC, left) or the blood (right).
Survival of embryos was monitored over a three-day period (n=20
embryos for each curve). (B) At 21 h post-inoculation, infected
zebrafish were homogenized and bacterial titers determined. Each
square symbol represents an individual zebrafish and bars mark
median values (n = 10 embryos).
(PDF)
Figure S5 Description of pipeline used to define Tn-seq candidate
gene sets. Diagram describes each of the five steps in determining Tn-
seq-derived candidate genes and gene sets. (I) normalize insert read
counts, (II) identify strong negative selection events and median-
center output data, (III) performWilcoxon signed-rank test, (IV) initial
candidate list vetting and (V) final gene set construction and curation.
(EPS)
Figure S6 Relative contributions made by each replicate screen
to the in piscis gene set. For clarity, the in piscis gene set was divided
into the component genes sets (A) blood, (B) PC and (C and D)
multi-niche. The proportion of genes identified from only one
replicate screen (numbered 1, 2 and 3) is represented by dark
wedges, whereas colored wedges indicate genes that were
identified from two or more screens using Tn-seq (bottom key).
Fischer’s exact test was used to determine if there was significant
overlap between genes contributed by each replicate screen within
each gene set (p values indicated where significance was found).
(PDF)
Figure S7 Compositional features of the TEA metaproteome
database (TEA-MD). Pie graphs depict the proportion of protein
sequences contained within the TEA-MD that are contributed by
bacteria annotated with the indicated traits under the trait
categories (A) habitat of isolation, (B) niche of isolation, (C)
phylum and (D) phenotype. (E) Table detailing the total number of
bacterial genomes and respective aggregate of protein sequences
represented by specific traits within each trait category.
(PDF)
Figure S8 Comparison of phylum representation between NCBI
and the TEA-MD. The number of genome sequences currently
reported in the National Center for Biotechnology Information
(NCBI) database for Proteobacteria, Bacteroidetes, Firmicutes,
Actinobacteria, Chlamydiae and Cyanobacteria were aggregated
and the resulting proportion for each phylum plotted (blue bars).
In a similar manner, the proportion of genome sequences
represented by each of the indicated phyla within the TEA-MD
is plotted for comparison (gray bars).
(PDF)
Figure S9 In vitro growth kinetics of F11 mutants. (A) F11D3256,
(B) F11D3082, (C) F11D2628 and (D) F11D3933 were grown in
M9 minimal media shaking at the indicated temperatures. Optical
density (y-axis) of the cultures was recorded over time (x-axis).
Graphs are representative of at least three independent experi-
ments performed in quadruplicate.
(PDF)
Protocol S1 Description of techniques carried out during this
study.
(PDF)
Table S1 General sequence-based features of input and output
pools.
(PDF)
Table S2 Insertion events per 100 bp for annotated regions
within the F11 chromosome.
(XLSX)
Table S3 Listing of bacterial strains, accession numbers and
traits maintained within the TEA-metaproteome database.
(XLSX)
Table S4 Composition of TEA-defined pathogen-associated
genes within Tn-seq gene sets.
(PDF)
Table S5 Bacterial strains and plasmids.
(PDF)
Table S6 Primers used in this study.
(PDF)
Table S7 Raw calculated metrics used to rank fitness contribu-
tions for all annotated regions within F11 by Tn-seq.
(XLSX)
Table S8 TEA-assigned trait identities for known bacterial
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Figure A1. Plasmids used in this study. (A) pSAM_Bt was originally constructed to 
express the himar1C9 transposase (light green open reading frame) within Bacteroides 
thetaiotaomicron, facilitating insertion of the ermG erythromycin resistance gene (blue 
open reading frame) into the chromosome this bacterium. (B) pSAM_Bt was retrofitted 
using the indicated restriction sites with a kanamycin resistance gene (purple open 
reading frame) and a Plac promoter to drive expression of the himar1C9 transposase 
within E. coli. This plasmid, pSAM-Ec, was then transferred into E. coli strain F11 via 
conjugation. Other pSAM-Ec features include: two transcriptional terminators 
downstream of the kanamycin resistance gene (red stop signs), P7 priming sites for 
Illumina sequencing (dark green blocks), MmeI-modified restriction sites (red blocks) 
flanking the transposon (grey), a β-lactamase gene for donor selection (red open reading 
frame) and an RP4 oriT/oriR6K origin of replication (orange block) for specific 



































Figure A2. Assessment of transposon mutant pool diversity and saturation. 
(A) E. coli F11 transposon mutants were randomly isolated and subjected to Southern 
blot analysis. Genomic DNA was isolated, digested with the restriction enzyme HindIII, 
resolved by gel electrophoresis and probed with a digoxigenin-labeled probe specific for 
the kanamycin resistance gene within the transposon. (B to D) Representative 
colorimetric microbiological agar plates were used to estimate mutant occurrence 
frequency within mutant pools. (B) E. coli F11 transposon mutants grown on MacConkey 
agar to assay for the presence of mutants deficient for lactose utilization (white colony 
within inset). (C) Agar plates containing the dye Congo red were used to determine the 
frequency of insertion variants that disrupted normal curli production. Inset shows a 
white colony (not able to bind Congo red due to the presumed absence of curli) 
surrounded by curli producing mutant variants (red colonies). (D) Mutant colonies 
grown on Kornberg agar and subsequently exposed to iodine vapor to stain for the 
presence of glycogen. Normal colonies exhibit a brown coloration, colonies lacking 
glycogen synthesis are yellow-white (left inset) and colonies overloaded with glycogen 



















Figure A3. Diagram of a 48 h post-fertilization zebrafish embryo. E. coli F11 
transposon mutants were delivered into zebrafish embryos via one of two injections 
sites. The pericardial cavity (PC) simulates a localized infection—bacteria are restricted 
to the indicated area (green). The circulation valley (CV) is used to deliver bacteria 











Figure A4. Virulence of E. coli F11 within zebrafish embryos. (A) 
Approximately 2,000 colony-forming units of E. coli F11 were delivered into the 
pericardial cavity (PC, left) or the blood (right). Survival of embryos was monitored over 
a three-day period (n = 20 embryos for each curve). (B) At 21 h post-inoculation, infected 
zebrafish were homogenized and bacterial titers determined. Each square symbol 
represents an individual zebrafish and bars mark median values (n = 10 embryos). 
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Figure A5. Description of pipeline used to define Tn-seq candidate gene sets. 
Diagram describes each of the five steps in determining Tn-seq-derived candidate genes 
and gene sets. (I) normalize insert read counts, (II) identify strong negative selection 
events and median-center output data, (III) perform Wilcoxon signed-rank test, (IV) 
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protein alignments are made between 
the F11 proteome and the TEA-MD
F11 protein-coding genes are given
‘trait identities’ if their homologues are
found to be significanly associated 
with specific bacterial traits
‘trait groups’, e.g. all the F11 genes that have 
homologues commonly found in pathogen 
genomes, are cross-referenced with Tn-seq 







Figure A6. Relative contributions made by each replicate screen to the in 
piscis gene set. For clarity, the in piscis gene set was divided into the component genes 
sets (A) blood, (B) PC and (C and D) multi-niche. The proportion of genes identified 
from only one replicate screen (numbered 1, 2 and 3) is represented by dark wedges, 
whereas colored wedges indicate genes that were identified from two or more screens 
using Tn-seq (bottom key). Fischer's exact test was used to determine if there was 
significant overlap between genes contributed by each replicate screen within each gene 



































Figure A7. Compositional features of the TEA metaproteome database (TEA-
MD). Pie graphs depict the proportion of protein sequences contained within the TEA-
MD that are contributed by bacteria annotated with the indicated traits under the trait 
categories (A) habitat of isolation, (B) niche of isolation, (C) phylum and (D) phenotype. 
(E) Table detailing the total number of bacterial genomes and respective aggregate of 








Figure A8. Comparison of phylum representation between NCBI and the 
TEA-MD. The number of genome sequences currently reported in the National Center 
for Biotechnology Information (NCBI) database for Proteobacteria, Bacteroidetes, 
Firmicutes, Actinobacteria, Chlamydiae and Cyanobacteria were aggregated and the 
resulting proportion for each phylum plotted (blue bars). In a similar manner, the 
proportion of genome sequences represented by each of the indicated phyla within the 

















































Figure A9. In vitro growth kinetics of F11 mutants. (A) F11Δ3256, (B) F11Δ3082, 
(C) F11Δ2628 and (D) F11Δ3933 were grown in M9 minimal media shaking at the 
indicated temperatures. Optical density (y-axis) of the cultures was recorded over time 
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